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SUMMARY 
Twenty seven consecutive black male patients who were admitted as acute admissions 
to FEH were examined in this thesis. 
The fo)lowing demographic information characterized the sample group. 
a) Age. 
Bimodal distribution with peaks at 21-25 years and 31-35 years. Five patients were 
older than 35 years. 
b) Marital Status 
In the sample. 59.2% were single. 11.1 % married and 29.6% the marital status was 
unknown. 
c) Number of Children 
In the sample. 75% did not know how many children they had. Numbers ranged 
from no children (14.3%) to 2 children (7.1% of the sample). 
d) Employment Status 
In the sample 81 .1 % were unemployed 
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e) Level of Schooling 
In one third of cases, level of schooling was unknown. Most men did reach 
secondary level of education. 
The men were divided into 5 groups depending on: 
a) The written history which accompanied each patient 
b) History on presentation 
c) Physical examination 
d) Laboratory testing of blood and wine samples 
The sample was distributed as follows: 
Group Number of Patients 
THC+\LFf- 5 
THC-\ LFf + 9 
THC-\ LFf- 7 
THC+\LFf+ 2 
VDRL+ _4_ 
Total 27 
Tests used to examine for cognitive function: 
These tests had to be simple, practical and suitable for a population with no formal 
education and had been tested for reliability and validity in the literature. 
a) The perceptuo-motor pencil tapping test (page 153). This test was done on 
admission and a few day's later as follows: 
Ill 
Group Time Interval Between the Two Attempts 
(in days) 
THC+\LFT- X = 3, R = 2-4 
THC-\LFT+ X = 3.2, R = 2-4 
THC+\LFT+ X=2 
THC-\LFT- X= 3.7, R = 2-6 
. VDRL+ X=3 
b) The Coursi block tapping test using the WAIS digit sequence (page 154). 
This test was done on admission and a few days later as follows: 
Group Time Interval Between the Two Attempts 
On days) 
THC+\LFT- X = 3.6, R = 2-5 
THC-\ LFT+ X = 3.9 R = 2-5 
THC-\LFT- X = 3.4 R = 2-6 
THC+\LFT+ X = 3.5 R = 2-5 
VDRL+ X=4 R = 3-5 
c) Immediate and delayed recall of a group of common familiar objects based on the 
Satz et al (1976) and Dornbush (1973) model. 
This test was done on admission and a few days later as follows: 
lV 
Group Time Interval Between the Two Attempts 
(In days) 
THC+\LFT- X = 6.4, R = 2-8 
THC-\ LFT+ X=5 R = 3-7 
THC-\ LFT- X = 4.1 R = 3-6 
THC+\LFT+ X = 1.5 R = 0-3 
VDRL+ X = 4.3 R = 0-7 
d) Test for reproductive memory based on the Graham Kendall memory for design test 
(page 166). 
The test was done on admission and a few days later as follows: 
Group Time Interval Between the Two Attempts 
(In days) 
THC+\ LFT- X = 3.6 R = 2-5 
THC-\ LFT+ X = 3.9 R = 2-5 
THC-\LFT- X = 3.4 R = 2-6 
THC+\LFT+ X = 3.5 R =2-5 
VDRL+ X =4.5 R = 4-5 
The above tests were done on admission and a few days later to rule out any effects of 
intoxication. 
Retesting at a later interval (such as 6 weeks later as in the Swartz et al 1989 study) was not 
done as most patients were discharged from hospital as follows: 
V 
Group Average Length of Stay Range in Length of Stay 
in Hospital (in days) in Hospital (in days) 
THC+\LFT- 13 7-23 
THC-\LFT + 13 10-16 
THC-\LFT- 17 7-32 
THC+\LFT+ 14 12-30 
VDRL+ 14 -
The reason for the brief hospital stay was due to the pressure on beds. 
Follow up for re-testing in the community was not possible as the patients come from 
outlying rural areas. 
Aggression was a common presenting feature in the sample group. The concept of 
aggression could not be further explored because: 
a) There is no universal instrument to measure aggression 
b) All patients come from outlying rural areas and the initially reported 
aggression was no longer evident on admission to FEH due to the delays in 
transporting the patients from the site of initial presentation to FEH. 
1 
INTRODUCTION 
Cannabis sativa Linn., the plant from which cannabinoids are derived is thought to 
have originated from the Caspian Sea region and then spread with human migration. 
Cannabis has been used as a medicine from at least 2737 BC and was only removed 
from the USA pharmacopoeia in 1942. Its use as an anti-emetic following 
chemotherapy was advocated up until 1992. 
Cannabis remains one of the most widely abused drugs in the world . In the USA, an 
estimated 67,7 million Americans (33,4% of the population) have used cannabis at 
least once in their lifetime (Kaufman et al 1992). 
South Africa has a long history of cannabis use. Initially it was used in a highly 
structured, ritualized setting amongst the indigenous people. In the present time, the 
social restraints on cannabis use have largely disappeared and it has emerged as a 
drug of abuse. 
Cannabis use can present with a variety of syndromes which will be examined in the 
present thesis. Of particular significance is the role of cannabis in producing either 
short term and\or long term cognitive disturbances and the possible link between 
cannabis use and subsequent aggression. 
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Both of these factors will be examined in the present work. 
Similarly the use of alcohol has changed in the black population. McAllister (1986) 
recorded in his research work that the Xhosa people in the Eastern Cape had a very 
ritualized approach to the use of traditionally brewed beer and the consumption of 
alcohol was governed by a well understood, ordered and accepted set of rules. 
However, by the turn of the century, research workers in the E . Cape were reporting 
on the use of spirits ( especially brandy) and that consumption, freed from the social 
restraints governing the use of alcohol, had resulted in alcohol becoming a drug of 
abuse. 
Earlier evidence suggests that alcohol abuse amongst the Xhosa was established at the 
time of the frontier wars, as recorded by the artist W. Langschmidt in 1850 (see 
frontispiece) . 
The present sample represents 27 consecutive black male acute admissions to Fort 
England Hospital, a 400 bed mental institution in Grahamstown, E. Cape. This 
hospital drains a large area stretching from East London through to the Transkei . 
The 27 subjects examined in the present study were all subjected to a variety of 
psychoprojective tests on admission and a few days later. 
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Urine and blood tests as well as patient history and physical examination was used to 
consign the men to 5 groups, namely: 
I. THC+\LFT- (Use of cannabis alone detected) 
2. THC-\LFT+ (Use of alcohol alone detected) 
3. THC-\LFT- (Control group, no toxins detected) 
4. THC+\LFT+ (Use of both cannabis and alcohol detected) 
5. VDRL+ (Patients positive for neurosyphilis) 
In the final analysis of the results, the toxin abusing sub-groups were combined 
(referred to as group 7) and those patients with neurosyphilis were excluded. 
Two physical signs noted in the cannabis users were: 
a) Bum marks on the palms of the hands from use of a bottle top 
Cannabis pipe (fig. 11 ) . 
b) An area of hypopigmentation on the lower lip, presumed to represent 
the damage caused by the heat generated from burning cannabis. 
Both results and a conclusion are presented in this study. 
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The following abbreviations have been used in this study: 
1. THC Delta 9 Tetrahydro-cannabinol. 
2. EMIT Enzyme multiplied immunoassay technique. 
3. STM Short term memory. 
4. LTM Long term memory. 
5. BVRT Benton visual retention test. 
6. ALT Serum alanine aminotransferase. 
7. AST Serum asparate amintransferase. 
8. GGT Gamma glutamyl transpeptidase. 
9. ALP Alkaline phosphatase. 
10. FEH Fort England Hospital, Grahamstown, E . Cape. 
11. MFD Graham Kendall memory for design test. 
5 
Frontispiece: · Canteen scene during the frontier wars, 1850. 
Artist: W. Langschmidt 
Provence: W. Fehr collection, the Castle, Cape Town, 
S. Africa. · · 
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BOTANICAL HISTORY OF CANNABIS, ITS EARLY USE IN SOUTH 
AFRICA AND ITS EARLY MEDICAL USE 
The cannabis plant, Cannabis sativa Linn. (Fig. I) was classified by Linnaeus in 1753 
(Du Toit 1980). The latin name Cannabis is derived from the Assyrian word 
"Kunnapu" = away to produce smoke (Maykut 1985). 
La Marek classified the Indian plant as C indica but later research has shown it does 
not merit the status of a distinct species, but is rather a sub-species of C sativa. The 
two sub-species recognised and the wild and cultivated varieties are: 
C sativa spp. sativa (fibre type) 
wild var. spontanea 
cult var. sativa 
C. sativa spp. indica (drug type) 
wild var. Kafiristanica 
cult var. indica 
The division into 2 sub-species each with 2 varieties is supported by cannabinoid 
analysis of the plants which has indicated that at least 5 phenotypes exist (Gill et al 
1970. Vree et al 1971, Merkus 1971, Gill 1971, Small et al 1973, Small et al 1973). 
Small et al (1973) and Fairburn et al (1974) have demonstrated that plants with a high 
THC content have been grown in temperate climates and the view that tropical or sub-
tropical climates are required for high production of THC is erroneous. 
C sativa Linn. is thought to have originated in the semi-desert regions 'of South and 
East of the Caspian Sea and then spread to the Himalayas and then through out Asia. 
(Du Toit 1980, Johnson et al 1990). 
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EigJ The Cannabis plant, Cannabis sativa Linn. 
(from a herbaruim specimen, Albany Museum, Grahamstown, 
E.Cape, South Africa. 
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The spread of Cannabis sativa is associated wit the spread of human settlement. Early 
trading between India and Africa resulted in the spread of Cannabis to the African 
continent. Arab traders had moved into the interior of the African continent via the 
river systems at the start of the sixteenth century (Fagan 1965). At the same time there 
was migration of black people southwards and by the time of the white settlement in 
the Cape, cannabis was in common use among the indigenous populations (Du Toit 
1980, Mkhize 1989). 
The earliest treatise on Cannabis use in South Africa was by Dr Armstrong, district 
Surgeon, Craddock, E. Cape in 1855 (Du Toit 1980). He described the use of 
Cannabis amongst the local population and noted its intoxicating affect. He reported 
Cannabis was usually mixed with tobacco and smoked . 
The first full study of Cannabis use in South Africa was conducted between 1908 and 
1912 by C. Bourhill. His M.D thesis was entitled, "the smoking of dagga amongst the 
native races of Southern Africa and the resultant evils" . 
Seventy percent of Cannabis in South Africa is grown in a rectangle formed by latitudes 
and longitudes 28 ° and 30° which includes most of Swaziland and part of the 
Transkei . Most of the rest is grown in N. Natal and Zululand (Ben-Arie 1984). 
Newspaper reports of recent Cannabis use in the East Cape appear in appendix 1. 
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Medical Use of Cannabis 
The earliest known medical use of Cannabis was 2737 BC when it was listed in the 
Chineese pharmacopoeia of Emperor shen Nung (Talbott et al 1969, Du Toit 1980, 
Johnson et al 1990). 
In India, the stimulating and euphoric properties of Cannabis were recognized and 
recorded in the Atharua Veda (2000 - 1400 BC) (Du Toit 1980). 
In the seventeenth century, Cannabis was planted in the colonies of North America 
(Rubin 19_71). 
Its medicinal properties were recognised and over 100 medical reports were published 
in the nineteenth century recommending the use of Cannabis derivatives (Talbott et al 
1969). Cannabis was only removed from the USA Pharmacopoeia in 1942 (Du Toit 
1980). 
Therapeutic use of Cannabis has been reported in this century. Table 1 lists the 
reported therapeutic uses of Cannabis. 
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THERAPEUTIC USE AUTHOR(S) 
Anorexia Zinberg 1974 
Epileps}:' Carlini and Cunha 1981 
Rheumatism, asthma, Noys et al 1975 
pain Jain et al 1981 
Nausea induced by chemotherapy Reiman 1982 
Abood et al 1992 
Table 1: Modern therapeutic uses of Cannabis 
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BIOCHEMISTRY AND EXCRETION OF CANNABINOIDS 
1. BIOCHEMISTRY AND METABOLISM OF CANNABINOIDS 
Over 421 different compounds have been isolated from Cannabis (ARF\ WHO report 
1981, Maykut 1985). 
The Cannabinoids are carboxylic acids with 21 Carbon atoms. 61 natural cannabinoids 
unique to C. sativa have been identified (Megersee, Turner et al 1980, Maykut 1985, 
Mason et al 1985, Harvey et al 1990, Abood et al 1992). 
Wicl<ler (1970) classified the canabinoids as psychotomimetic drugs. Only THC is 
known to be psychoactive and is present in high amounts in the plant, usually 1 - 5 % 
by weight (Ellis et al 1985). All parts of the plant contain psychoactive cannabinoids 
with the highest concentration being in the flowering tops (Abood et al 1992, Talbott et 
al 1969). The cannabinoids form part of the plant's resin that is produced as a 
protective agent against the harmful effects of the sun (Talbott et al 1969). 
THC has a basic structure of 3 rings, terpenoid, pyran and aromatic (fig 2, Maykut 
1985). THC was first synthesized by Mechoulam et al (1965). 
Two other derivatives of THC are known to be: 
Psychoactive: 
1/ The isomer of Delta 9 THC = Delta 8 THC 
67 - 75 % as potent as delta 9 THC. It is a degradation product of THC and 
is not present in fresh cannabis. 
2/ The propyl homologue of THC, delta 9 tetrahydro-cannabivarin (delta 9 
THCV), 25 % as potent as THC. This is found in fresh cannabis but only in 
small amounts . (Gaonis et al 1964, Hively et al 1966, Gilman et al 1985). 
Another degradative product, Cannabinol (CBN) may be psychoactive. It is found in 
fresh Cannabis (Lindgren 1981). 
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8 OH 
69 Te1rohydroconnobinol (.69 THC) . 7 Go C~: 
c~O 
6 8 Te1rohydroconnobinol (.68 THC) 
CH3 
OH 
Connobinol (CBN) 
CH3 0 C5H11 
CH3 
OH 
Connobidiof (CBD) 
CH3 : ) 
C5H11 CH2 OH 
Fig. 2 THC Structure (after Maykut 1985). 
14 
Cannabidiol (CBD) is another major cannabinoid found in Cannabis but it is not 
psychoactive in humans (Lindgren 1981 , Ohlsson et al 1986, Harvey et al 1990). 
When cannabis is smoked, the natural 2 and 4 carboxylic acids of THC are 
decarboxylated to form THC. Other than de-carboxylation reactions, there seems to be 
little interconversion or isomerization of the cannabinoids during pyrolysis. The ARF\ 
WHO report ( 1981) noted that pyrolysis of Cannabis produces hundreds of 
compounds that make up the vapour and particulate phase of the smoke. The vapour 
contains nitrogen oxides, CO, HCN, Nitrosarnines and other toxic materials. The 
particulate phase contains carcinogens including phenols, cresols and polynuclear 
aromatic hydrocarbons . 
Estimates of total THC survival during pyrolysis range from 32 (Mikes et al 1971) to 
50 % (Gaoni et al 1966, WHO/ ARF report 1981 , Maykut 1985, Johnson et al 1990) to 
a maximum of 62% (Fehr 1972). 
Systematic bioavailability of THC administered by smoking has been reported to be 
18 ± 6 %. 
15 
Maykut (1985) and Abood et al (1992) have pointed out that the bioavailability of THC 
is also dependent on the smoking technique and the time the smoke is held in the lungs. 
THC is rapidly absorbed from the lungs (ARF/ WHO report 1981 ). 
Peak THC plasma concentration develops very quickly after smoking Cannabis and 
then falls to+ 10% of the peak concentration within the first hour (Johnson et al 1990, 
ARF/ WHO report 1981). After a single smoke of Cannabis, THC can be detected for 
up to 20 hours in the blood (Hunt et al 1980). 
Subjective effects of Cannabis reach their peak between 20 and 40 minutes after 
smoking and usually last 4 hours (Weil et al 1965, Abel 1975, ARF/ Who Report 1981, 
Cocchetto et al 1981 , Perez - Reyes et al 1981 , Hollister et al 1981, Perez - Reyes et al 
1982, Maykut 1985). 
The potency of a preparation delivered by smoking is up to three times that of an 
equivalent amount injested orally because of the more rapid absorption from the lungs, 
avoidance of first pass metabolism and the enhanced release of THC from the pyrolysis 
of the THC acid (Ishbell et al 1967). Oral injection leads to a slow absorption (about 3 
hours) but results in a longer duration of effect (Lemberger et al 1972). 
In blood, THC is almost (97%) completely bound to plasma proteins alpha and beta, 
lipoproteins and albumin (Paton 1975, Maykut 1985). THC is rapidly distributed from 
the central compartment to peripheral tissues with high lipid content. This includes the 
salivary glands, spleen, adrenals, brain, liver, kidney and reproductive organs (Maykut 
1985, Gill 1976, Margolis et al 1980, Deahl 1991 ). There is poor penetration of the 
blood brain barrier with less than 1 % THC entering the brain (Johnson et al 1990). 
Nahas et al ( 1981) have demonstrated that with chronic smoking of Cannabis, there is 
fat and liver accumulation of THC. Rolfe et al (1993) noted that Cannabinoids, being 
highly lipophilic; accumulate in body fat leading to a long THC half life in Chronic 
users . 
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THC is metabolized in the liver through a process of hydroxylations (fig . 3, Negrete 
1973, Mason et al 1985, Maykut 1985, Abood et al 1993). Fig .4 is a summary of this 
process. 
Ohlsson et al (1986) noted that THC is a high clearance drug with a very large volume 
of distribution and is eliminated slowly from the body. Mirin and Weiss (1983) noted 
that THC remains in fatty tissue for up to two to three weeks. 
Cridland et al (1983) assumed that excretion followed first order kinetics. They 
estimated THC half life to be three to four days (R = 1 - 10 days), However in chronic 
cannabis users, the metabolizing enzymes may be induced such that a shorted halflife is 
seen (Johnson et al 1990). 
Lindgren ( 1981) in his experiment with 9 heavy users of Cannabis (ie used cannabis 
more than once a day) and 9 light users of cannabis (ie. used cannabis less than once a 
month) found no statistical difference in the plasma levels of THC between the two 
groups. Perhaps the reason why he failed to demonstrate a shorter half life of THC in 
chronic users was because his experimental group was too small and the amount of 
THC used was insufficient to cause stimulation of the liver enzymes. 
Hansten (1979) proposed that the metabolizing enzymes are inhibited by the use of 
neuroleptics in the subjects and Negrete (1973) noted that in impaired liver function 
there may be stronger and longer lasting cannabis intoxications. This observation may 
be of direct importance in subjects who abuse both cannabis an alcohol simultaneously. 
Ishbell ( 1971) demonstrated that if cannabis is given in sufficient doses (200 - 250 
microgram\ kg), it invariably produces a psychotic state. However in those individuals 
who are simultaneously abusing alcohol in addition to cannabis, smaller concentrations 
of cannabis resulted in a psychoti~ state. 
Table 2 lists the time lapse between last use of Cannabis and consistent negative urine 
results. 
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V 
18 
hydroxylation 
11 hydroxy delta 9 THC 
Active metabolite 
Half life over 50 hours ((Johnson et al 1990) 
Excreted in the feces 
I 
V 
oxidation 
Series of Polar metabolites 
I 
V 
Carboxylic and Polyhydroxy acids 
Excreted in urine and feces (Wall et al 1985, 
Gilman et al 1985) 
Eig._A. Metabolism of THC in the liver through a series of hydroxylation 
reactions. 
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TIME LAPSE AUTHORS 
3 days Hollister et al 1980. 
Over 1 week Lemberger et al 1971 
14 - 36 days Dackis et al 1982 
Up to 30 days Hunt et al 1980 
Ng et al 1990 
Mathers et al 1992 
---
Several weeks Ellis et al 1985 
Table . 2 Time lapse between last exposure to cannabis and negative THC 
results. 
20 
2. POTENCY OF CANNABIS 
Cannabis potency is a factor of soil, climate, cultivation, and the harvesting, and curing 
process. Potency is also dependent on whether the mixture contains leaves, stalks, 
shoots or flowers (Abel 1977, Paris et al 1980, Johnson et al 1990). 
Rolfe et al (1993) recorded that there is a decrease in THC content when the Cannabis 
plant is grown in cool climates. This hypothesis was not supported by Small et al 
(1973) and Fairburn et al (1974). 
Weil et al (1968) noted that the potency of Cannabis can vary by a factor of 2000. 
The ARF I WHO report ( 1981) and Tennant et al ( 1972) commented on the high 
frequency of Cannabis induced psychosis observed in North Africa and India and it was 
felt that one possible explanation was cannabis from these areas had a high THC 
content. Talbott et al ( 1969) noted the potency of Cannabis in Vietnam was twice that 
available in USA but Deahl ( 1991) has now reported a new high potency seedless 
variety of Cannabis (sinsemilla) which is available in USA. 
Field (1980) noted the South African cannabis ranks among the more potent variants of 
the plant in terms of its THC content. He examined cannabis from the kokstad district 
of Transkei, the Pongola district of Natal and the Tzaneen district of the Transvaal. 
The Transkei cannabis had the highest THC content in South Africa. 
Solomons et al (1990) found the potency of South African cannabis to be 20 to 30 
times greater than the potency of the USA cannabis. 
Rottanburg et al ( 1982, 1983) recorded that the South African cannabis lacks 
cannabidiol and this may account for the psych-toxicity of South African cannabis in 
that cannabidiol may protect users in other countries from becoming psychotic 
following the use of cannabis. 
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3. URINARY EXCRETION OF THE METABOLICS OF CANNABIS 
The major psychoactive compound of cannabis is THC (Johansson 1989, Johansson et 
al 1990) and over 99 % of this is metabolized prior to excretion (Mason et al 1985). 
About 80 % of THC is eliminated in the feces an 20 % is eliminated in urine 
(Meggersee) . There are a large number of urinary metabolites and the major metabolite 
of THC is 11 - nor - delta - 9 - THC - carboxylic acid or a combination of : 
11 hydroxy delta 9 THC 
8, beta - hydroxyl, delta 9 THC 
8, beta - 11 - hydroxy - delta 9 THC 
(Ellis et al 1985, Johansson 19\989, Meggersee) . 
Urinary excretion patterns of cannabinoids vary greatly between subjects (Meggersee) 
an even differ for an individual at different times. 
Clearance rate of the metabolites is limited by a slow deep compartment return of 
sequestered THC. 
Excretion is also related to hydration of the subject, kidney function, and the subject's 
prior exposure to Cannabis (Mason et al 1985). 
Upon abrupt cessation of cannabis use, there is initially a rapid period of clearance 
followed by a period of relatively prolonged persistence and slowed clearance. 
Johansson et al (1990) gave 19 mg 14 C - THC to a sample of four people and 
collected urine for up to 120 hours. They found that the major part of the radio-active 
dose (54%) was excreted in the O - 8 hours fraction after smoking. 
LENGTH OF TIME THAT CANNABIS METABOLITES ARE DETECTABLE 
IN THE URINE 
The urinary excretory half life of cannabinoid metabolites is function of whether the 
subject is a naive or chronic user of cannabis. 
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In naive smokers, urinary metabolites are detectable for 4 to .10 days after the last use 
of cannabis (Johansson et al 1990, Mason et al 1985, Meggersee) . 
Johansson ( 1989) used 13 males who were heavy cannabis users and examined the 
urinary metabolites of THC after cannabis use. He discovered that the half life range 
was 0,8 to 9,8 days with the average being 3,0 + 2,3 days. 
Ellis et al (1985) also looked at urinary excretory patterns in chronic users of cannabis. 
They had a sample size of 86 people who had used cannabis on average for 8, 9 years. 
Cannabis was the only drug of abuse used in 60,5% of the sample and 55,8% of the 
sample used cannabis and one other drug of abuse. Ellis et al reported a biphasic 
excretory pattern, the first phase of which showed rapid excretion of THC metabolites 
and followed by a slower phase of excretion. They found it took up to 46 days to reach 
the first negative result. 60, 6% of the sample had THC positive urinary results 21 days 
after last cannabis use, 32,7% had positive results 30 days after last use, and 5 subjects 
who had used cannabis for over 12 years still had positive urinary results 50 days after 
last use. 
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In summary, chronic users of cannabis have positive results from day 9 up to day 50 
after last cannabis use. 
Table 3 summarises these findings . 
Tests used to detect the metabolites of Cannabis in urine. 
The most commonly used method to detect cannabinoids in urine is EMIT ( enzyme -
multiplied immunoassay techniques), a semi-quantative enzyme immunoassay kit with 
a 95% confidence limit for detecting the major metabolite of the THC, 11- nor - delta 9 
- carboxylic acid at concentrations greater than 50 micrograms\ ml (Rodgers et al 1978, 
O'Connor et al 1981 ) . EMIT also detects : 
11 hydroxy delta 9 THC 
8 beta hydroxy delta 9 THC 
8 beta - 1 1 - hydroxyl - delta 9 THC 
(Rottanburg et al 1982, Cridland et al 1983, Ellis et al 1985, Johansson et al 1990, 
Mathers et al 1991, Mathers et al 1992). 
A cut off point of 25 ng\ ml is used , ie results below this are regarded as negative. 
Table 4 is used to interpret the EMIT results. 
Figure 5 depicts in a graphical manner how EMIT operates. 
Necessary precautions to observe when performing the EMIT test 
(a) Time lapse between initial admission to hospital and the collection of urine. 
This time lapse should be as short as possible. Mathers et al ( 1991) obtained urine 
from patients within 72 hours of admission., and Onyango et al ( 1986) obtained 
urine within 48 hours of admission . 
24 
THC POSTIVE URINE RESULTS AUTHOR (SJ 
detected up to 
9, 8 days Johansson (1989) 
20 days Mason et al (1985) 
36 days Meggersee 
50 days Ellis et al (1985) 
Table • 3: Detection of THC Metabolites in the urine of chronic cannabis 
users after the cessation of cannabis use. 
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Amount of THC metabolites detected 
using standard calibration curve Interpretation 
~rom EMIT assay 
-- -
less than 20 - ng\ ml Negative 
20 - 50 ng\ ml Suggests person is using Cannabis 
50 -100 ng \ml ' Diagnostic that person is using cannabis 
Greater than 150 ng\ ml Associated with psychosis 
Table • 4 : Interpretation of EM IT results. 
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(b) Temperature at which urine sample is stored. It is recommended that samples are 
placed in a refrigerator on collection and should be stored at - 20° c if not analysed 
within 48 hours of collection. 
(c) Drugs which can interfere with the EMIT assay. 
Certain drugs and compounds can give false positive and false negative results. 
These are listed in tables 5 and 6. 
It is possible to have a false positive urinary THC result as a result of passive 
inhalation of cannabis smoke. Factors which need to be considered are : 
(a) .Amount of side stream smoke released. 
(b) Concentration of THC in the smoke. 
(c) Distance between the smoker and non-smoker. 
( d) Length of time person is exposed to smoke. 
(e) Type and size of enclosure. 
(f) Amount of ventilation during exposure. 
It is possible to record a concentration greater than 25 ng\ ml THC in the urine of 
passive smokers but any positive result quickly reverts to negative. 
False negative results are possible if the subjects consumes excessive water prior to 
giving a urine sample. The resultant urine is diluted and a result of less that 25 ng\ ml 
urinary THC may be recorded. 
False negative results have proven to be more of a problem than false positive results. 
One survey (Solomons et al 1990) recorded 2,9 % false positive results and 18 % false 
negative results, ie under-estimation of urinary cannabinoids is more likely than an 
over-estimation. 
Interpretation of the Urinary cannabinoid results. 
There is no reliable method for predicting the degree of impairment in the individual 
from the urinary cannabinoid concentrations (Mason et al 1985) although Table 4 gives 
an approximation in interpretation. 
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Compounds which could result in a false negative reading in 
~he EMIT assay for urinary THC metabolites. 
Vitamin C 
Bilirubin 
Creatinine 
Ethanol 
Glucose 
Protein 
Table. 5 Compounds which could result in a false negative result when 
when testing urine with the EMIT assay. (leass than 10% chance 
these compounds result in a false negative reading). 
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Amitriptyline Fluphenazine 
Amoxil Haloperidol 
Ampicillin lmipramine 
Antabuse ' Maprotyline 
Methyldopa 
Caffeine Orphenadrine 
Carbamazepine Oxazepam 
Chloramphenicol Perphenazine 
Clomipramine Phenytoin 
Codeine Trazadone 
Desipramine Trimipramine 
!)iazepam 
Table . 6 Drugs that can result in a false positive result in the EMIT assay for 
urinary THC metabolites. 
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Impairment is difficult to predict because of the highly variable excretory patterns of the 
urinary cannabinoids seen in individuals. Excretion is a function of hydration of the 
individual. In a dehydrated individual, high urinary cannabinoids may be detected but 
no cannabis induced psychological effects are present. Therefore high urinary THC 
concentrations may indicate recent cannabis intake but they cannot be used to indicate 
the presence of any effects of impairment. Ellis et al ( 1995) have pointed out that 
because of the large individual variability, a positive THC result may reflect use within 
the past few hours, days or weeks. 
Johnsson et al (1990) noted that in addition, urinary cannabinoid levels give no reliable 
clue as to the total amount of pharmacologically active cannabis in the body at that 
time. Blood or plasma are the only specimens that can be used to correlate 
experimentally determined THC concentrations, and resultant effects because they are 
the only easily obtainable specimens that can be analyzed to provide concentrations of 
cannabinoids that are potentially relatable to the concentrations of psychoactive 
cannabinoids at the active sites in the CNS. However the correlation between THC 
plasma concentration after smoking and subjective self reported ps:;:.chological effects is 
not strong (Mason et al 1985). 
Ellis et al (1985) found that body weight or height\ weight index were of no predictive 
value in determining cannabinoid excretion patterns. 
CONCLUSION 
The EMJT assay is the most commonly used technique to detect cannabinoid 
metabolites in the urine. Both false positive and false negative results are possible. 
Concentrations of cannabinoids metabolites recorded in the urine have no predictive 
value as to the individual's clinical presentation. A test result of over 25 ng\ ml 
indicates that the individual has recently used cannabis. 
THE THC RECEPTOR IN THE BRAIN 
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The strict structure - activity relationship for the cannabinoids was for many years the 
only evidence to support the existence of a cannabinoid receptor. The development of 
novel potent analogs has played a major role in the characterization and cloning of 
cannabinoid receptors (Howlett et al 1986, Matsuda et al 1990). One such analog 
CP55940 was developed by Melvin and Johnson (1986) . Howlett et al ( 1986) worked 
with cell membranes from : 
(a) Nl8 TG2 neuroblastoma cells 
(b) NG 108 - 15 neuroblastoma X glioma hybrid cells. 
They reported that the psychoactive cannabinoids inhibited adenyl-cyclase activity in 
these cells. These two cell lines are known to contain opioid receptors and muscarinic 
acetyl choline receptors but the effects of the cannabinoids are not inhibited when 
antagonists are used to block both the opioid and muscaranic acetyl choline receptors. 
Amino - alkyl-indole analogs are known to compete for the cannabinoid binding sites 
(Pacheco et al 1991). One particular amino alkyl indole WIN - 55212, has been shown 
to share a common site of action with the cannabinoids (Eisenstat et al 1990). 
Autoradiographic studies have demonstrated a heterogenous distribution of 
cannabinoid binding sites in the brain. Most sites were located in the hippocampus, 
cerebellum and basal ganglia. The role of the hippocampus in memory dysfunction will 
be discussed in this thesis. 
Less abundant sites were located in the cerebral cortex and corpus striatum 
(Kerkenham et al 1990, 199 1 ). 
Kaufman et al (1992) have postulated that there may be an endogenous substance in 
humans that resembles the cannabinoids. 
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THE ROLE OF CANNABIS IN PRODUCING STRUCTURAL AND 
FUNCTIONAL DAMAGE TO THE BRAIN 
Introduction : 
It is difficult to evaluate the precise role of Cannabis in producing structural and 
functional damage to the brain because of the large number of variables operating. For 
instance, cannabis may not be the only drug of abuse used by the individual. Alcohol is 
often used together with cannabis (Grant et al 1979). Also many factors in the 
individual's life style have to be considered such as nutritional status and exposure to 
head trauma as a result of falls, assaults, and overdoses with resultant anoxia (Wert et 
al 1986). 
Structural changes 
1. Macroscopic changes : 
CT brain scans in cannabis users have reported : 
(a) No atrophy (Fink 1976, Karacan et al 1976, Co et al 1977, Kuehnle et al 1977, 
ARF/WHO report 1981). 
(b) Possible atrophy (Kolansky et al 1972). 
(c) Atrophy (Campbell et al 1971). 
In the Campbell et al (1971) study, cerebral atrophy was demonstrated in 10 individuals 
who had smoked cannabis for 3 to 11 years. In addition, all 10 individuals were 
polysubstance abusers and 3 of the 10 had had a head injury. 
2. Microscopic and biochemical changes. 
Synaptic alterations in the septum, hippocampus and amygdala have been described . 
These include widened synaptic clefts, clumping of vesicles in the pre-synaptic nerve 
ending and disruption of the rough endoplasmic reticulum. (Health et al 1980, Maykut 
1985). 
Maykut (1985) also mentioned that Cannabis may cause damage to the septa! area and 
such individuals are prone to violence when smoking Cannabis. 
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Mc Issac et al ( 1971) and Drew et al ( 197 4) have demonstrated the preferential 
concentration of THC in the hippocampal region. 
Kourron et al ( 1978) found that when primates were exposed to moderate to heavy 
doses of cannabis, there were persistent (7 - 8 months post exposure) EEG changes in 
the septa! area. 
The studies of Fehr et al ( 1976, 1979) and Radouco-Thomas et al (1976) looked at the 
effects of chronic cannabis exposure in rats. Their studies indicated decreased learning 
ability in the rats and it was thought this was due to changes in the hippocampus. The 
acetyl-choline system was postulated to have been disrupted by cannabis. Cannabis is 
thought to decrease the release and turn over of AC in the hippocampus (Knudson et al 
1984). The -anticholinergic hypothesis has noted the many behavioural and 
pharmacological similarities between cannabis and anticholinergic drugs and this has led 
to the suggestion that cannabis exerts its effect on the hippocampus via a cholinergic 
mechanism. It is known that the main hippocampal afferents are cholinergic (Shute et 
al 1967). This model explains why THC, hippocampectomy and anticholinergic drugs 
all impair the retention of new information (Drew et al 1974, Paton 1975, Scoville et al 
1957, Carlton et al 1965, Meissner 1966, Safer et al 1971, Abel 1971, Miller et al 
1972). It is known that digit span memory is impaired when an individual is exposed to 
cannabis and scopolamine (Tinklenberg et al 1970, Safer et al 1971, Dombush 1971) 
and this observation has been explored using the Corsi board in the present thesis. 
Even though the hippocampus is involved with the aquisition of new memory, it is not 
thought to be the storage site for such memories (Drew et al 1974). Drew et al (1972) 
reported that there was confabulation in cannabis subjects and felt this was reminiscent 
of the cognitive deterioration seen in alcoholic dementia which is characterized by 
lesions in the hippocampus and mamillary bodies (Barbizet 1963). 
Schuster ( 1990) noted that cannabis is toxic to the cells of the hippocampus and noted 
that the toxic alterations in the hippocampal neurons induced by THC are similar to 
those observed in ageing. 
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It should be noted that the complexity of the limbic forebrain\ limbic midbrain system 
with its many reciprocating subconnections within the brain stem complicates the 
finding of the precise locus of Cannabinoid action. 
In addition to the effect of THC on the cholinergic neurotransmitter system, Gardner et 
al ( 1988, 1990) using the Lewis Strain of rats, found that THC augments intra-cranial 
electrical self stimulation in the median forebrain bundle and also enhances pre-synaptic 
basal dopamine efflux in the nucleus accumbens and pre-frontal cortex. This finding 
has only been recorded in the Lewis Strain of rats . 
In addition to the effect of cannabis on the cholinergic neurotransmitter system in the 
hippocampus, Lipparini et al (1969) have demonstrated that THC abolished 
hippocampal alpha rhythm and Hockman et al (1971) found THC induced spindling and 
high amplitude slow wave activity in recordings obtained from the hippocampus. 
Kaufman (1992) reported that cannabis is toxic to the cells of the hippocampus. 
Milner ( 1971) did not work with subjects who abused cannabis but with brain damaged 
individuals. He noted that in subjects with a right temporal lobectomy which involved 
the hippocampal region, there was a marked deficit in the short term memory of the 
subject. 
Dornbush (1973) conceptualized STM as being a complex of 3 stages (fig: 6) . He 
postulated that cannabis has a direct effect on the storage procedure in that because of 
decreased attention in cannabis smokers, storage of information does not occur because 
of inadequate rehearsing. This hypothesis is supported by Dittrich ( 1973) ( fig : 7) . 
Diltrich noted that the larger the dose of cannabis and the longer the interval between 
aquisition of information and its retrieval, the greater the decay of the stored 
information. 
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Dombush (1974) and Darley et al (1977) supported the model proposed by Dittrich 
( 1973) that cannabis causes a faulty storage of material. If material is learnt prior to 
cannabis exposure, Darley et al ( 1977) demonstrated that such material is equally well 
retrieved when the subject is exposed to cannabis or a placebo. 
Fig . 8 demonstrates the proposed sites of action of cannabis on the cognitive process. 
Abel (1971), Drew et al (1974) and Maykut (1985) all supported the hypothesis that 
the main action of cannabis on memory function was by inhibiting the flow of 
information from STM to L TM. Maykut (1985) proposed that the faulty transfer 
process was due to synaptic cleft alteration in the memory traces between the STM and 
LTM. 
In contrast, Weil et al (1969) and Low (1973) proposed that cannabis affects the 
retrieval mechanisms in both STM and L TM. 
Tinklenberg et al (1973) and Paton (1973) proposed that cannabis alters the intial 
coding of new information through a process of sensory disinhibition which results in 
perceptual flooding and hence faulty strorage of new information . 
Rosenkraz et al ( 1971) demonstrated that there was a consistent severe loss of brain 
protein and RN A in the brain tissue of rats exposed to chronic long term cannabis use. 
Kolansky et al ( 1972) postulated that the same changes may be present in humans. 
Physiological changes seen with cannabis use 
1/ EEG changes: 
Studies have demonstrated long term residual abnormalities in the EEG tracings from 
the cortex and hippocampus of cats (Baratt et al 1972), rats (Fehr et al 1976, 1979) and 
monkeys (Heath 1976) who had been exposed to chronic long term cannabis use. 
Maykut (1985) noted that in humans exposed to an oral dose of210 mg\ day THC, 
there were alterations in the observed EEG sleep trace with a decrease in REM and an 
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FIG. 8 : The different sites of action of cannabis on the cognitive process. 
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increase in non-REM sleep . Mehndiratta et al ( 1975) recorded insomnia in one third of 
all cannabis users. 
Campbell ( 1971) reported marked abnormalities in the EEG from the temporal lobe 
region of a group of patients who had a cannabis induced psychosis. 
2/ Cerebral blood flow (CBF) changes 
CBF is closely coupled with brain function . It is known that significant CBF changes 
are caused by benzodiazepines, caffeine and ethyl alcohol (Mathew et al 1989). 
Mathew et al (1986) looked at CBF in 17 chronic cannabis users who had smoked six 
cannabis cigarettes a week for over six months. Using the 133 Xenon inhalation 
technique, they were unable to detect any CBF changes in the cannabis users . However 
this technique measures predominantly cortical perfusion and not subcortical perfusion. 
Also the amount of THC is not specified and 6 cannabis cigarettes per week may have 
been too small a dose to detect any changes in CBF. The study size may also have 
been too small to have detected subtle changes to CBF. 
Mathew et al (1989) repeated their experiments, this time the experimental group used 
10 cannabis cigarettes a week for three years . They detected an increased CBF to the 
right and left frontal regions and left temporal regions when the experimental group 
was exposed to "one high potency cannabis cigarette", but overall there is a lower 
resting CBF in chronic cannabis users compared to a control group. It is thought that 
this lower resting CBF is associated with the reported cognitive dysfunction in cannabis 
users and the temporary increase in CBF to certain brain regions when exposed to 
cannabis results in the observed euphoria and decreased anxiety associated with 
cannabis use. 
3/ Glucose utilization defects. 
Primate studies have revealed a glucose utilization defect in cannabis smokers (Ames et 
al 1979). 
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Conclusion 
The exact role of cannabis in causing structural and functional damage to the brain has 
been difficult to assess because of the variables involved. 
The tentative conclusions conclusions are : 
1/ Possible structural changes : 
(a) global cerebral atrophy. 
(b) Widened synaptic clefts, clumping of vesicles in the pre-synaptic nerve endings and 
disruption ofRER in the septa!, hippocampal and amygdala regions of the limbic 
system. 
2/ Possible functional changes : 
(a) Decrease release and turnover of AC in the hippocampal region resulting in 
disturbance of memory. 
(b) loss of brain proteins and RN A. 
(c) Changes in the EEG patterns in the hippocampal area. 
( d) lower resting CBF which is thought to reflect on cognitive dysfunction. 
(e) glucose utilization defects. 
DEMOGRAPHIC DATA ON CANNABIS USERS. 
Table 7 summarizes the demographic data on cannabis users. 
The emerging profile is that cannabis users are : 
1/ Male 
2/ Young 
3/ Single 
4/ No children 
5/ Poorly educated 
6/ Poor work record or unemployed 
7 / A possible history of delinquent behaviour 
8/ Homeless 
9/ Come from a disturbed family background 
10/ Started using cannabis when a teenager 
11/ Use of cannabis over many years 
41 
Table . 7 Demographic data on Cannabis users. 
Personal details 
1/ Vast majority of users are male 
2/ Age : 
Young 
15 - 50 years (Average = 39) 
16 - 60 years 
18 .- 3 7 years 
23 years (R = 17 - 52) 
24, 5 years (R = 15 - 35) 
29, 5 
Under 35 
Under 40 
3/ Marital status 
Single 
Majority single 
4/ Number of children 
Nil 
5/ Level of education 
Poorly educated 
25 % had no formal education 
12 % had std 10 education 
60, 6 % illiterate 
80 % illiterate 
References 
Mathers et al 1992 
Mehndiratta et al 1975 
Rolfe et al 1993 
Onyango et al 1986 
Solomons et al 1990 
Soueif 1975 
Mathers et al 1992 
Wig et al 1977 
Rottanburg et al 1982 
Varma et al 1988 
Rolfe et al 1993 
Onyango et al 1986 
Carney et al 1984 
Solomons et al 1990 
Soueif 1975 
Varma et al 1988 
Solomons et al 1990 
References 
Solomons et al ( 1990) 
Rolfe et al 1993 
Low 1973 
Soueif 1975 
Mehndiratta et al 1975 
6/ Work record 
Poor 
Less than 5 % had jobs 
Unemployed 
High unemployment 
Criminal Record 
1/ History of delinquency 
Social History 
1/ Homeless 
2/ Family disturbance 
Cannabis History 
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1/ Age at which cannabis use was 
Started 
14 years 
i 5 years 
< 17 years 
17 years (R = IO - 28) 
< 20 years 
2/ Length of time that Cannabis had been used 
70 % of sample > 2 years 
> 4 years 
50 % of sample > 5 years 
5 - 30 years 
9, 4 years (R = 1 - 25 years) 
10 years 
15 years 
Mehndiratta et al 1975 
Rolfe et al 1993 
Solomons et al 1990 
Peck et al 1986 
Onyango et al 1986 
Hammer et al 1985 
Kendall et al (?) 
Onyango et al 1986 
Mehndiratta et al 1975 
Ben Arie 1984 
Louw 1973 
Botha et al 1981 
Mathers et al 1992 
Mehndiratta et al 1975 
Ng et al 1990 
Mehndiratta et al 1975 
Ng et al 1990 
Soueif 1975 
Mathers et al 1972 
Botha et al 1981 
Wig et al 1977 
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3/ Dependent on Cannabis alone 
21 % white sample 
41 % coloured sample 
30 % white sample 
4/ _Dependent on Cannabis and other drugs 
68 % of the white sample 
5/ Amount of Cannabis used 
60 % of sample smoking Cannabis > 1 x day 
6/ Cannabis use and the psychiatric population 
Drug related admissions 8,3 % 
Prevalence of Cannabis use in the 
psychiatric population 17, 4 % 
33 % daily users 
66 % weekly users 
47 % men, 24 % women in general 
psychiatric unit had drug related problems 
30,8 % of admissions THC positive 
Drug of abuse on admission Cannabis in 
77 % of cases. 
Ben Arie 1984 
Ben Arie 1984 
Levin 1974 
Levin 1974 
Soueif 1975 
Ohaeri et al 1993 
Onyango et al 1986 
Nga et al 1990 
Nga et al 1990 
Brady et al 1991 
Rolfe et al 1993 
Ohaeri et al 1993 
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12/ High frequency of simultaneous use of other drugs 
13/ High prevalence of a concurrent mental disorder 
Yamaguchi et al ( 1985) in their longitudinal study found that many young people 
stopped using cannabis once they had established families of their own, ie the 
socialization into an adult role resulted in the cessation of cannabis use due to the 
theory of role incompatibility. Kandel et al ( 1989) have pointed out that in those 
individuals who experience a delay in establishing an adult role (for example through 
unemployment) have a higher probability of continuing cannabis use. 
Hamner et al (1990) have found that in those individuals who remained unemployed, 
there was a high probability of continued cannabis use. 
Sullivan ( 1993) studied the characteristics of repeat users of a psychiatric emergency 
service and found that such individuals were most likely to be young separated or 
divorced, black unemployed males with a diagnosis of schizophrenia, personality 
disorder or substance abuse. 
PREVIOUS STUDIES OF CANNABIS USE IN SOUTH AFRICAN BLACKS 
One of the most importance studies on the use of cannabis in South African was done 
by Du Toit between 1972 and 197 4 and published in 1980. He concentrated on urban 
and rural blacks in Natal but also looked at cannabis use in the coloured, Indian and 
white population. 
Du Toit had 457 rural blacks in his sample, 94,7 % of whom were male. Use of drugs 
besides cannabis and alcohol was almost non existent. 51,6 % of the sample used both 
drugs concurrently, the alcohol being mainly consumed over the weekend. 
Table 8 summarizes the data collected on rural blacks and Table 9 lists the reasons 
given by rural blacks for smoking cannabis. Of interest is reference to the Rastafari 
movement in that the term "Rasta" in the E Cape has come to mean a person who 
smokes cannabis. A common reason given for smoking cannabis in the present study is 
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Table. 8: 
Rurnl Blacks in Du Ioit's surve)'. No= 457 Age IO - 90 years 
5-ucial No % 
Married 177 38,9 
Single 278 61, I 
Educational 
No formal Ed 145 32,5 % 
Up to std 6 114 25 % 
Up to std 10 5 0,8 % 
Cannabis history 
Age of I st use 9 - 45 X = 18,7 
Age. No % sample started Regular use 
13 - 15 75 16,3 % 
16 - 19 172 37,9% 
20 - 29 130 28,4% 
Introduced to cannabis by a relative 18,4 % 
Introduced to cannabis by friends 58,8 % 
First experience in a group setting 82, 1 % 
First experience alone 12, 7 % 
Length cannabis use I - 77 years x = 11, 7 years 
Quantity 2, 7 zols\ day 6,8 days\ week 
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Cannabis increases concentration. 
Cannabis decreases one's worries. 
- - . 
-- --- ---- --· ---------~ 
Cannabis increase's one's physical endurance. 
Cannabis promotes general good health. 
Cannabis increase's one's happiness. 
It is patriotic to smoke cannabis. 
Cannabis cures "idliso" ( ie being poisoned in 
the traditional way). 
Cannabis is used to attract the ancestral 
spirits. 
Table. 9. Reasons given for smoking Cannabis in Du Toit's survey (1980) of 
Rural black people 
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that the subject is a "Ras ta". Hickling et al (1994) have articulated what Rastafarianism 
is, ie a cult and a political movement which speaks for the needs of the black underclass 
in Jamaica. They believe the true home of blacks is Ethiopia and that god was re-
incarnated in Haile Selassie. They do not believe in violence, follow a vegetarian diet 
and use no other drugs except cannabis. No indiV1dual in the present sample who 
claimed to be a "Rasta" was able to formulate the beliefs of the movement. 
Solomons et al ( 1990) looked at 110 consecutive black men who were admitted to 
hospital with acute psychiatric symptoms. The average age was 28,2 years, 81 % were 
single and 83 % had no children. Most were poorly educated with the average subject 
reaching a standard 4 education. Only 5 % had matriculated and 7 % had no formal 
education. 69 % of the sample were unemployed. 31 % of the sample were diagnosed 
as having a cannabis induced psychosis. 
Using the brief psychiatric rating scale (BPRS), they found that whereas 25 % of the 
sample were assessed as being extremely disturbed on admission, only 7 % were still 
disturbed 7 days later. 27 % of the sample admitted to using cannabis in the month 
preceding admission and 40 % had used alcohol in the month preceding admission. 
The average length of stay in hospital was 27 days and 72 % were discharged within 
one month of admission. 
Meursing et al (1989) administered a self report questionnaire to a random sample of 
1135 students, aged 11 to 27 years old in Lesotho, South Africa. The majority of the 
sample (62 %) were female . 3 % admitted to cannabis "sometimes" or "daily" and 
3 % admitted to cannabis "once" . Almost all the cannabis smokers were male. 
Mkhize (1989) looked at 70 people from Swaziland, South Africa to discover their 
reasons for smoking cannabis. The reasons included : 
1/ Loss of socio-cultural norms. 
2/ A belief that cannabis enhances concentration 
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3/ A means of coping with anger. 
4/ A means of enjoying the sense of being powerful and in control, flaunting authority 
figures. 
Mkhize felt that the pervading sense of futility and powerlessness was crucial to the 
initiation and continuation of cannabis u~e. This hypothesis is supported by Gerard et 
al (1955) who found that the subject used drugs to cope with overwhelming anxiety in 
anticipation of adult roles in the absence of adequate preparation, role models and 
prospects. 
Table l O summarizes the work done on the South African black population. 
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Author Sex Population Age Size of sample Cannabis use 
Group 
Bourhill (1913) Male Admission to a 20 - 60 627 40% 
Psychiatric -
Hospital 
f?_u_ Tol!_(1980L 947% General - 10 - 90 457 60% 
------ - · ------- - ------··-·- ·- --- ·-------
Male population 
Meursing et 62% Students 11 - 22 1135 3 % some-
al (1989) Females times used 
cannabis, 3 % 
had used 
cannabis 
-----
once. 
Solomons et Male Admission to a Average 110 31 % cannabis 
al (1990) Psychiatric - = 28,2 psychosis, 
Hospital 45 % history 
of cannabis 
abuse. 
Table. 10: 
Su~mary of work done on the use of Cannabis in the black South 
African population. 
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THE CULTIVATION OF CANNABIS PLANTS 
Two subjects in the present survey grew cannabis primarily for their own use. All other 
subjects purchased their cannabis from a dealer. 
One subject grew his cannabis from seed planted in old tins containing a rich mixture of 
soil and cow manure. The seedlings were then planted out when they had attained a 
certain size. 
The other subject obtained seedlings from a friend . These were planted out using a lot 
of cow dung as manure. The seedlings required frequent watering but not on a daily 
basis. He waited until the plants had reached 1,5 m. in height and then he harvested the 
leaves and dried them over a primus stove. 
METHODS USED TO SMOKE CANNABIS IN SOUTH AFRICA. 
There are many pipe forms and diverse ways of inhaling cannabis smoke. The most 
comprehensive descriptions of the various cannabis pipes in use in South Africa appears 
in the study of Du Toit (1980) . Fig. 9 is a drawing done by one subject in this study. 
He was a single man in his early 20's. He described how he and his friends used a large 
potato to make a cannabis pipe. This pipe form was not described by Du Toit (1980). 
Cannabis in the East Cape is usually sold in small quantities for the private use of the 
purchaser (fig. 10). The crude cannabis mixture often contains seeds and this impedes 
the smooth burning of the cannabis . Consequently, users often grow one long finger-
nail in order to facilitate the quick removal of seeds from the crude mixture prior to 
smoking (fig. 11 ). 
Most often the cannabis was mixed with tobacco prior to smoking. Du Toit ( 1980) 
lists two reasons for this practise: 
a) Economy 
b) The belief that the smoking of pure cannabis causes madness and\ or foot ulcers of 
the type called "impehlwa". 
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. i 
Fig. 10 : Recent purchas·e· of Cannabis found in the possession of~ patient 
/ . 
admitted to Fort England Hospital. The cannabis in the packet 
was a crud~ preparation of flowering tops, leaves seeds and 
stems. 
Du Toit (1980) mentioried that blacks buy small amounts of 
Cannabis at a time, often buying one '..' zol" at a time or a 
handful (as featured in the photo) which is eno~gh to make 
15 "zols" and represents a week's purchase. 
"\ 
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Fig • 11. Hand of a Cannabis user demonstrating the long finge,r-nail to 
facilitate the .removal of seeds from the crude Cannabis mixture. 
. . 
· This particular subject had a THC level of 660 ng\ ml and an 
AST\ ALT ratio of 2:1. Du T-0it (1980) mentioned that m;1ny 
bla~ks in' his survey believed that smoking pure .cannabis (ie 
without tobacco) caused insanity and that the seeds of Cannabis 
were responsible for causing insanity. · 
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Fig. 12 is from Du Toit's survey and illustrates the most common "pipe" in use in the 
East Cape. 
The "zol" is also in common use, ie. Cannabis and tobacco are rolled together using 
commercial cigarette papers or brown wrapping paper. After the "zol" is rolled, it is 
greased with butter, sunflower oil or saliva to make it burn more slowly and evenly. 
A 
B 
C 
LOADING 
OPENING 
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DAGGA 
MIX-
TURE 
A kind of "pipe" currently in use among urban African youths. A 
filter called a "gidinga " is used and the mouth opening is covered 
with a cloth called a "saafi" ..,hich p r events ash from entering the 
mouth . 
Fig. 12. Some Cannabis pipes from the Du Toit (1980) survey 
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CANNABIS INDUCED SYNDROMES. 
The DSM IV lists the following syndromes : 
1/ Cannabis dependence. 
2/ Cannabis abuse. 
3/ Cannabis intoxication. 
4/ Cannabis intoxication delirium . 
5/ Cannabis induced psychotic disorder with delusions. 
6/ Cannabis induced psychotic disorder with hallucinations. 
7 I Cannabis induced anxiety disorder. 
8/ Substance withdrawal delirium. 
The following three syndromes will be considered : 
1/ Cannabis intoxication. 
2/ Cannabis withdrawal delirium . 
3/ Cannabis induced psychotic disorder. 
Cannabis Intoxication 
Intoxication can be examined in a variety of ways : 
1 / Noted physiological response to cannabis. 
2/ Noted psychological response to cannabis. 
3/ Noted behavioural response to cannabis. 
Three models of intoxication have emerged from the examined literature : 
1/ Dose - response model. 
2/ The phases of intoxication model. 
3/ The acute vs chronic use model. 
It is also recognised that the individuals response to cannabis intoxication is influenced 
by a variety of factors which include the individual's personality, pre-existing mental 
illness, cultural factors, expectations of the user, environmental factors and external 
incentives offered to the user. 
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Noted physiological responses to cannabis. 
The following systems have been noted to be affected by cannabis : 
1. Nervous System 
(a) Central nervous system. 
(i) Level of consciousness. 
The ARF\ WHO report ( 1981) noted that at high doses cannabis can induce a 
stuperous state. The same conclusion was reached by lshbell et al ( 196 7), Thacore et 
al (1976) and Ashton (1987). 
(ii) Hypothalamic axis. 
An increase in appetite has been noted (Abel 1982). Also hypothermia has been 
associated with high doses of cannabis (Ishbell et al 1967, Thacore et al 1976, Ashton 
1987). 
(iii) Brain Stem. 
The following eye signs have been noted : 
Ptosis (Ishbell et al 1967, Gilman et al 1985, Ashton 1987, ). 
Pupillary constriction (Maykut 1985). 
Photophobia (Ishbell et al 1967, Gilman et al 1985, Ashton 1987). 
(b) Automic nervous system. 
The following anticholinergic effects have been noted with cannabis use : 
Increased thirst (Abel 1982) 
Dry mouth (Abel 1982) 
Constipation (Ishbell et al 1967, Gilman et al 1985, Ashton 1987) 
2. Cardiovascular system 
The following effects have been noted with cannabis use : 
(a) bradycardia with high doses of cannabis (lshbell et al 1967, Thacore et al 1976, 
Ashton 1987) 
(b) Tachycardia (lshbell et al 1967, Talbott et al 1969, Maykut 1985, Abood et al 
1992) 
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( c) Raised blood pressure (Ishbell et al 196 7) 
( d) Orthostatic hypotension when cannabis is used in high doses (Ishbell et al 1967, 
Thacore et al 1976, Ashton 1987, Abood et al 1992) 
(e) cold extremities (Ishbell et al 1967, Thacore et al 1976, Ashton 1987) 
(f) Dilation of conjunctiva! blood vessels (Abood et al 1992) 
3. Respiratory system 
(a) Dyspnoea (Talbott et al 1969) 
(b) Irritation of bronchial mucosa (Marray 1985) 
Johnson et al (1990) noted that cannabis can aggravate chronic lung disease such as 
emphysema and that cannabis could be carcinogenic to lung tissue because of the high 
content of polyaromatic hydrocarbons . 
(c) Bronchodilation (Ishbell et al 1967, Thacore et al 1976, Ashton 1987) 
4. Muscular - skeletal system 
(a) hypomobility following high doses of cannabis (ARF\ WHO report 1981) 
(b) Ataxia following high doses of cannabis (Ishbell et al 1967, ARF\ WHO report 
1981 , Gilman et al 1985, Ashton 1987). 
( c) Manneristic behaviour\ Posturing 
Rashid et al ( 1991) looked at 15 subjects, he noted 20 % presented with manneristic 
behaviour 
5. Reproductive system and immune system 
A decrease in testosterone levels (Kolodmy et al 1974), decreased spermatogenesis 
(Margolis et al 1980) and decreased libido (Maykut 1985) have been reported 
following the chronic use of cannabis. 
Abood et al ( 1992) felt that there may be some alterations in the reproductive system, 
immune system and respiratory system following chronic long term use of cannabis, but 
they concluded, "however convincing evidence has yet to emerge that cannabis is solely 
responsible for any alterations that have been observed in these organ systems". 
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Noted Psychological responses to cannabis 
The psychological responses to cannabis depends on many variables which include dose 
of cannabis, the smoking technique, prior experience with the drug, concomitant use of 
other drugs, individual's expectation, whether cannabis is consumed in a group setting 
or alone, whether cannabis is consumed in a hostile atmosphere or not and whether the 
individual has a past psychiatric history (Abood et al 1992). 
A review of the literature identifies three categories of response : 
1. Affective response 
2. Perceptu_al response 
3. Cognitive disturbance 
Table 11 summarizes the. psychological responses to cannabis. 
1. The affective response. 
(a) Anxiety 
Onyango et al ( 1986) looked at a sample of 25 patients admitted to a psychiatric 
hospital in inner London and noted that in those patients whose urine was positive for 
cannabis, the features of anxiety, conceptual disorganization and grandiosity were 
especially prevalent. 
(b) Fear\ Panic 
The ARF\ WHO report ( 1981) noted that acute panic states were the most commonly 
observed short term adverse psychological effect following cannabis use. 
Weil ( 1970) reported that in the panic state, cannabis users can believe they are dying 
or loosing their minds and that such states can be terminated by "simple reassurance" 
from medical staff. He felt that medication or hospitalization was contra-indicated 
except in cases of extreme agitation. 
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Table. 11 The psychological responses to Cannabis. 
1. AFFECTIVE RESPONSE 
Anxiety 
Fear\ Panic 
Euphoria\ hypomania 
Grandiosity 
Laughter 
AUTHOR(S) 
Onyango et al 1986 
Johnson et al 1990 
Mathew et al 1989 
Maykut 1985 
Rashid et al 1991 
Talbott et al 1969 
Levin 1974 
Du Toit 1980 
ARF\ WHO Report 1981 
Talbott et al 1969 
Rashid et al 1991 
Rottanburg et al 1982 
Abood et al 1992 
Rashid et al 1991 
Mathew et al 1989 
Johnson et~ 1990 
Christov 1965 
Negrete 1973 
Onyango et al 1986 
Rashid et al 1991 
Du Toit 1980 
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Melancholy\ Dysphoria 
Anger\ Aggression 
Apathy 
2. PERCEPTUAL DISTURBANCES 
Delusions : 
Depersonalization 
Talbott et al 1969 
Negrete 1973 
Levin 1974 
Johnson et al 1990 
Shiling et al 1980 
Rashid et al 1991 
This has been examined in detail in 
a separate section of this thesis. 
Kolansky et al 1972 
Johnson et al 1990 
Onyango et al 1986 
Talbott et al 1969 
Negrete 1973 
Abood et al 1992 
Rashid et al 1991 
ARF\ WHO report 1981 
Maykut 1985 
Weil 1970 
Talbott et al 1969 
Negrete 1973 
Keshaven et al 1986 
Maykut 1985 
Mathew et al 1989 
Johnson et al 1990 
Dittrich et al 1973 
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Derealizations 
Auditory hallucinations 
Visual hallucinations 
3. COGNITIVE DISTURBANCES 
Confusion\ Drowsiness 
\ 
Cognitive Retardation 
Ishbell 1967 
Negrete 1973 
Keshaven et al 1986 
-
Johnson et al 1990 
Weil 1970 
I sh bell 196 7 
Christov 1965 
Talbott et al 1969 
Onyango et al 1986 , 
Johnson et al 1990 
Rashid et al 1991 
Du Toit 1980 
Du Toit 1980 
Johnson et al 1990 
Onyango et al 1986 
Negrete 1973 
Ishbell 1967 
Talbott et al 1969 
Mathew et al 1989 
Rashid et al 1991 
Kolansky et al 1972 
ARF\ WHO report 1981 
Kolansky et al 1972 
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Altered time sense 
Decreased attention 
Memory disturbances 
Negrete 1973 
Johnson et al 1990 
Mathew et al 1989 
ARF\ WHO report 1981 
ARF\ WHO Report 1981 
Maykut 1985 
Mathew et al 1989 
Onyango et al 1986 
Negrete 1973 
Rashid et al 1991 
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Negrete et al (1973) felt that panic states, together with depression and 
depersonalization reactions are a function of individual psychological factors and 
environmental cues rather than an intrinsic property of cannabis use. 
(c) Euphoria\ hypomania 
Abood et al ( 1992) have noted all the variables which need to be considered in 
assessing the individual's response to cannabis but they felt there are some behavioural 
effects which are observed regardless of all the possible variables. One such response is 
initial euphoria when smoking cannabis. Ishbell (1967) expressed a similar view point. 
(d) Grandiosity 
Rashid et al ( 1991) looked at a sample of 15 psychiatric patients and they noted 73 % 
presented with grandiosity following cannabis use. 
( e) Melancholy\ Dysphoria 
Weil (1970) reported that Depressive reactions were mainly seen in obsessive 
compulsive individuals who were ambivalent about using cannabis. 
(f) Anger\ Aggression 
The complex inter-relationship between cannabis use and subsequent aggression has 
been examined in a separate section of this thesis. 
2. The perceptual disturbances 
The phenomenon of a cannabis induced psychosis has been examined in a separate 
section of this thesis. 
(a) Delusions 
Johnson et al ( 1990) have noted that at concentrations of over 250 micrograms\ kg 
THC, the emergence of psychotic phenomena becomes more likely. Apprehension, 
suspiciousness, and morbid preoccupation herald the emergence of confusion, delusions 
and hallucinations. 
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Christov (1965) looked at 140 patients admitted to a Moroccan mental hospital and he 
felt that the content of the delusions was determined by local cultural traits. 
The ARF\ WHO report ( 1981) noted that the setting alone does not explain the 
occurrence of the observed delusions . 
Kolansky et al ( 1972) had a small sample of 13 people and noted that paranoid 
delusions were frequent in those who were "heavy cannabis smokers". 
Weil ( 1970) felt that depersonalization was more likely to occur in vulnerable 
individuals who smoked cannabis. Ishbell (1967) noted that depersonalization only 
occurred with large doses of THC, together with auditory and visual hallucinations. 
Usually depersonalization is short lived but Keshaven et al (1986) reported a case study 
of a 20 year old male whose sense of depersonalization lasted 10 months after last 
smoking cannabis. They also reported on another case study of a 24 year old male who 
had been cannabis free for one year but presented with a six month history of 
depersonalization. They noted "cannabis is known to be excreted over several weeks 
but this does not explain the symptoms spanning almost a year and the possibility of a 
residual neurotoxic effect of cannabis has to be evoked" . 
(b) · Auditory hallucinations 
Rashid et al (1991) in their sample of 15 patients noted their 66, 6 % exhibited 
hallucinatory behaviour after smoking cannabis. 
3. Cognitive disturbances 
This has been examined in detail in a separate section of this Thesis . 
Negrete (1973) noted poverty of ideation and concrete thinking in cannabis smokers. 
The ARF\ WHO report ( 1981) found decreased concept fonnation and decreased 
learning in subjects who used high doses of cannabis. 
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In most cases, the duration of measurable memory disturbances is a matter of hours 
after smoking cannabis but there may be some vulnerable individuals who have more 
long lasting cognitive disturbances. 
Noted behavioural changes following cannabis use 
Motor excitement (Du Toit 980), decreased co-ordination with decreased reaction time 
(ARF\ WHO report 1981, Maykut 1985, Johnson et al 1990) and lethargy (Christov 
1965, Mathew et al 1989) have all been noted in cannabis users. 
The three models of Cannabis intoxication 
1. The dose - response model of cannabis intoxication. 
This model attempts to demonstrate that the observed physiological, psychological and 
behavioural responses to cannabis are a function of the THC dose. Ishbell et al (1967) 
noted that the acute psychomimetic effects of cannabis are dose related. 
Johnson et al (1990) divided dosage into two categories : 
(a) low dose of THC (under 50 micrograms\ kg) . 
There is a clear but not linear. relationship between dose and observed 
effect. 
(b) High dose of THC (over 250 micrograms\ kg) . 
At this dose, psychotic features present following cannabis use. 
The ARF\ WHO report ( 1981) refer to the dose\ response model as a "biphasic pattern 
of response" . 
This biphasic pattern of response to cannabis dose has been supported with animal 
studies on rodents, dogs and monkeys (ARF\ WHO report 1981 ). 
Johnson et al ( 1990) felt that the psychological sequalae were not as closely related to 
dosage as were the physical sequalae of cannabis use. 
Table 12 summarizes the features of the dose - response model. 
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Table. 12 The Dose\ Response model of Cannabis use 
Low doses of THC (less than 50 micrograms\ kg) 
1. Non Specific 
The behavioural effect of low doses of Cannabis are relatively non specific and show 
extensive overlap with the effects of amphetamines, opiates, hypnosedatives and 
alcohol (ARF\ WHO report 1981) 
2. Psychological 
Mild ego decompensation (Kolansky et al 1972) 
Minimal perceptual and cognitive dysfunction (Rhea et al 1971) 
3. Physiological 
(a) Decreased reaction time : (Kvalseth 1977), Rhea et al (1971) did not confirm that 
low doses of cannabis affected reaction time. 
(b) Decreased co-ordination (K valseth 1977) 
(c) Increased sensitivity to auditory and tactile sensations (ARF\ WHO report 1981) 
4. Pharmacological 
Mutual enhancement with the effects of amphetamines or opiates (ARF\ WHO report 
1981) 
5. Behavioural 
Hyperactivity (ARF\ WI-IO report I 981) 
High doses of THC (over 250 micrograms\ kg) 
1. Physiological 
(a) Stupor (ARF\ WHO report 1981 , Johnson et al 1990) 
(b) Hypomobility (ARF\ WHO report 1981) 
(c) Ataxia (ARF\ WHO report 1981) 
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( d) Decreased auditory and visual reaction time (Rhea et al 1971) 
(e) Loss of weight (ARF\ WHO report 1981) 
2. Psychological 
(a) Decreased insight (Abood et al 1992) 
(b) Depersonalization (Abood et al 1992) 
( c) Psychosis 
( d) Decreased in STM (Rhea et al 1971) 
( e) Acute panic (Abood et al 1992) 
(f) Paranoid ideation (Abood et al 1992) 
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2. The phases of intoxication model. 
Abood et al ( 1992) erected a model of cannabis intoxication which recognized three 
distinct phases : 
(a) Initial euphoria 
(b) Drowsiness with sedation, followed by a distortion in time, hearing and 
VISIOn . 
There may be illusions and hallucinations. 
(c) Cognitive disturbances, slowed reaction time, overt aggression. 
3. The acute -chronic use model of cannabis use. 
This model proposes that the effects observed in the individual depend on the time 
exposure to cannabis, ie whether the individual is a naive smoker or chronic smoker of 
cannabis. 
Maykut (1985) observed the following in naive smokers : 
(a) altered time sense 
(b) memory dysfunction 
( c) decreased concentration 
( d) increased anxiety 
(e) Alteration in time sense 
(f) Paranoid ideation 
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Noyes et al (1975) noted that naive smokers have presented with acute anxiety and 
transient reality distortion, mild paranoia or a delirium. 
Abel (1977) noted that chronic cannabis users tend to be more hostile and rebellious in 
their attitudes than do naive users of cannabis. 
The following have been described in chronic cannabis users : 
(a) Confusion and paranoia (Kolansky et al 1972) 
(b) residual neurotoxic effects (Keshaven et al 1986) 
(c) amotivational syndrome. This was described in middle class, highly motivated 
American college students who had had little more than experimental exposure to 
cannabis . The features described include : 
Apathy 
Childlike thinking 
Impaired memory 
Loss of interest in achievements 
disorganization of life style 
Dullness 
Impaired judgement 
Loss of interest in personal appearance 
(McG!othin et al 1968, Negrete 1973, Johnson et al 1990, Abood et al 1992) 
Samples of people from a more representative sample of the population have been 
unable to replicate the earlier studies. (Campbell 1976, Sutz et al 1976, Abood et al 
1992) 
However Kolansky et al ( 1972) and Levin ( 1974) felt the amotivational syndrome 
existed. Levin reported that 26, 1 % of his sample of 448 white males fulfilled the 
criteria for the amotivational syndrome. 
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( d) Chronic users reported that the effects of cannabis are easily suppressed. Weil et al 
( 1968) reported that chronic users of cannabis did better on some tests when under the 
influence of cannabis and that chronic users do not show the same degree of 
impairment compared to naive subjects. 
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Factors which determine the individual's response to cannabis 
The observed effects following cannabis use depend on a combination of specific drug 
effects and many variables which are summarized in fig . 13 . (Kolansky et al 1972) 
1. Cultural effects : 
Abood et al ( 1972) mentioned the role of the individual's culture in shaping the 
observed response to cannabis. 
Table 13 summarizes the role of one's culture in defining the resultant expected 
experience following use of cannabis. 
Rubin (1975) also commented on the role of culture in defining the subjective 
experience reported following cannabis use. He noted that the reported behaviour 
varied from aggression, agitation and delinquent behaviour to passivity and conviviality. 
He noted that, "most differences observed are likely to be determined by factors other 
than the pharmacological action of the drug" . 
This view point was supported by Bowman ( 1973) 
73 
C.U L TURE 
Soc...o-sc.0NoM1c. s,,.,;-rvS 
E:Nv1R.0N l"1 ENT 
IHE. IN l:>\V I l:>U ,._ L_ 
~<'.r.-..NIC 
1>,._lvV,~E 
To 
~trro CA.M 
Fig. 13 The individual response to cannabis use depends on a variety of 
factors found in the culture, environment and intra-psychic 
process of the individual. 
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CULTURE BELIEF AUTHO_~(§J_ 
Egyptian Cannabis will increase sexual potency Soueif (1967) 
Indian Cannabis alleviates hunger Chopra et al (1957) 
Moroccan Cannabis increases personal endurance Bell (1972) 
in the face of physical hardship 
North American Cannabis counter-acted the alienating Negrete (1973) 
effects of modern society. It results in 
feeling more relaxed, allows the 
individual to express themselves more 
freely 
Table. 13 Different culture beliefs shape the individual's response to cannabis 
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2. Personality of the user : 
This factor has been recognised as being important in the observed effects of cannabis 
(Allecluck et al 1942, Talbott et al 1969, Negrete 1973, ARF\ WHO report 1981 , 
Johnson et al 1990). 
Hochman et al ( 1973) examined the personality profiles of chronic cannabis users who 
had failed to complete their schooling education and who lived in suburban areas. 
They found such individuals : 
(a) were areligious 
(b) had had early sexual experiences. 
( c) were more rebellious, independent, reckless and anti-authoritarian 
Similarly, Krug et al (1974) found cannabis users to be : 
(a) more domineering 
(b) more impulsive 
(c) more socially uninhibited 
( d) unconventional 
3. Expectations of the user 
Negrete (1973) noted that the novice smoker of cannabis had to learn from more 
experienced smokers how to smoke effectively and how to recognize the effects of 
cannabis and how to define such effects as pleasurable. 
4. Pre-existing psychiatric illness 
The existence of a pre-existing psychiatric illness is known to influence the individual's 
response to cannabis (Negrete 1973 , Abood et al I 992). 
Naditch ( 1974) noted that pre-existing psychopathology may predispose some sensitive 
individuals to adverse psychological reactions, Boyd et al ( 1984) noted that in those 
individuals with an underlying affective disorder, there was an increased risk of 
developing psychiatric symptoms after the use of cannabis. 
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5. Factors relating to the environment 
Talbott et al (1969) noted that "environmental stressors may potentiate, exaggerate or 
otherwise effect the symptoms of cannabis intoxication". A similar view point was 
expressed by Negrete ( 1973) and by the ARF\ WHO report (1981 ). 
Abel ( 1977) noted that if Cannabis was smoked in a situation not considered to be 
threatening or aggressive laden, then the user would be unlikely to react in an 
agg'ressive function . 
6. External incentives 
The ARF\ WHO report (1981) noted that the motivation for cannabis users to perform 
well in psychological tests can be enhanced by incentives such as money and this 
enhancement can decrease some of the cannabis effects. 
2. Cannabis withdrawal delirium 
The earliest report of a cannabis withdrawal delirium was reported in nine Indian 
soldiers who were deprived of cannabis when their garrison was moved to an isolated 
out-post where no cannabis was available (Fraser 1949). For the first few days 
following abrupt cannabis withdrawal, the soldiers presented with no symptoms. There 
was then an increase in irritability which escalated into violent outbursts which subsided 
after 48 to 72 hours, only to re-emerge as a violent out burst with psychotic features 
which lasted up to 4 weeks and then a spontaneous remission. 
Jones et al ( 1983 ), in a survey of the literature, noted that frequent users of cannabis 
reported sudden onset of irritability, restlessness, insomnia and perspiration after 
cessation of regular cannabis use. Jones et al looked at 53 male volunteers all of whom 
were between the ages of 21 and 3 1 years old and who smoked cannabis at least twice 
a week for the past 5 years. These volunteers were given IO - 30 mg THC every 3-4 
hours for 21 days. Sudden cessation of cannabis use in this group resulted in : 
mood changes 
disturbed sleep with insomnia 
restlessness with hyperactivity 
irritability 
hand tremors 
anorexia with weight loss 
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Increased sweating with an increased temperature 
nausea 
Their work further reported that both subjective and objective changes as listed above 
were decreased when the subjects were given cannabis again . 
Wallace (1978) also reported an increase in "psychic discomfort" when cannabis is 
stopped. He noted there was a peak disturbance 4 days after stopping cannabis which 
then subsided and disappeared by the tenth day. 
Insomnia as part of the withdrawal delirium was also noted by Alterman et al 1980 and 
Brady et al 1991. 
Rohr et al (1989) also supported the idea of a cannabis withdrawal syndrome. 
Frederick's study (1980) demonstrated that when animals are deprived of cannabis, 
there was an increasing restlessness, tooth bearing and increased eye contact. 
Kaymakcalan (1973) used IV THC in monkeys and demonstrated significant 
withdrawal effects . However his work is open to question as the observed effects were 
not unequivocally reversed when the monkeys were re-exposed to THC. 
Beardsley et al (1986) did similar work with monkeys. They found that abrupt 
withdrawal of THC resulted in a disruption of schedule controlled behaviour and this 
could be reversed by the re-introduction of THC. 
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Other authors believe that there is no characteristic cannabis withdrawal syndrome 
(Ishbell et al 1970, Lemanna 1981 , Keshaven et al 1986, Abood et al 1992). 
McMillan et al ( 1971) showed that administration of increasingly larger doses of THC 
to dogs and pigeons resulted in the development of tolerance yet no withdrawal 
syndrome. 
Abood et al (1992) stated, "chronic heavy use of cannabis does not result in a 
withdrawal delirium with severe symptomology. Psychological dependence is more 
probable than physical dependence" . 
3. Cannabis induced psychotic disorder 
Introduction : 
The DSM IV currently recognises two psychotic disorders linked to cannabis use : 
(a) Cannabis induced psychotic disorder with delusions. 
(b) Cannabis induced psychotic disorder with hallucinations. 
Psychosis associated with cannabis use has been known for over 100 years (Tunving 
1985). 
Moreau de Tours (1845) described, "acute psychotic reactions, generally lasting a few 
hours, but occasionally as long as a week, its main features include paranoid ideation, 
illusions, hallucinations, depersonalization, confusion, restlessness and excitement. 
There can be delirium, disorientation and clouding of consciousness" . 
The Indian Hemp Commission of 1893 (Mehndiratta et al 1975) estimated that 
cannabis was a factor in 7 to 13 % of all admissions to mental institutions. Tien et al 
(1990) looked at 4994 individuals who had used cannabis. They reported that 11 , 4 % 
(N= 507) individuals had experienced at least one psychotic episode and that daily use 
of cannabis was associated with a 3 0 % increased risk for the onset of a psychotic 
episode, without daily use of cannabis, the risk of a resultant psychotic episode is "much less 
likely" . 
Solomons et al (1990) reported that 31% of their sample of 110 black South African men 
who presented with acute psychiatric symptoms had a diagnosis of cannabis induced 
psychosis. 
Many workers have found support for the unique entity of a cannabis induced psychosis. 
(Marihuana 1969, Carney et al 1984, Thornicroft 1990, Mathers et al 1991, Mathers et al 
1992). 
Marihuana ( 1969) concluded that the syndrome has a central core of symptoms and the 
condition is self limiting, recovery is complete and symptoms to not re-occur unless there is 
further exposure to cannabis . 
Mathers et al (1991) looked at a sample size of 908 hospitalised patients, 34.5% of whom 
used cannabis and they found, "a highly significant association between urine samples 
positive for cannabis and an initial diagnosis of psychosis". 
In contrast, many researchers felt that even though pharmacological studies have provided 
strong evidence that use of amphetamines, cannabis, alcohol and other psychoactive drugs 
can induce delusions and hallucinations (Tien et al 1990), there was either no unique entity of 
a cannabis induced psychosis or alternatively it was a rarely observed phenomenon seen in 
certain predisposed individuals who had an underlying functional illness . 
Negrete (1973) felt that individual psychotherapy and environmental setting dictated the 
observed response to cannabis use, rather than a unique psychomimetic property of THC. 
Campbell (1971) proposed a similar line of reasoning in that he found those individuals who 
developed a cannabis induced pyschosis had pathological EEG traces with excess theta 
waves. 
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Ohaeri et al (1993) reported that when a subject presented with cannabis induced 
psychosis, follow up with a diagnosis of schizophrenia, "could be made for most cases 
of cannabis users" . Ohaeri et al added that, "the impression of cannabis being a major 
aetiological factor in psychosis is so strongly rooted among health workers in the north 
[of Nigeria] that one senior doctor said that from his experience the majority of 
schizophrenic symptoms among male suffers were associated with abuse of cannabis. 
In practise, when all admissions in his centre for 1989 were reviewed, only 13 % were 
reported to have used cannabis" . 
The problem with this conclusion is that no urine testing was done to validate whether 
the subject had used cannabis or not . 
Spenser (1987) worked for several years in Australia and did not observe a single case 
of cannabis induced psychosis. He did however suggest that the controversy which 
arises as to whether cannabis induced psychosis exits or not is associated with variance 
of the THC content of the cannabis plant. 
Stringaris (1972) concluded that the existence of , "cannabis induced psychosis has not 
been proven but such a psychosis must be presumed" . 
Tennant et al (1972) looked at 36000 men, 46 % of whom reported, "some use" of 
cannabis. They observed 18 cases of a cannabis induced psychosis and 85 cases of a 
psychotic illness when alcohol and cannabis were used together. However it appears 
that the dose of cannabis used together with the THC content and the degree of 
regularity of use are all important variables which regulate whether a cannabis induced 
psychosis is manifested or not. 
Weil (1970) felt that psychiatric intervention in psychosis would result in a 
prolongation of the psychotic episode and that such a psychosis is the result of a re-
inforcement from staff following an admission to a psychiatric unit. 
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He felt that the observed cannabis psychosis was the result of a medical mishandling of 
the more benign pathological intoxication state. 
Identified variables which are thought to play a role in the manifestation of a 
cannabis induced psychosis. 
Fig . 14 summarized the important variables. 
(a) Personality of the cannabis user : 
Spenser (1970) looked at 12 young males who had been admitted to hospital because 
of severe behavioural disorder following the use of cannabis. All were under 25 years 
old and had smoked cannabis every day for several years. He went on to describe the 
resultant cannabis induced psychosis but added that the study of the individuals pre-
morbid personality would have helped to clarify why these men presented with an 
organic psychosis. 
Talbott et al (1969) looked at a total of 35000 American soldiers in Vietnam. They 
identified 12 cases of cannabis induced psychosis. Of the cases, 2 had a premorbid 
history of personality disorder (not specified). 
Lishman (1978) felt that the personality structure was an important determinant in the 
manifestation of a cannabis induced psychosis, together with the circumstances under 
which cannabis is used and the individual expectations accompanying drug use. Negrete 
(1973) was of the same opinion. 
No author has linked a specific personality profile with the development of a cannabis 
induced psychosis. Gersten ( 1980) believed that at high doses, cannabis can cause 
significant ego disruption. Usually the individual is able to reconstitute rapidly as 
cannabis is eliminated from the system. However in those individuals who have a pre-
existing ego deficit, they may not reconstitute as expected and present with a 
psychiatric picture when exposed to cannabis. 
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Fig . 14 Identified variables which are thought to play a role in the 
manifestation of a cannabis induced psychosis. 
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(b) The setting in which cannabis is used : 
Negrete (1973) believed that the symptoms observed following cannabis use were 
influenced by psychological and environmental factors . He assumed that paranoid 
reactions occurred in settings which were unfamiliar to the users and that the reactions 
observed were not so much as due to the pharmacological effects of cannabis but rather 
due to cannabis acting as a precipitant in a specific set. 
Talbott et al ( 1969) also believed the environmental setting was important in the 
manifestation of a cannabis induced psychosis in that, "the environmental stressors may 
potentiate, exaggerate or otherwise affect the symptoms" . 
( c) Cannabis dose : 
Thornicroft ( 1990), noted "there is widespread agreement that high doses of cannabis 
precede acute organic toxic reactions" . 
The same conclusion was reached by Palsson et al (1982) who found that the 
"extensive consumption" of cannabis resulted in a short lived psychosis. 
Johnson et al (1990) noted that with absorption of over 250 micro-gms\ kg THC 
delivered by smoking, then , "the appearance of psychotic phenomena becomes more 
likely" . Johnson et al (1990) also noted that at lower doses of cannabis, a psychosis 
can result as part of an idiosyncratic reaction. 
Ishbell (1967) noted that "THC is a psychomimetic drug and its psychomimetic effects 
are dependent on dose" . 
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The work of Tennant and Groesbeck (1972) looked at 720 cannabis using USA 
soldiers. They suggested that under 12 gms of cannabis a month was only associated 
with minor respiratory ailments, whereas up to "30 gms of cannabis in a short space of 
time" was associated with an acute toxic reaction and up to 600 gms a month produced 
a chronic intoxicated state. They were also aware that the more potent preparations of 
cannabis, "precipitate a more severe and rapid reaction" . 
Other workers have supported the conclusion of Tennant and Groesbeck (Ishbell et al 
1967, Talbott et al 1969, Tart 1970). 
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( d) Prior exposure to cannabis. 
Negrete (1973) noted that certain psychotic features occur more frequently in the early 
stages of cannabis usage when the individual has not yet learnt to understand and 
predict the course of intoxication. 
In summary, it appears that in naive cannabis users, with pre-existing ego deficits, using 
a sufficient dose of cannabis in an unfamiliar or hostile setting, they can present with a 
cannabis induced psychosis. The absence of these variables may explain why some 
authors have failed to identify cannabis induced psychosis. 
Characteristics of the studied population 
In studies which have looked at a cannabis induced psychosis, the following aetiological 
factors were considered : 
(a) Sex of the subject : 
All but one study used male subjects. The implication was that cannabis use was more 
prevalent in males. 
Ohaeri et al (1993) looked at male patients admitted to a Nigerian psychiatric unit and 
felt that, "drug abuse cases consist predominantly of young males from a low socio-
economic status and exhibit schizophrenic-like symptoms" . 
Sample size ranged from 12 males in Spenser's work (1970) to 36,000 USA soldiers 
serving in West Germany, 46 % of whom had smoked cannabis on at least one occasion 
and. 16 % smoked cannabis at least three times a week (Tennant et al 1972). 
The largest sample size consisted of 350,000 USA soldiers present on active duty in 
Vietnam from 1967 to 1968, 30 % of whom had used cannabis at least once (Talbott et 
al 1969). 
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(b) Age of subjects. 
Most subjects examined were young, although Mathers et al ( 1991 , 1992) did consider 
people who were aged 60 years . 
Table 14 lists the age range of subjects examined. Age may have a direct relevance on 
whether a psychotic episode is manifested after cannabis use or not. Age may influence 
the development of ego strengths and prior experience with cannabis. It may therefore 
be that psychotic episodes are more readily observed in young males. 
(c) Socio-economic Status. 
Oha~ri et al ( 1993) in the Nigerian study noted that those individuals who presented 
with a cannabis induced psychosis came from a lower socio-economic status. 
( d) Occupation. 
Most studies did not record the occupation of the subjects who experienced a cannabis 
induced psychosis. Only two occupational categories were listed : 
(i) Soldiers (Talbott et al 1969, Tennant et al 1972, Thornicroft 1990). 
(ii) Unskilled workers (Solomons et al 1990). 
Research indicated that young men of low socio-economic status are more likely to 
present with a cannabis induced psychosis. Solomons et al ( 1990) further added that 
such individuals were childless, urban dwelling, poorly educated, often unemployed and 
with a history of concurrent alcohol abuse. 
Various classifications of cannabis induced psychosis 
Fig . 15 summarizes the various classifications of a cannabis induced psychosis. 
Many researchers have disputed the existence of such an entity arising de novo . It is 
felt that the cannabis induced psychosis is only seen in vulnerable individuals with an 
underlying undiagnosed functional illness (Talbott et al 1969, Thornicroft 1990). 
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AGE ill':!_ YEARS) AUTHOR(S) _ _____ 
16 - 60 Mathers et al 1991,_ 1992 ___ _________ 
18 - 32 Rashid et al 1991 
18 - 49 Tien et al 1990, Solomons et al 1990 
23 (R = 17 - 52) Rottenburg et al 1990 
Under 25 Spencer 1970 
Table. 14 : Age range of men who exhibited a cannabis induced psychosis. 
_ , 
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Cannabis induced psychosis 
/v\ 
Exists Does not exist 
Acute Sub acute Chronic 
1. Arising de novo 
2. Exposing a previously latent functional psychosis 
3. Precipitating a relapse of a known pre-existing functional 
psychosis 
main manifestation of the entity is : 
1. Paranoid 
2. Schizophreniform 
3. Manic 
4. Organic 
Fig. 15 The various classifications of a cannabis induced psychosis 
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Tho micro ft ( 1990) stated that the entity of cannabis induced psychosis was "not 
warranted on phenomenological grounds" . However the work of Thacore et al ( 1976) 
has demonstrated the phenomenological distinction between a cannabis induced 
psychosis and a functional psychosis. In addition, Thornicroft has ignored the rapid 
resolution of the cannabis induced psychosis which usually resolves within seven days. 
Andreassen et al (1987) followed 45,570 Swedish men for 15 years . 9,4 % had used 
cannabis and 1, 7 % were "high consumers" of cannabis. The relative risk of 
schizophrenia for such high consumers of cannabis was twice that compared to people 
who had never used cannabis ie the presentation of a cannabis induced psychosis is a 
label for an underlying functional psychosis. 
Stefanis ( 1978) found that cannabis users were four times more likely to have 
underlying schizophrenia. 
Other workers have felt that an established functional psychosis may lead to an 
increased risk of cannabis use because of the anticholinergic properties of cannabis. 
The various view points of the inter-connections between cannabis and psychosis have 
been summarized by Benabud 1957, Chopra et al 1957, Ames 1958, Talbott et al 1969, 
Colbach 1970, Kemp 1970, Grossman 1969, Chopra 1971, Stringaris 1972, 
Spencer} 971, Davidson et al 1972, Harding et al 1973, Breakey et al 1974, Rottanburg 
et al 1982, Palsson et al 1982, Thornicroft 1990, Rolfe et al 1993 . 
There appears to be less evidence for the existence of a chronic psychotic state as a 
result of cannabis use (Spenser 1970, Winkler 1970). 
Spenser ( 1970) described a chronic form of cannabis induced psychosis as : 
(a) persistent amnesia for the onset of the illness 
(b) Flattening of affect 
( c) Thought disorder / ( d) Perceived as being odd and\ or suspicious. 
Spenser felt the chronic form persisted for "an indefinite time". 
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Tennant et al ( 1972) also reported on a chronic psychotic state in cannabis users 
"similar to a schizophrenic reaction in predisposed individuals" . 
Negrete (1973) believed that a chronic psychotic state following prolonged use of 
cannabis existed. Chopra et al (1974) felt that the chronic psychotic form was 
particularly likely to occur in third world countries but added that the distinction 
between this category and schizophrenia was not clear. 
Behaviour prior to the onset of a cannabis induced psychosis 
Several researchers have reported that individuals increase their cannabis use prior to 
the onset of a drug induced psychotic episode (Bernhardson et al 1972, Palsson et al 
1982, Thornicroft 1990). Palsson et al ( 1982) noted that the intensifications of 
cannabis abuse was over a period of weeks to months prior to the onset of the observed 
psychotic episode. 
The features of the cannabis induced psychosis 
Table 15 and Table 16 summarize the described features of a cannabis induced 
psychosis. 
In length, the reported psychotic episode appears to be short lived, usually about seven 
days. 
Table 15 records the Reported features of a psychotic episode. The most often 
reported features are : 
(a) Confusion with cognitive dysfunction 
(b) hypomania 
( c) Aggression 
(d) Paranoid delusions 
( e) hallucinations 
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SYMPTOM AUTHOR(S) 
Sudden onset after smoking cannabis Spenser 1970 
Tennant et al 1972 
Palsson et al 1982 
-
Decreased sleep Spenser 1970, Palsson et al 
1972,_ N~_grete 1988 
GENERAL: 
Dishevelled appearance Gersten 1980 
Blunted Gersten 1980 
Manneristic Rashid etal 1991 
Increased psychomotor acitivity Spenser 1970, Gersten 1980 
Circumstantial speech Gersten 1980 
AFFECT AND MOOD 
Labile, elevated affect seenser 1970 
Talbott et al 1969, Harding~_ 
al 1973, Rottenburg_et al 1982 
Thornicroft 1990 
Rashid et al 1991 
Anxiety Talbott et al 1969, Thornicroft 
1972, Tennant et al 1972, 
Negrete 1973 
Palsson et al 1982 
-
-- -· · ---
. -
-· -· ---- - -·- -- - -- . -· ---- . - - --- -- ·- - ·---. -- - -
Panic 
___ Thac~re 19!2, ~egrete _1973 ___ 
-- ----------- -- - --·--· 
Thacore and Shuklar 1976 
-- · 
-----··- ------------- ·- - -------- - -- - - .... . - -- ··- - -- · -·- - ---
Fear Talbott et al 1969 
Suspicion Talbott et al 1969 
~ression Spenser1970 
Bernhardson et al 1972 
Thacore et Shuklar 1976 
-
Palsson et al 1982 
Rashid et al 1991 
Rolfe et al 1993 
DEPRESSION Talbott et al 1967, Davidson et 
al1972 
Ne_grete 1973, 
Palsson et al 1982 
THOUGHT PROCESS 
Pressure of thought Talbott et al 1969, 
Spenser 1970 
Thought fragmentation se~~ser 1970, Thornicroft 1990 
Rolfe 1993 
PERCEPTUAL DISORDER 
Derealization Ames 1958, Talbott et al 1969, 
Tennant et al 1972, 
Negrete 1973 
Paranoid delusions Talbott et al 1969, Spenser 
1970, Tennant et al 1972, 
Thacore 1972, Negrete 1973, 
A~\ WHO re~!11981, 
Palsson et al 1982, Thornicroft 
1990, Rashid et al 1991, Rolfe 
etal1993 
(CONTINUED ... .. ..... ) 
Table. 15 (continued) 
- ·-· -- -- - - - - -- -- -· - - -- - -- --- - - -- ---(C(_)NTINUEO ... ....... ) 
Hallucinations Talbott et al 1969,_ Weil 1970, 
Tart 1970, Keller et al 1971, 
Thacore 1972, Tennant et al 
c----- -
1972, Palsson et al 1982, 
Thornicroft 1990, Rashid et al 
1991, Rolfe et al 1993 
------------ ----------------
COGNITION: 
Poor concentration Talbott et al 1969, 
Thornicroft 1990 
Confusion, disorientation 
----
__ Talbott_ et al 1969, _Weil 1970, 
Tennantetal1972, ____ _ 
ARF\ WHO reeort 1981, 
--
Palsson et al 1982, 
Thornicroft 1990, 
Rashid et al 1991 
-
Amnesia for the episode Spenser1970 
Table . 15 : Reported features of a cannabis induced psychotic disorder. 
~!-E~~TH OF PSYCH9TIC E~ISQDE (DAY AUTHORS 
NON SPECIFIC : 
Rapid resolution Carney et al (1984) 
Symptoms remit rapidly Mathers et al 1982 
Short lasting Thacore 1972 
Acute, short lived Weil 1970, Mayer 1975 
Few days Ch~ra et al 197 4 
few days to four weeks ARF\ WHO report 1981 
few weeks Gersten 1980 
SPECIFIC 
-
three days Carney et al 1984, Tennant et al 1972 
four+ days Talbott et al 1969 
_!!ve days Rashid et al 1991 
seven days Rottanburg et al 1982, Palsson et al 1982, 
Solomons et al 1990, Rolfe et al 1993 
14 days Tennant et al 1972 
15 d~~s Negrete 1973 
Table. 16 : The reported length of a cannabis induced psychotic episode in 
hospitalized patients treated with nenroleptics. 
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Solomons et al ( 1990) examined 110 consecutive black South African men admitted to 
hospital with acute psychiatric symptoms. They felt that the diagnosis of a cannabis 
induced psychosis could only be made when all three of the following criteria were met 
( a) The patient had a history of recent cannabis use or the patient's urine tested positive 
for cannabinoids or both. 
(b) The patient was psychotic or had been psychotic shortly before admission to 
hospital , ie evidence of : 
formal thought disorder 
hallucinations 
delusions 
behavioural disturbances 
lack of insight 
( c) During hospitalization the patient responded reasonably rapidly to treatment with 
clear evidence of return to pre-episode personality function . 
Furthermore, Solomons et al ( 1990) did not view a cannabis induced psychosis as a 
single clinical entity but rather a group of disorders whose main clinical presentation 
was : 
(a) Maniform : 
Agitated, restless, pressure of speech, grandiose, circumstantial, flight of ideas. There 
wa·s a decreased need for sleep and over activity in a purposeless manner. 
(b) Paranoid form : 
(c) Schizophreniform : 
Blunted, withdrawn, poverty of ideation, poverty of volition, psychomotor retardation, 
bizarre somatic delusions or other delusions . 
(d) Organic form 
Clouding or fluctuating level of consciousness, disorienatation. Cognitive deficits 
evident. 
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Solomons et al reported on the following frequency of presentation of the different 
forms of cannabis induced psychosis : 
Number of cases % 
Schizophreniform 13 41 ,9 
Maniform 8 25,8 
Paranoid 5 16, 1 
Organic 5 16, 1 
Total : 31 
Solomons et al did consider the concurrent use of alcohol with cannabis in their sample. 
32,3 % had consumed alcohol together with cannabis whereas 45,2 % of the sample 
had consumed no other drug besides cannabis. 
In contrast, Rottanburg et al ( 1982) felt that the most common presentation in heavy 
cannabis users was a psychotic illness characterized by marked hypomanic features . 
Edwards ( 1963) and Abel ( 1982) felt that there was no unique set of psychotic 
symptoms following the use of cannabis and the term, "cannabis induced psychosis 
could not be justified" . 
Thacore et Shukler ( 1976) felt there were considerable differences in the clinical 
features of a cannabis induced psychosis and paranoid schizophrenia and felt that the 
former was characterized by more bizarre and violent behaviour, a greater affective 
component and less thought disorder compared to paranoid schizophrenia. 
The concurrent use of other drugs together with Cannabis 
A commonly used argument against the existence of a unique entity of a cannabis 
induced psychosis is that the effects observed may have been in response to the 
concurrent use of drugs by the patient. 
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Tennant et al (1972) looked at a sample size of 36,000 USA soldiers serving in West 
Germany, 46 % of whom had smoked cannabis on at least one occasion and 16 % 
smoked cannabis more than three times a week. When cannabis samples were 
analyzed, 3 % were found to be contaminated with cocaine, opiates, spices, shoe polish 
and feces. They also mentioned that 112 observed psychotic reactions were associated 
with the concurrent use of cannabis, amphetamines and alcohol. 
In all, only 18 cases recorded in their sample size presented with a psychotic episode 
due to cannabis use alone, whereas 85 psychotic episodes were due to concurrent use 
of alcohol and cannabis. 
Conclusion 
Most researchers felt that the existence of the entity cannabis induced psychosis is 
merited on phenomological grounds. Its presentation depends on many factors which 
include dose of cannabis used, the users familiarity with the drug, personality of the 
user and the setting in which cannabis is used. 
There are less convincing arguments for the existence of a chronic form of cannabis 
induced psychosis. 
Many workers have felt that cannabis induced psychosis is a rare entity (Onyango et al 
1986) but Solomons et al ( 1990) reported that 31 % of their sample of acute 
admissions presented with a cannabis induced psychosis. Similarly, Rottanburg et al 
(1982) noted in their sample of 117 acute admissions, 30 % had a diagnosis of cannabis 
induced psychosis. 
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THE CONCURRENT USE OF CANNABIS AND ALCOHOL 
Introduction 
It has been reported in the literature that the concurrent use of cannabis and alcohol is 
common in Western countries (Manno et al 1970). 
Galletly et al (1993) looked at 121 patients admitted to a psychiatric hospital in 
Adelaide, South Australia. Urine samples were obtained within two hours of 
admission. In 85 patients (70,2 %) only one drug was detected in the urine. In 31 
samples (25,6 %) drugs were present which had not been reported by the patient. 
In 12 samples (9,9 %), alcohol and cannabis was present in the urine . The authors 
concluded that there was, "considerable discrepancy" between the patients self report 
of recent drug intake and the results of urine drug screens. Many patients would admit 
to recent alcohol intake but not to cannabis. They reported the drug screen provided 
clinically useful information that was not obtained at interviews in 25,6 % of the 
sample. 
Mehndiratta et al (1975) mentioned that by comparison in the East, it is uncommon for 
cannabis to be used concurrently with alcohol or any other drug because the use of 
cannabis has been ritualized and traditionally accepted but this sanction does not extend 
to alcohol. In their sample of 50 cannabis users, no subject used alcohol on a "regular 
basis" . 
Concurrent use of cannabis and alcohol in South Africa 
Bourhill ( 1913) conducted the first full length study of cannabis use in South Africa. 
His sample size was 627 male patients. He noted, "many dagga smokers are also heavy 
drinkers and it is almost impossible to differentiate how much of the insanity in a given 
case is due to alcohol anD how much to dagga" (page 2 & 3 Bourhill, 1913). 
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Du Toit (1980) did not support that there was widespread concurrent use of alcohol 
and cannabis. He concluded, "urban blacks are not party to the polydrug phenomenon 
which is emerging world wide" (Du Toit 1980, p. 195). 
The black male subjects in his survey who smoked cannabis gave the following reasons 
for not using alcohol simultaneously : 
" alcohol has a bad taste" 
" alcohol numbs the senses" 
" alcohol produces a head-ache and hang-over" 
" alcohol slows a person down" 
Of the sample who did use alcohol concurrently with cannabis, most alcohol was of the 
traditionally brewed type and its consumption was based on cultural grounds. The use 
of alcoholic spirits was uncommon but was positively linked to the educational level of 
the individual. 
Concurrent use of cannabis and alcohol in Scandanavia 
In contrast to the South African experience, Hammer et al (1985) have reported that , 
"cannabis use is clearly associated with high alcohol consumption" . 
THE EFFECT OF CANNABIS ON COGNITION 
Introduction 
Controversy exists as to whether cannabis use results in a cognitive deficit in the user 
(Satz et al 1976, National institute on drug abuse, Marijuana and health 1980, Varma 
1988). 
The possible connection between cannabis use and cognitive deficit remains a complex 
interaction because of the multiplicity of variables which will be examined in this 
Section. 
It is also important to establish whether there was any evidence of cannabis 
intoxication, delirium, psychotic disorder or anxiety disorder at the time of testing. All 
these states could influence the results of any attempt to measure cognition (Wert et al 
1986). 
Early research work on the effects of cannabis on cognition 
Over 80 % of the published research on chronic cerebral effects of cannabis has been 
conducted since 1970 (Wert et al 1986). 
In 1892, the Indian Hemp Drugs Commission examined the, "physical, mental and 
moral effects of cannabis use" (Wert et al 1986). The Commission interviewed 1193 
individuals and reviewed the records of all the judicial proceedings for the previous 20 
years in which cannabis was thought to have been used by the alleged offenders . The 
Commission also looked at 222 individuals whose admission to a mental institution in 
1892 was though to have been linked to the recent use of cannabis. 
The Commission concluded that the "moderate" use of cannabis produced no cognitive 
deficit, whilst "excessive" use may have caused a cognitive deficit. However, the 
Commission failed to define what was meant by ''.moderate" and "excessive" use of 
cannabis and also failed to define how cognitive deficit was measured and whether any 
cognitive deficit was of a temporary or permanent nature. 
The next major report was also completed in India by Chopra et al (1939). A total of 
1238 cannabis smokers were examined. They concluded that "moderate" use of 
cannabis caused no cognitive deficit, but "excessive" use lead to impairment. The 
problems associated with this survey was that the effects of poor nutrition on cognitive 
performance was not considered. Also 2,5 % of the sample had syphilis and the 
population examined were of low socio-economic status such that cognitive deficits 
would be hard to detect. 
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Varma et al (1988) made a detailed study of cognitive function in 26 long term heavy 
Indian cannabis users following 12 weeks of abstinence. The battery used contained 10 
different domains and the conclusion was that cannabis did cause a selective and 
significant impairment in STM in addition to poor performance in perceptuo motor 
function . 
The first USA report on the effect of cannabis on cognitive functioning was done by the 
Mayor's committee in 1943 (Wert et al 1986). They looked at 72 prison inmates, 48 of 
whom were cannabis users . Their conclusion was that cannabis did not appear to cause 
any cognitive deficit. The La Guardia report (1944) and Williams et al (1946) did not 
support the conclusion of the Mayor's committee. These two research teams reported 
that there was impaired intellectual functioning in cannabis smokers. 
One problem with many early North American studies which failed to detect any 
cognitive deficits in cannabis smokers was that the experimental groups were college 
students who were occasional light users and therefore did not represent cannabis users 
overall (Deahl 1991). 
In conclusion, studies conducted between 1960 and the l 980's on cognitive impairment 
in long term cannabis users showed inconsistencies (Soueif 1967, Soueif 1971, Soueif 
1975, Agarwal et al 1975, Satz et al 1976, Soueif 1976, Wig et al 1977, Fletcher et al 
1977, Ray et al 1978, Mendhratta et al 1978, Fletcher et al 1978, Schaefer et al 1981 ). 
Table 17 summarises the different population groups which have been surveyed for 
possible cognitive impairment following the use of cannabis. 
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COUNTRY AUTHOR(S) 
Jamaica NIMH 1972, Bowman 1973, Rubin 1975 
--
INDIA Agarwal et al 1975, Wig et al 1977, 
Ray et al 1978, Mendhratta et al 1978, 
Varma et al 1988, 
-- ----- -
GREECE Stefanis et al 1977 
', 
EGYPT Soueif 1967, Soueif 1971, Soueif 1975, 
Soueif 1976, Fletcher et al 1977 
USA Wig et al 1977, Wert et al 1986, 
Schwartz et al 1989 
COSTA RICA Satz et al 1976, Page et al 1988 
NORTH AFRICA Christov 1965, Negrete 1973 
Table. 17 : The different population groups which have been surveyed for 
possible cognitive impairment following the use of cannabis. 
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West et al (1986) have pointed out that often people in countries outside the USA 
consume cannabis with a higher content of THC. Also other factors such as poor 
nutrition, low socio-economic status and the concurrent use of other substances to 
enhance the effects of cannabis all result in a bias of finding neurological deficits in the 
samples surveyed. West et al have also pointed out that cross culture studies often use 
tests developed in the USA which have not been standardized for other culture groups . 
The Jamaican Studies 
The Jamaican project (Rubin et al 1975) looked at chronic long term use of cannabis. 
In all , 19 different neuropsychological tests were used. The study used 30 subjects and 
30 controls. Subjects had a history of regular cannabis smoking of 8 cannabis 
cigarettes\ day for 7 - 37 years. However the amount of THC consumed was not 
stated . 
The results of the survey failed to demonstrate any major differences in 
neuropsychological functioning between the controls and the subjects . 
A serious flaw of the study was that no attempt had been made to standardize the 
neuropsychological test battery on a group of Jamiacan residents prior to the study. 
Also of note is that the study had virtually no measure of STM deficit. 
Furthermore, the study was flawed in that a multivariate analysis of the results was not 
used . 
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Bowman ( 1973) similarly looked at the effect of chronic, heavy, daily use of cannabis in 
Jamaican men who came from the lower social classes. Heavy use of cannabis was a 
term not defined but the experimental groups had all used cannabis for more than 10 
years. The battery of tests used by Bowman have been used to demonstrate 
impairment in individuals who abuse alcohol or other substances known to cause 
organic damage to the brain. 
His work likewise failed to show any differences in memory function between the 
subject and control group . However, as in the case of the Jamaican project (Rubin et al 
1975), Bowman' s neuropsychological battery was not standardized for the Jamaican 
population and also by using subjects from the lower socio-economic classes, it would 
be difficult to detect any cognitive dysfunction in the experimental group . 
The Costa Rican studies. 
Satz et al (1976) standardized their neuropsychological tests on their test subjects in 
Costa Rica. They used the Williams Memory Scale (1968) and the Benton visual 
retention test (Benton 1963). They used 41 chronic cannabis users and 41 controls. 
Their definition of chronic cannabis user was up to and in excess of 8 cannabis 
cigarettes a day for 10 years. THC content was not measured. 
Satz et al (1976) concluded that, "chronic marijuana use is not associated with 
permanant or irreversible impairment in higher functioning" . This conclusion was 
supported by (Mendelson et al 1972, Grant et al 1973 and Knights 1975). 
Page et al (1988) conducted a follow up study of the work of Satz et al (1976) and 
re-tested 27 ofthe original 41 experimental group and 30 of the original controls . They 
found that the experimental group had a decreased capacity for sustained attention and 
significant impairment of STM in 3 of the 7 neuropsychological tests that had been 
standardized for the population. 
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The Indian Studies. 
Several investigators (Agarwal et al 1975 , Wig et al 1977, Mendhratta et al 1978, Ray 
et al 1978) have found that cannabis is associated with abnormal Bender-Gestalt and 
Weschler memory scale scores in Indian subjects . The problem with these studies is 
that they had absent or poorly matched controls, inadequate consideration of the 
pre-morbid variables, unreliable ascertainment of the duration and severity of cannabis 
or other drug use and the use of culturally inappropriate psychometric tests that had not 
been adequately validated on the sample population. 
The study of Varma et al (1988) consisted of an experimental group of 26 heavy users 
of cannabis with daily intake of 150 mg of THC at least twenty times each month for 5 
years, and a control group of 26 individuals. 
They noted that the large majority of cannabis users in India came from the main stream 
of society because social sanctions against cannabis smoking were not as pronounced 
as in the West. 
Varma et al (1988) used a battery of 13 tests. 3 tests specifically looked at a measure 
of intelligence, all of which had been standardized on the Indian population, namely the 
W AIS-R, Bhatia short scale and Raven ' s standard progressive matrices. Users were 
hospitalized for 12 hours prior to testing to minimize the risk of acute effects of 
cannabis compounding the results . 
Varma et al (1988) found that the experimental and control group did not differ 
significantly on any of the various sub-tests of memory. 
The authors then developed their own tool to measure memory function in IO different 
areas and found no significant differences between the experimental and control group. 
The only differences noted pertained to perceptuo-motor tasks . 
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This work therefore failed to support the earlier work of Agarwal et al ( 1975) who 
used the Weschler memory scale, the Benton visual memory test and the Bhatia battery 
of intelligence in 40 cannabis users . Agarwal et al (1975) felt that there was cognitive 
impairment in cannabis users but their work had no control group. 
Negrete ( 1973) made mention oflndian Studies of individuals who had a "heavy, 
chronic consumption" of cannabis and "have as a common denominator a severe 
deterioration of higher cognitive functioning" . Negrete did not elaborate on the above 
conclusion. 
The Egyptian Studies. 
Several investigators (Soueif 1967, 1971, 1975, 1976, Fletcher 1977) found that 
cannabis use in Egypt was associated with abnormal Bender-Gestalt tests and Weschler 
memory scale scores. 
Soueif (1976) studies 1700 Egyptian cannabis users and controls using a wide range of 
psychological tests . He found that cannabis users performed significantly more poorly 
on 10 of the 16 measures used but the differences noted were small. 
Wert et al (1986) found that place ofresidence (urban vs rural) and degree of literacy 
affected the test scores at least as much as cannabis use. 
The USA Studies. 
Schwartz et al ( 1989) looked at a group of white middle class adolescents with a 
medium age of 16 years, all of whom had an I.Q . between 90 and_125 and had no 
history of chronic alcohol intoxication and all of whom had at least 8 years of formal 
education. There were l O experimental subjects and 17 controls . 
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A total of 7 neuropsychological tests were used, which included tests of SIM. Testing 
was done between day 2 and 5 following hospital admission to dissipate any obvious 
short term effect of cannabis intoxication on cognition. 
The group was then tested 6 weeks later after cannabis abstinance was checked by 
bi-weekly urine testing. 
They found the experimental group committed more errors on the Benton visual 
retention test (BVRT) and also the experimental group did not improve statistically 
across time on any of the memory tests which raised the possibility of long lasting 
cognitive deficits in cannabis users. 
This work supported the earlier findings of Wig and Varma (1977) . 
Wert et al ( 1986) have pointed out that , "the majority of studies have found no 
clinically significant differences between groups of cannabis users and controls on 
commonly accepted neurological and psychological measures of cerebral function" . 
They pointed out that this finding was all the more surprizing given the number of 
variables such as, "polydrug abuse, low motivation and acute effects which bias the 
results towards finding impairment in cannabis using subjects". 
The North Africa Studies. 
Christov ( 1965) examined 140 cases that had been admitted to a Morocan mental 
hospital following the use of cannabis . The symptoms on admission included 
behavioral disturbances, impaired sensorium, disturbed thought process, and impaired 
intellectual function comprising of poor concentration, memory and comprehension. 
However Christov concluded that he was uncertain whether the observed cognitive 
deficits were the result of cannabis use per sea or, "merely a reflection of the attitudes 
consciously adopted within a frame of reference of a new philosophy of life". 
1 U / 
Negrete (1973) mentioned that publications from North Africa which dealt with, 
"heavy, chronic consumption" of cannabis and "have as a common denominator a 
severe deterioration in higher cognitive functioning". 
The Greek Studies. 
Stefan is et al ( 1977) looked at 4 7 Greek cannabis users and 41 controls. They found 4 
significant differences on the W AlS subtests and concluded that cannabis was 
responsible for the cognitive deficits in the experimental group. 
Complications in measuring the effect of cannabis on cognition. 
Many variables must be considered when an attempt is made to measure the effect of 
cannabis on cognition. Variables reported in the literature are summarized in Table 18 
and are discussed in detail below. 
(a) THC dose. 
The potency of cannabis can vary by a factor of2000 (Weil et al 1968, Paton 1975). 
Mason et al ( 1985) have noted that above a certain threshold dose, increasing doses of 
THC produced a linear dose - dependent decrease in mental and physical performance. 
This is supported by an article in the Lancet (1989), Levin (1974), Dornbush (1973), 
Ray et al (1978), Wert et al (1986) . 
Wert et al (1986) noted that there is no standardized amounts of THC in street 
samples. Self report of frequency of drug use is often suspect and therefore light to 
moderate users, especially if use has been short term, would be unlikely to demonstrate 
impairment and so their presence in a sample could serve to statistically mask 
impairment in heavier users. 
Satz et al ( 1976) noted that many of the early studies on the effect of cannabis on 
cognition failed to control the dosage level of THC. 
108 
Stone 1970, Manno et al 1971, Wert et al 1986, Marks et al 
'.;1989, Deahl 1991, Abood et al 1992. -
Deahl 991 ;0 Soueif 1976, Ray et al 1978, ARF/ WHO report 
1981; Wert et al 1986; Lancet 1989, Johnson et al 1990 . 
. , . . 
Wert et.al 1986; Deahl 1991. 
' ' 
Weil et al 1968, Abood et al 1992. 
Table 18 : Identified variables which need to be considered when investigating 
the effect of cannabis on cognition. 
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The ARF\ WHO report ( 1981) noted that animal studies with rodents, dogs and 
monkeys had revealed a biphasic dose effect of cannabis. This biphasic pattern has 
been described in humans. Higher doses of cannabis may cause greater cognitive 
deficits but this observation is influenced by the subject's degree of prior exposure to 
cannabis. 
(b) The time lapse between smoking cannabis and testing for cognitive deficit. 
This needs to be considered such that there is no cannabis intoxication, delirium or 
withdrawal delirium or a cannabis induced psychotic disorder at the time of testing for a 
cognitive deficit. 
The ARF\ WHO report (1981) noted that in most studies, the cognitive deficits noted 
occur only within a few hours of smoking cannabis but also suggest that there may be a 
more lasting effect of cannabis on the transfer of information from STM to LTM. 
Reviews of Weil et al (1968) and Hollister (1971) suggest that cannabis may have an 
immediate depressing effect on some cognitive or attentional tasks but such defects are 
of a temporary nature. · 
(c) Experienced vs naive users of cannabis. 
Weil et al (1968), Caldwell et al (1969), Dornbusch (1973) and Marks et al (1989) 
noted that naive users of cannabis performed worse on cognitive tests compared to 
experienced users. 
Abood et al ( 1992) felt that experienced users had developed some kind of 
compensation which enabled them to perform better on cognitive tests . 
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( d) The concurrent use of alcohol. 
Abood et al (1992) noted that cognitive impairment noted in cannabis users was more 
marked if there was concurrent use of alcohol. This is supported by the work of 
(Manno et al (1971), Wert et al (1986), Deahl (1991) . 
Marks et al (1989) looked at the effect of 3 levels of cannabis use combined with 3 
levels of alcohol consumed. They found evidence of marked cognitive deterioration 
when cannabis was combined with alcohol use. The authors also found cross tolerance 
between cannabis and alcohol use in that there is a resistance in heavy cannabis users to 
consume concurrent large doses of alcohol. A similar conclusion was reached by Stone 
(1970) . 
( e) The concurrent use of other drugs ( excluding alcohol) 
Many previous studies have reported on the role of cannabis in producing irreversible 
cognitive damage but these studies were flawed both in terms of design and 
methodology. One factor which was not controlled was the concurrent use of other 
drugs . 
In the Campbell et al (1971) study all 10 reported cases had used LSD in addition to 
cannabis and 9 cases had also used amphetamines, barbiturates, heroin or morphine. 
Wert et al ( 1986) pointed out that in many cases opium and datura had been used 
concurrently with cannabis and this made interpretation of results difficult. 
A similar conclusion was reached by Deahl ( 1991 ). 
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(f) Motivation of the subjects. 
Motivation of the test subject is thought to influence the test results (ARF\ WHO 
report 1981). Wert et al (1986) noted that many drug users may be poorly motivated 
and so exhibit minimal co-operation during testing and so produce spuriously low test 
results. 
(g) Variables within the individual subjects. 
Little is known about individual vulnerability to cannabis (Deahl 1991 ). Some factors 
which have been identified and are thought to be important are: 
(i) Intelligence of the subject. 
The Lancet ( 1989) noted that individuals with learning disabilities and those with 
borderline or low IQ may be more susceptible to cannabis induced STM deficits. The 
ARF\ WHO report (1981) is not in agreement with this and felt that impaired cognitive 
deficit was more likely to be recognized in University students than in agricultural 
labourers or in other groups for whom intellectual tasks were not important. 
(ii) Access to formalized education. 
Ray et al (1978) and Wert et al (1986) noted that the degree of literacy in subjects was 
found to effect the test scores at least as much as cannabis use. 
(iii) Socio-economic status and cultural background of the subjects. 
The ARF\ WHO report (1981) felt that socio-economic factors as well as cultural 
factors influence the identification of adverse effects of cannabis, especially those 
related to emotional and cognitive function . 
(iv) Ethnic variation. 
The ARF\ WHO report ( 1981) noted that, "another item that requires exploration is the 
possibility of ethnic variation in drug response which has not yet been studied 
systematically with respect to cannabis". 
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(v) Urban vs rural populations. 
Wert et al (1986) commented on the Egyptian study of Soueif (1976) and felt that 
factors such as place of residence affected the test scores at least as much as cannabis 
use. 
Ray et al ( 1978) came to the same conclusion. 
(vi) Individual psychic vulnerabilities. 
The ARF\ WHO report (1981) felt that the adverse effects experienced in users of 
cannabis, including cognitive deficits were a factor of: 
(a) Cannabis dose. 
(b) Individual psychic vulnerability 
( c) Individual physical vulnerability 
(d) The Social\ cultural matrix in which cannabis is consumed. 
Their conclusion was that any cognitive deficit that was observed in cannabis users was 
"more likely to be determined by factors other than the pharmacological action of the 
drug". 
The same conclusion was reached by Johnson et al (1990) . 
(h) Nutritional factors 
Deahl (1991) noted that a variety of pre-morbid factors may be over-represented in 
drug users and as such may influence the results of cognitive testing. Such factors 
include the nutritional status of the subject. 
Wert et al (1986) came to the same conclusion. 
(i) The use of psychiatric patients in cognitive studies: 
Deahl ( 1991) noted that the effects of cannabis on healthy subjects may differ from 
those in individuals with a co-existing mental illness or brain damage. 
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Satz et al (1976) noted that many of the early studies which claimed that cannabis 
caused severe and irreversible brain damage were, "grossly marred" in terms of design 
and methodology and one bias was the use of psychiatric patients in the early studies 
who would not be representative of the general population of chronic cannabis users. 
U) Setting in which cannabis is smoked. 
Wert et al (1986) have recorded that the setting is an important variable in influencing 
the response to cannabis. Abood et al (1992) came to the same conclusion. 
Evidence for cognitive deficits in users of cannabis. 
(1).Temporary cognitive deficits 
Table 19 lists the reviews that have suggested cannabis may have an immediate 
depressing effect on some cognitive or attentional tasks but these effects are not severe 
and persist from 3 weeks after the last use of cannabis up to 6 weeks (Swartz et al 
1989, Lancet 1987). 
Table 20 summarizes the various tests used in the detection of cognitive deficits . 
(2) Permanent cognitive deficits 
In general, it is thought that permanent cognitive deficits may arise from cannabis use 
after exposure to high doses over a prolonged period. 
Many of the early studies (Campbell et al 1971 , Kolansky et al 1971 , Heath 1973 , 
Kolansky et al 1975) were flawed in terns of design and methodology. It has proven 
difficult to control all the variables listed earlier and as such it is difficult to attribute 
any observed cognitive deficit to be due solely to the use of cannabis. 
Table 19: 
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Author Date Psychological test 
Swartz et al 1989 BVRT 
Agarwal et al 1975 
Stefanis et al 1977 Weschler memory scale 
Wig et al 1977 
Swartz et al 1989 
Agarwal et al 1975 
Wig et al . 1977 Bender gestalt test 
Soueif 1976 
Page et al 1988 Selective reminding test of Bushka 
Page et al 1988 Continuous performance test of 
Buchsbaum and Sostek 
Dornbush 1971 
Safer et al 1971 Digit memory scan 
Soueif 1976 
Agarwal et al ' 1975 Bhatia battery of intelligence 
Rhea et al 1971 Consonant Trigram test 
Table 20: Reported temporary cognitive deficits and the psychological tests used . 
l 16 
Evidence for no cognitive damage in users of cannabis 
(1) Temporary cognitive deficits : 
Many researchers have stated that even when variables are controlled as far as is 
possible, there is insufficient evidence to suggest any temporary cognitive deficit. 
(Darley et al 1977, Varma et al 1988). 
Tests used to demonstrate no temporary cognitive deficits in cannabis users are 
summarized in Table 21 . 
Varma et al (1988) looked at memory function in 10 different areas and they 
concluded, "it appears that the differences, if any, between users and non-users in terms 
of cognitive function pertain to perceptuo-motor tasks". 
(2) Permanent cognitive deficits: 
Many researchers have failed to find any evidence of permanent cognitive deficits in 
chronic long term cannabis smokers (NIMH Jamaican study 1972, Bowman 1973, Ray 
et al 1978, Schaeffer et al 1981, Varma et al 1988, Abood et al 1992). 
Satz et al (1976) recorded that their sample group who smoked in excess of 8 cannabis 
cigarettes a day for over 10 years, there was no cognitive deficits and they concluded, 
"thus on the basis of these studies, one might conclude, with caution, that chronic 
marijuana use is not associated with permanent or irreversible impairment in higher 
brain functions or intelligence". 
The ARF/ WHO report ( 1981) noted that, "most studies which have compared 
performance of chronic users with controls in neuropsychological tests have failed to 
elicit significant differences in cognitive functioning" . 
Table 21: 
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Varma et al 1988 
Varma et al 1988 
Ray et al 1978 
Tests used to demonstrate no temporary cognitive defects in 
cannabis users. 
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Bowman's ( 1973) Jamaican study used subjects who had been "heavy daily consumers" 
for over 10 years. He could find no evidence of permanent cognitive deficit in the 
experimental group. 
Varma et al (1968) looked at the use of long term heavy cannabis use in Indian subjects 
who used a daily intake of 150 mg, THC at least 20 times a month for 5 years. They 
found no significant difference between the experimental and control group on the 
W AIS-R. Bhatia short scale and Raven's standard progressive matrices. The deficits 
which were recognized by Varma et al ( 1988) related to the individual ' s personal, 
social and vocational functioning . 
Ray et al ( 1978) examined the effects of cannabis on cognitive functioning . They used 
a series of tests (Table 21) and concluded there was no difference between the 
experimental and control group on attention, concentration, visuo-motor co-ordination 
and memory function (except in one sub-test) . Their conclusion was that there was no 
significant association between long term heavy cannabis use and cognitive dysfunction . 
Abood et al (1992) concluded that even though there is no conclusive evidence for 
chronic psycho-pathology, it is premature to conclude there is none. 
General conclusion regarding the effect of cannabis on cognitive function 
Fig 16: Summarizes the variables examined when considering the effect of cannabis on 
cognition. 
Little evidence has been advanced which demonstrated that there is long term cognitive 
damage following the exclusive use of cannabis in healthy individuals. 
The study of Schwartz et al ( 1989) was the first adequately controlled work on the 
effects of cannabis on memory function . They attempted to control the listed variables 
as far as was possible and they believed there were cognitive deficits in the. 
experimental group which remained for up to 6 weeks after the last use of cannabis. 
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Experimental design 
1/ Method was to measure cognition. 
2/ Standardization of test used. 
3/ Time lapse between last cannabis use and time of testing. Setting in 
which drug (s) 
taken 4/ Degree of individual motivation to participate 
in the tests. 
Perceived impact on cognition 
Drugs 
1/ Cannabis dose. 
2/ Period for which cannabis is used. 
3/ Concurrent use of other drugs 
Individu...al.d1aracteristics 
1/ Experimental vs. naive 
smokers. 
2/ I.Q. 
3/ Educational level. 
4/ Socio - economic 
status. 
5/ Ethnicity. 
6/ State of physical 
health. 
7 / Past psychiatric 
history. 
Fig 16: Variables examined in considering the effect of cannabis on 
cognition. 
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Wert et al ( 1986) felt that there may be some cognitive deficits following the long term 
use of cannabis but that the individual adapted and overcame the deficit through a 
process of relearning . They also noted, "whilst the vast majority of cannabis using 
subjects are not impaired, there may be a very small number of users who are 
vulnerable to cannabis producing impairment". Wert et al (1986) also raised the 
possibility of the currently used tests being too insensitive to detect cognitive damage. 
They suggested that prospective studies would test the hypothesis of differential 
vulnerability in cannabis users. 
The ARF/ WHO report (1981) stated that , " the overall conclusion from a review of the 
literature is hampered by a general inadequacy of reported data, especially in the clinical 
studies which have often been characterized by poor sample size and selection, poor or 
no differentiation between intoxication, withdrawal and residual change and an absence 
of before and after longitudinal studies of regular users" 
In conclusion, the possibility remains that cannabis may cause cognitive deficits in the 
short term at least but there is inadequate evidence at presence to suggest that the 
deficits observed are long lasting. 
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RESEARCH INTO THE POSSIBLE RELATIONSHIP BETWEEN CANNABIS 
USE AND RESULTANT AGGRESSIVENESS 
(1) Introduction 
The possible relationship between cannabis use and resultant cognitive deficit has been 
expJored. It was pointed out that many variables need to be considered and the same 
applies when the inter-relationship between cannabis use and resultant aggressiveness is 
examined. 
Abel et al ( 1977) noted that, "one of the most controversial issues in all of 
psychopharmacology is the nature of the relationship between cannabis and violence". 
He proposed 4 possible kinds of relationship: 
(1) Cannabis is a major cause of aggression. 
(2) An underlying predisposition towards violence may be precipitated by cannabis. 
(3) There is no connection between cannabis and resultant violence. 
(4) Cannabis reduces the likelihood of violence occurring in pre-disposed individuals . 
It also needs to be established whether any observed increase in aggressiveness is a 
specific effect related to THC or a nonspecific result of repeated exposure to a noxious 
stimuli . 
Abel et al (1977) noted that specific neural mechanisms lying within the limbic system 
are involved in aggressive behaviour. Campbell et al (1971) reported on the marked 
abnormality in the EEG recorded from the temporal lobe region of a group of patients 
suffering from a cannabis induced psychosis and suggested that increased activity in the 
temporal lobe may set off neural impulses in those areas of the brain that underlie 
feelings and behavior involved in aggression. 
2. The variables that need to be considered when examining the connection between 
cannabis use and resultant aggression. 
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Table 22 summarizes the variables which have been considered in the literature. 
(a) The dose 
Nahas (1973), Salzman et al (1976) and Abel (1977) have all referred to the THC dose 
as a factor in causing aggression. 
' Salzman et al (176) noted that at low THC doses, the effect induced in subjects may be 
mild disinhibition whereasJughe~ result in the potential for aggressiveness in 
certain settings. 
A similar finding was reported by Abel (1977) who also felt that at lower doses of 
THC, environmental variables are important in determining the degree of 
aggressiveness displayed whereas at higher doses, such environmental cues are of less 
importance. 
Nahas (1973) added that at very high doses of cannabis, the over all effect would be 
sedation regardless of all the other variables operating. 
(b) Biphasic response to THC 
The biphasic response to THC refers to the ability of THC to cause stimulation and\ or 
depression in a subject. This response was reported by Garriott et al (1968) . 
Salzman et al ( 1976) have similarly noted that in animal studies, the biphasic response 
to a singe dose of THC has been noted . Initially there is a phase of excitement 
followed by a period of depression . 
(c) Development of tolerance to the effects of Cannabis 
Harris ( 1971) noted that naive cannabis smokers may exhibit aggressive behaviour 
following the use of cannabis but in experienced smokers, aggressiveness is less 
common. 
Table 22: 
lLJ 
Variables that need to be considered when examining the 
relationship between cannabis use and resultant aggression. 
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( d) The setting in which cannabis is consumed 
The setting in which cannabis is consumed is generally considered to affect how the 
subject behaves. Abel (1977) and Salzman ( 1976) noted that if cannabis is smoked in a 
situation not considered to be threatening, then the subject would be unlikely to react in 
an aggressive manner. Salzman ( 1976) noted that cannabis may produce different 
effects when taken in a social group or when taken in isolation. Jones ( 1971) 
commented that cannabis, when smoked by the subject on his own, resulted in a state 
of slight drowsiness with relaxation. However, in a group setting, no sedation was 
seen, rather an euphoric mood was evident. 
Nahas (1973) noted that, "overt aggressive behaviour requires the absorption of 
enough active material and also an unfavourable setting". 
( e) The species specific response 
Animal studies have noted a variable response to cannabis in producing an aggressive 
response (Scheckel et al 1969, Gershon 1970, Grinspoon 1971 ). 
Bose et al (1964), Carlini et al (1966) and Alves et al (1973) noted an increase in 
aggressive behaviour in dogs and rats exposed to cannabis whereas Santos et al ( 1966) 
and Grunfeld et al (1969) noted a decrease in aggression when mice and the Rhesus 
monkey were exposed to cannabis. 
Luthra et al (1976) worked with rats and questioned whether aggressiveness is a 
specific effect of cannabis inhalation or a non specific result of repeated exposure to a 
noxious stimuli. They exposed rats to smoke from cannabinoid free cannabis and noted 
no development of aggressiveness which tends to support that view that there is a 
specific drug effect. 
(f) Underlying psychiatric illness in the subject 
Minkoff et al ( 1991) noted that substance abuse is the most common co-morbid 
complication among severely mentally ill persons. 
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Regier et al ( 1984, 1990) research indicated that people with schizophrenia have a 10, 1 
times greater rate of concurrent alcohol use disorder and a 7,6 times greater rate of 
other drug use disorder compared to those who do not have schizophrenia. 
Galander et al ( 1988), Ananth et al (1989) and Lehman ( 1992) found that over one 
third of patients in an outpatient setting and over one half of those in an inpatient 
facility have a concurrent substance abuse problem. Alcohol, cannabis and cocaine 
were the drugs most commonly used . 
An increase in hostility and assaultativeness in psychiatric patients who abused toxins 
was noted by Alterman et al (1982), Bartels et al (1991), Convit et al (1988), Yesavage 
et al (1983), Knudsen et al (1984) . 
Knudsen et al (1984) examined schizophrenic patients who abused cannabis. They 
found the cannabis aggravated the patients functional illness and resulted in confusion, 
impaired memory, and impulsive behaviour. · In one case, the patient became violently 
aggressive after using cannabis and presented with persecutory delusions. 
Sanguineti (1993) noted that in those patients with an affective disorder and cannabis 
use, higher scores were obtained on hostility and depression sub scales compared to a 
control group of patients . 
It appears therefore that in those individuals with an underlying psychiatric illness and 
cannabis use, there is a greater possibility of aggressive behaviour being exhibited after 
cannabis use compared to a control group when there is no such underlying psychiatric 
illness. 
(g) Concurrent use of alcohol and cannabis 
Johnsson et al ( 1990) noted that when alcohol is consumed with cannabis, the two 
drugs act together in increasing the chance of possible aggression . 
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3. Demographic and personal characteristics which have been considered in the 
aetiology of aggressive behaviour. 
The following were considered: 
(a) Age, race, sex and socio-economic status of the cannabis user. 
On the whole, there were no connections between these variables and the emergence of 
aggression, except Davis ( 1991) felt that assaultative patients were more likely to come 
from a low socio-economic status. 
(b) Adaptive ego defenses . 
Saltzman et al (1976) felt that in those individuals who were experienced users of 
cannabis and had a well developed healthy obsessional character style, then the 
development of aggression following the use of cannabis is unlikely since adaptive ego 
defenses are mobilized in the face of some aggression inducing threat. 
Naditch (1974) felt that in vulnerable individuals, the use of cannabis could overwhelm 
the ego defenses leading to a variety of emotional responses which included aggression . 
( c) Personality type and the development of aggression following the use of cannabis. 
It is generally accepted that those individuals who have a pre-morbid anti-social 
personality structure will have a greater probability of expressing aggression following 
the use of cannabis (Oshaughnessy 1838, Marcovitz et al 1944, Salzman et al 1976, 
Abel 1977, Carrey et al 1984). 
Mehndiratta et al ( 1975) whilst accepting the above, did add a note of caution that in 
the absence of well controlled prospective studies, it is very difficult to be sure whether 
cannabis per sec produces social disturbances or previously disturbed personalities opt 
more often for cannabis . 
Saltzman et al (1976) noted that in those individuals with an anti-social personality 
structure and in the presence of a strong stumulus in a non supportive environment, 
then there may well be aggressive behaviour following the use of cannabis. 
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4. Anecdotal evidence linking cannabis use with aggression. 
Kaplan (1969), Goode ( 1970) and Grinspoon ( 1971) reported on anecdotal evidence 
which linked cannabis with aggression. 
Stringaris (1972) collected anecdotal material from the near East and noted that 
cannabis use is "often accompanied by restlessness and vagabondage". 
Similar reports are available from North Afica (Bouquet 1951) and West Africa 
(Lambo 1965). These reports suggest that chronjc users of cannabis tend to be more 
hostile in their attitudes compared to light users of cannabis. 
Such reports are of limited value as there has been no standardization in method and 
no attempt to control the multiple variables. 
5. Arumal studies showing the variable effects of cannabis on aggression levels. 
Table 23 summarizes some research into the effect of cannabis on aggression in a 
variety of arumals. 
Salzman et al (1976) and Abel (1977) felt that the variable response was due to the 
biphasic activity of THC, a dose response , the development of tolerance with repeated 
dosing and a spes:ies specific response. 
The ARF\ WHO report (1981) noted that observed behavioural changes only emerged 
months after continual cannabis administration. 
Luthra et al ( 1976) noted that rats exhibited an increase in aggressive behaviour when 
exposed to cannabis, but when exposed to smoke from cannabinoid free cannabis, there 
was no development of aggressiveness which tends to support the view that there is a 
specific drug effect. 
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Table 23: 
Santos et al 1966, Grunfeld et al 1969 
, Grunfeld et al 1969 
- · .. 
Bose et al 1964, ARF/ WHO report 1981, 
Carlini et al 1966, Alves et.al 1973, Luthra · 
_et al 1976, ARF/ WHO report 1981, 
ARF/ WHO report 1981 
Animal studies which demonstrate the variable effect of cannabis 
on aggression levels. 
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Abel ( 1977) commented on the additive effect a stress ( eg food deprivation, cold, pain, 
sleep deprivation) had when combined with exposure to cannabis. This resulted in an 
increase in aggression in animals compared to animals that were not stressed in a 
similar manner. 
In summary, it appears that certain experimental animals do exhibit an increase in 
aggression when exposed to cannabis . 
This effect is due to cannabinoid content of the cannabis . The observed increase in 
aggression is exaggerated if the cannabis is combined with some stressor. 
6. Research which supports a connection between cannabis use and aggression . 
Tunving ( 1985) quoted the 1893 report from British Guyana where a doctor described 
the state of cannabis intoxication, "he moves incessantly, waving his arms, throwing 
himself from one side to the other, running up and down, crying and singing. It may be 
associated with violent behaviour. Sometimes he refuses to eat, sometimes he gets an 
intense hunger. The states may change rapidly and very soon he will recover and seem 
quite normal again". 
Salzman et al (1976) in reviewing many of the early reports have disputed the 
correlation between cannabis use and subsequent aggressive behaviour because the 
reports were anecdotal in nature. The same criticism applies to the work of Palsson et 
al (1982) . They looked at 11 subjects who abused cannabis and reported that 7 of the 
11 presented with aggressive behaviour. 
Tart ( 1970) attempted to quantify his work by administering a lengthy questionnaire to 
experienced cannabis users. He asked them to rate how they felt and behaved when 
intoxicated . 77% said they had never displayed aggressive behaviour, 22 % said they 
had on rare occasions and 1 % admitted to aggressive behaviour whilst intoxicated. 
Table 24 summarizes the many papers which support the hypothesis that cannabis use 
results in subsequent aggression. 
Table 24: 
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1944 
1965 
1970 
1970 
1971 
1972 
1973 
1973 
1974 
1975 
1976 
1976 
1976 
1976 
1977 
1978 
1982 
1984 
1986 
1986 
1990 
1991 
1993 
Examination of the relationship between cannabis use and 
resultant aggression : research which supports that such a 
relationship exists. 
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Some researchers have drawn the distinction between aggressive feelings which may be 
of an intermittent or continuous nature following cannabis use and overt aggression 
behaviour. Halikas et al ( 1971) reported that 43% of their sample of cannabis users 
admitted to "occasional aggressive feelings", but did not exhibit overt aggressive 
behaviour. 
53% of the sample reported that only once or alternatively they had never experienced 
aggressive feelings following the use of cannabis. Fisher and Stecker (1974) looked at 
530 cannabis users. Only 22 reported feeling more anger whilst under the influence of 
cannabis. 
Ghodse ( 1986) found that up to I 0% of cannabis users may be at risk of developing an 
acute cannabis psychosis which results in aggressive outbursts and the need for 
enforced admission to hospital. 
Rashid et al (1991) looked at 15 subjects and IO controls . The subjects used only 
cannabis. A brief psychiatric rating scale was used and they reported that 80% of the 
sample presented with excitement and hostility. However, the quantity of cannabis 
consumed was not reported . 
Rolfe et al (1993) and Jones et al (1976) reported that, "occasionally, very frequent 
cannabis users have a sudden onset of irritability, restlessness, and insomnia following 
the use of cannabis". 
In summary, although there have been many reports on the link between cannabis use 
and subsequent aggression, the work is largely anecdotal or the work consists of poorly 
controlled trials characterized by loosely defined terms and the lack of a standard 
measurement of aggression . 
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Mehndiratta et al (1975) felt that "in the absence of a well controlled prospective study, 
it is very difficult to be sure whether cannabis per sec produces overt aggression or 
whether previously disturbed personalities opt more often for this drug" . 
With reference to those researchers who did find a correlation between cannabis use 
and resultant aggression, not all individuals presented with aggression following 
cannabis use. 
Ghodse (1986) reported 10% and Rashid et al (1991) reported 80% of their sample 
presented with post use cannabis aggression. Likewise, Palsson et al ( 1982) reported 
that 63% of their sample presented with aggression. The small sample size and the 
tools used to measure aggression may have exaggerated the findings but it appears that 
in certain vulnerable individuals, in the presence of certain settings, aggression is a 
possible outcome to cannabis consumption. 
7. Research which does not support a connection between cannabis use and subsequent 
aggression. 
Table 25 summarizes the research work which indicates there is no correlation between 
cannabis use and subsequent aggression. 
There is difficulty in evaluating the literature because of the lack of standardization and 
the use of different scales to measure aggression. 
Little attempt was made to examine compounding variables such as the concurrent use 
of other drugs, education and socio-economic status. The evidence presented is 
therefore largely of an anecdotal nature. 
Hollister et al ( 1968) used the Clyde mood scale and found that there was a decrease in 
aggressiveness following the use of cannabis but the observed result may be a dose 
related phenomenon. 
Table 25: 
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1968 
1972 
· 1972 
1974 
1976 
1990 
1992 
., 
Examination of the relationship between cannabis use and 
resultant aggression : research which does not support such a 
relationship. 
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Tinklenberg (1974) felt, "there is no convincing evidence that the pharmacological 
properties of cannabis incite or enhance human aggression". He felt that many other 
variables could explain the observed aggression noted in some individuals who smoked 
cannabis . 
The Salzman et al (1976) study found a decrease in hostile feelings in a group of 60 
male volunteers is invalidated since 30 out of the 60 volunteers only smoked cannabis 
once a week and the research was done in a clinical setting. 
Conclusion 
It appears that there may be a group of vulnerable individuals who, when exposed to a 
sufficient amount of cannabis in a hostile, threatening environment, can react in an 
aggressive manner following the use of cannabis . The situation is aggravated by the 
concurrent use of other drugs such as alcohol and the user's perceived expectation of 
the effect of cannabis. 
The problem is whether cannabis per sec has a specific aggression inducing property or 
whether it acts as a general disinhibitor of impulse control. The work of Abel ( 1977) 
does suggest that cannabis does indeed have a specific aggression inducing effect . This 
is also supported by the hypothesis that cannabis acts on the limbic system which is 
involved in the expression of aggression. 
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THE USE OF CANNABIS IN THE PSYCHIATRIC POPULATION 
The importance of identifying substance abuse in the psychiatric setting critically affects 
the diagnosis (Elangovan et al 1991 ), treatment (Bowers et al 1990) and planning 
phases of the mentally ill. Failure to detect substance abuse results in misdiagnosis, 
over treatment of psychiatric syndromes (Ananth et al 1989) and neglect of 
appropriated interventions such as detoxification and substance abuse education (Drake 
et al 1993). Other problems identified in the psychiatric population who abuse drugs 
are: 
(a) Premature discharges against medical advise (Muller et al 1989) 
(b) A more severe course of illness (Alterman et al 1982) 
(c) Hostility and assaultativeness (Alterman et al 1982, Bartels et al 1991, Convit et al 
1988). 
Mathers et al ( 1991) looked at all acute admissions presenting with psychotic 
symptoms to two hospitals in England for a period of 1 year. Urine was tested for the 
presence of THC and the research group found 34,5% of patients had urine positive for 
cannabis. However only 9% admitted to the use of cannabis during the week preceding 
admission. The researches also pointed out that cannabis users were significantly 
younger than non users (28,4 years old and 39,7 years old respectively) and that users 
were predominantly male . A similar finding was reported by Cuffe! et al (1993). 
Mathers et al ( 1991) concluded that there was "a highly significant association between 
urine results positive for cannabis and initial diagnosis of psychosis" and suggested that 
urine testing for THC is a good practice in young psychiatric patients. Safer ( 1987) 
came to the same conclusion. 
Zuckerman et al (1989) also reported urine analysis had revealed a higher incidence of 
cannabis use than is disclosed by self report . 
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Wilkens et al ( 1991) examined 56 male psychiatric patients who were admitted to 
hospital. They were asked about abuse of drugs and signs of intoxication on admission 
were recorded. No structured interview was used . Table 26 records the results. 
Fifteen of the patients with a positive THC urine result denied substance abuse in the 
week prior to admission. 
In 23 out of the 3 5 patients who had urine positive for THC, the doctors did not 
identify that the patient was using cannabis . It was felt that drug tolerance in the 
chronic user tends to confound the assessment since tolerance can mask the outward 
signs of acute intoxication . 
Barber et al (1987) pointed out that such factors as depression, IQ, fatigue and the 
need for approval all influence self report of substance abuse. 
Solomons et al (1990) working with 110 black man admitted to a South African 
psychiatric hospital noted that 31 % of the sample had a diagnosis of cannabis induced 
psychosis but few admitted to using cannabis prior to hospital admission . They 
concluded that, "urinary THC results were more valuable in diagnosing a cannabis 
induced psychosis than a history of previous cannabis use" 
Similarly, Ben-Arie (1984) found that two-thirds of young psychotic coloured men 
admitted to hospital had urine positive for THC and in one third of cases, this level was 
considered high . 
Rottanberg et al ( 1982) found that 59,8% of male black psychotic admissions had urine 
positive for THC. 
In contrast, Martin et al ( 1998) found that self report is a valid measure of recent use of 
cannabis. Also, Elangovan et al ( 1991) looked at a random sample of 200 patients 
presenting to a psychiatric emergency service in USA. 
Table 26: 
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The results of Wilkins et al (1991) survey of 56 male psychiatric 
patients admitted to hospital. 
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They used a structured clinical interview and also obtained urine samples from the 
pa~ients. Of the sample, 24% tested positive for THC. They found the structured 
clinical interview correctly identified those individuals using cannabis and the 
toxicology screening, although helpful, did not increase diagnostic sensitivity. 
Gersten ( 1980) and Elangovan et al ( 1991) have also pointed out that cannabis can 
pose a risk for individuals who are predisposed to develop a psychiatric illness . 
Negrete (1986), Andreasson et al (1987) and Mathers et al (1991) have all noted that a 
cannabis induced psychosis may precede a functional psychosis by years, ie the 
presentation of a cannabis induced psychosis is a marker for the subsequent 
development of a functional psychosis. 
Rover (1990) found that those individuals who smoke cannabis were 5 times more 
likely to be schizophrenic, 4 times more likely to have an affective illness and 8 times 
more likely to have an anti-social personality disorder. Similarly, Mueser et al ( 1990) 
found the rate of co-morbid diagnosis of schizophrenia and substance abuse ranged 
from 15,4 to 64,7%. 
Cuff el et al ( 1993) noted that substance abuse is the most prevalent co-morbid 
psychiatric condition associated with schizophrenia. Furthermore, those schizophrenics 
who abused toxins were more likely to present with increased hostility, increased 
non-compliance with medication and increased management problems in the 
community. 
Breakey et al (1974), Tsuang et al (1982) and Kovasnay et al (1993) noted that in those 
schizophrenics who abuse toxins, there is an earlier onset of t·he functional illness. 
Andreassen et al (1989) have reported that schizophrenics who abuse cannabis have a 
more abrupt onset of illness compared to those schizophrenics who do not use 
cannabis. 
Rohr et al ( 1989) noted that cannabis can exacerbate a pre-existing affective disorder 
previously controlled on neuroleptic medication. 
It is known that cannabis is an anti-parkinsonian agent (Thornicroft 1990) and people 
on neuroleptic medication may use cannabis in an attempt to diminish the extra 
pyramidal side effects of neuroleptic medication . 
.. 
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THE SAMPLE GROUP 
A total of 27 consecutive acute black male admissions to Fort England mental hospital, 
Grahamstown, E Cape were used in the present study. 
Tables 27, 28, 29, and 30 record personal details of the sample group. 
Table 27 records the age distribution of the sample group. There is a bimodel 
distribution with peaks being at ages 21 - 25 years and 31 -3 5 years. Only 5 patients in 
the sample were over the age of 35 years . The distribution of the different age groups 
is recorded in Table 27. The age group 21 - 25 years is equally distributed between the 
three groups of those who abuse cannabis or alcohol or neither toxin. The older age 
group 31 -35 years is not as evenly distributed between the groups and 3 subjects in 
this age group had neurosyphilis. 
Fig. 17 records the age distribution in Du Toit's (1980) sample. Most men in his 
sample were in the age range 20 - 30 years. Table 7 records the age distribution in 
previous research projects . 
Rottanberg et al (1982) recorded the mean age in their sample group as 23 years with a 
range of 17 to 52 years . 
Solomons et al (1990) looked at 110 consecutive black men admitted to hospital with 
acute psychotic symptoms and their average age was 28, 2 years with a range of 18 
years to 49 years . 
Varma et al (1988) recorded the mean age in his sample as 24,5 years with a range of 
15 years to 35 years. Similarly Rolfe et al (1993) recorded an average age of 29,5 
years in their sample group. 
21 - 25 
26 - 30 
31 - 35 
36 - 40 
41 - 45 
46 - 50 
TOTAL 
GROUP 
THC+\LIT+ 
THC+\LIT-
THC-\LIT+ 
THC-\LIT-
VDRL+ 
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9 
3 
9 
5 
1 
27 
AGE GROUP 
21-25 
3 
4 
3 
35,7 
10,7 
32,1 
17,8 
3,6 
AGE GROUP 
31-35 
3 
2 
1 
3 
Table 27: The age range of black male patients in the Fort England hospital sample. 
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16 
3 
8 
4 
1 
2 
20 
1 
23 
3 
59,2 
11,1 
29,6 
14,3 
3,6 
7,1 
75 
3,6 
82.1 
14,3 
SINGLE MARRIED UNKNOWN 
4 0 
7 1 
2 0 
1 1 
2 1 
: ; : . . ,. ::;·· - . . % OF KNOWN 'MEN SINGLE · - _.:- .. _.. ·. ~ '. :~} 
~ . - . - ... ·---•.I_ .... ~ 
Within the total sample 
14,8 
25,9 
7,4 
3, 7 
3, 7 
1 
1 
5 
0 
1 
Table 28: The marital status, number of children and employment status of 
the black male patients in the Fort England hospital sample. 
Table 29: 
143 
9 
2 
2 
2 
4 
2 
1 
1 
4 
1 
:._.-_i...-.•. : 
1 
7 _··s: 
,.:~ 
2 
2 . 
1 . •. :- i 
32,1 
7,1 
7,1 
7,1 
14,3 
7,1 
3,6 
3,6 
14,3 
3,6 
9 .:J..o_:UNKNOWN 
,,~ .. "' ' 
1 
• .... - ; ' 
- ;-,;·-~, -· ~ 
:.·.,.;;~-~ 
- ' 
0 
2 
3 
0 
3 
Standard of education attained by the sample group at Fort 
England Hospital. 
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18 66,7 
6 22,2 
1 3,7 
1 3,7 
1 3,7 
27 
Number of previous admissions to a Mental Hospital 111 the present 
Fort England hospital sample. 
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Fig. 17 
Black males using cannabis (Du Toit study 1980) N= 457 rural blacks 
440 
420 
410 
400 
380 
360 
340 
--1---1----' 
320 
300 
280 
260 
240 
220 
200 
180 
160 
140 
120 
100 
80 
60 
40 
20 
- 1111111111 
10 
f---+-- f---+---J-- l----+- -
- - - 1---l-- 1·- -- -
---I-~- -+--~ -+-+--~-! 
l --t--1- ·-
AGE 
146 
Table 28 records the marital status, number of children and employment status of the 
Fort England hospital sample. 
It is seen that the majority of men (59,2%) were single . Only 11,1% were known to be 
married whereas the marital status of over one quarter (29,6%) of the sample could not 
be established. 
Within the sub-divisions, 80% of cannabis smokers were sing!~, and an almost equal 
percentage (77,8%) used alcohol alone. Only 28,6% of the control group were known 
to be single and 50% of the group who abused both cannabis an alcohol were single. 
Soueif (1975), Varma et al (1988), and Solomons et al (1990) similarly found that 
cannabis users tended to be unmarried men. In Du Tait's study (1980), 61,1% ofthe 
cannabis using sample were single. 
Three quarters of the men in the sample did not know how many children they had . 
This was because most men in the sample were single and did not have stable 
relationships . Only a few men knew the number of children they had fathered. 
In most cases the men claimed paternity for a single child . In Solomons et al (1990) 
study, 83% of the men had no children. 
The majority (82, 1 %) of the present sample were unemployed. Only one man was 
known to be employed and in 3 cases the ·employment status was not known. In the 
cannabis smoking sub-group 4 men were unemployed and the status of the fifth man 
was unknown. Likewise, Solomons et al ( 1990) recorded that the majority of the men 
in their sample were unemployed . Rolfe et al ( 1993) recorded that less than 5% of their 
cannabis using sample were employed and Hammer et al ( 1985) refer to "high 
unemployment" in their cannabis group . 
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The highest standard of schooling attained is recorded in Table 29. In nearly one third 
of the cases, the standard of education achieved was not known. Most men in the 
sample did not reach a secondary school level of education and no-one in the sample 
had a tertiary education. 
Du Toit ( 1980) recorded that one third of his sample of cannabis users had no formal 
education and only 25% attained standard 6 and 0,8% reached Standard I 0. 
Similarly Solomons et al (1991) noted that the men in his sample were "poorly 
educated" and Louw (1973) reported only 12% of his sample had a secondary level of 
education. 
Rolfe et al (1993), Soueif (1975) and Mehndiratta et al (1975) have all recorded the 
poor level of education attained by cannabis smokers. 
The importance of considering the educational level of the sample groups is because 
Ray et al ( 1978) and Wert et al (1986) noted that the degree of literacy effects test 
scores as much as cannabis use. Therefore any differences in the test scores could be 
on the basis of degree of formal education rather than cannabis use. 
Examination of Table 29 does not reveal any particular educational trend in the 
different experimental groups. 
Tables 30 and 31 record the number of previous admissions to a mental institution. In 
over two-thirds of cases, it was not known how many previous admissions the subject 
had had. 
Over one-fifth (22,2%) of cases had had one previous admission . Only a small 
proportion had had more than two previous admissions to a mental hospital. 
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In those subjects who had had a previous admission, the previous diagnosis was always 
Schizophrenia except in one case of a patient who had previously undiagnosed 
neurosyphilis and had a diagnosis of epilepsy. In those cases where it was recorded, 
the prescribed treatment was Modecate (Table 31 ). The diagnosis of Schizophrenia 
could not be confirmed in any of the subjects examined. Sullivan (1993) likewise noted 
that repeat users of Psychiatric Services were most likely to be young single, black, 
unemployed men with a diagnosis of Schizophrenia, personality disorder or substance 
abuse. 
Table 32 records the length of stay in Fort England hospital. The average length of 
stay was two weeks with a rapid resolution of the presenting symptoms. 
The ritual of cannabis smoking. 
In most cases in the present sample, cannabis was mixed with tobacco and then smoked 
in the form of a cigarette(= zol). Alternative methods were used (see Fig. 9 and 12). 
An equal number smoked alone or in a group setting. In contrast, Du Toit (1980) 
reported the majority of black men in his sample (82, 1 % ) smoked cannabis in a group 
setting . . 
Reasons for smoking cannabis. 
Table 33 records the reasons why men in the present sample smoked cannabis. Du Toit 
( 1980, Table 9) likewise recorded that rural black men smoked cannabis to cope with 
their worries an increase their concentration. 
149 
.. • • : ..... ~ t- ........ " ..... , - -- ' • .i:..:--·~-~~-- ~ - .....,__,.._-,-,:' 
. . GROUP - ·- .' _. .. " ... DIAGNos,s: . _:~-·- -:{:. ... "' :·. t.REAtMENT ~::.::.,,.;___, 
Table 31: 
Schizophrenia Modecate 50 mg IMI 
monthly 
Schizophrenia Modecate 50 mg IMI 
monthly 
Schizophrenia 
Modecate 50 mg IMI 
monthly 
Schizophrenia Chlorpromazine 200 mg 
POTDS 
Schizophrenia 
Thioridazine 
Schizophrenia 
Modecate monthly 
S_chizophrenia 
.,. --
· Schizophrenia 
... 
•, ~~: ' Schizophrenia 
-, . --- ·"'-" 
Schizophrenia Modecate 25 mg IMI monthly 
Schizophrenia 
Schizophrenia 
Epilepsy Phenytoin 300 day 
Previous diagnosis an treatment of the Fort England Hospital 
sample. 
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' · AVERAGE LENGTH OF STAY . RANGE·IN LENGTH OF 'STAY · · '. 
_.,_ GROUP . IN HOSPITAL(DAYS) (IN.DAYS} . . , .. ·-· ___ :· ·~-· -,~~--~~::.·· 
Table 32: 
"I. • '• 
. 13 , 
, 13 
17 
14 
7 - 23 
10 -16 
7 - 32 
Recorded length of stay in hospital for the Fort England Hospital 
sample. 
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___ . .. . GROUP ., .: _ ·. . .. · ;,_ .. REASON ... _ ,: .. __ · __ :~~-
Table 33: 
To decrease worries 
To increase intelligence 
Smokes because of unemployment 
To increase intelligence 
To prevent being assaulted 
Reasons given by the present sample for smoking cannabis. 
DL 
METHODS USED 
1. LIVER FUNCTION TESTS: 
AST and ALT are present in high concentrations in the liver. ALT is formed in few 
organs and is therefore more specific for liver disease. In general, both ALT and AST 
are elevated with hepatic cirrhosis or metastases, ALT usually being more elevated than 
AST. 
An increase in AST is seen in 40% of those who abuse alcohol and an elevated ALT is 
seen in 20% of those who abuse alcohol. A ratio AST I ALT of greater than 2 is 
indicative of alcohol abuse (Mead 1993). 
GGT is usually elevated due to hepato-biliary and pancreatic disorders. Elevation of 
GGT is seen in over 90% of liver disease and therefore an elevated GGT is not specific 
for alcohol abuse but an elevated GGT is seen in over 80% of individuals who abuse 
alcohol (Mead 1993). Normal social drinking does not cause an elevation of GGT. 
However, after several weeks of persistent drinking, there is an increase in GGT levels 
and in binge drinkers there can be an excessive elevation of GGT within 18 hours of the 
binge episode (Mead 1993). 
ALP is moderately raised in hepato cellular disease. IN the case of jaundice, the higher 
the ALP, the more likely the jaundice is due to obstructive jaundice rather than hepato 
cellular jaundice. 
In the present sample, every man had blood taken for liver enzymes on the day of 
admission . The blood was stored in a fridge prior to sending it off to the laboratorium. 
LSJ 
2. URINE THC SAMPLES 
Urine was collected from the sample group on admission and stored in a refrigerator 
until it was sent off to the laboratorium. 
Testing was done using the EMIT assay and the results interpreted as recorded in Table 
4. 
3. TEST FOR PERCEPTUO-MOTOR FUNCTIONING - THE PENCIL 
TAPPING TEST 
It has been reported that perceptuo-motor functioning is impaired in those individuals 
under the influence of cannabis (Soueif 1975, Abood et al 1992). 
One commonly used test of perceptuo-motor functioning is the pencil tapping test. The 
subject is simply required to tap a piece of paper with a pencil as many times as is 
possible in a 30 second interval. The total number of dots gives an estimation of motor 
activity and speed . 
The 30 second interval was chosen so that performance on the tapping test would not 
generate reactive inhibition (ie muscle strain, fatigue, boredom). Hull (1952) noted that 
the more repetitive and homogenous a task is, the more reactive inhibition is bound to 
generate in a specified time limit . 
The pencil tapping test has been used by Soueif 1975, Varma et al 1988, Mendhiratta et 
al 1988. 
Researchers have shown cannabis users react more slowly on the pencil tapping test 
(Williams et al 1946, Kielholz et al 1973, Soueif 1975, Kvalseth 1977, Mendhiratta et 
al 1988, Varma et al 1988, Schwartz et al 1989, Deahl 1991). 
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K valseth ( 1977) has pointed out that perceptuo-motor performance is a function of 
both the individual's experience with cannabis and the dose of cannabis used . 
Varma et al (1988) gave the following values for the pencil tapping test: 
Cannabis users: 151,5 ± 25,40 dots in 30 seconds 
Controls: 167, 76 5 ± 18,35 
t value = 2,59, results significant at 0,05 level. 
In contrast, the Canadian Commission of enquiry (1972, quoted in Soueif 1975) 
reported that cannabis has no effect on the tapping speed . However the time limit used 
by the Canadian Commission was one minute and this time interval could be expected 
to generate reactive inhibition. 
The results for the pencil tapping test appear in Table 35 . The first attempt at the 
pencil tapping test was done on admission and the second attempt was done a few days 
later to rule out any cannabis intoxication effects. 
4. MEMORY TESTS 
a) TEST FOR RETENTION OF NEW INFORMATION : DIGIT SPAN 
MEMORY 
Reference has been made to the hypothesis that cannabis exerts its effect on the 
hippocampus via the cholinergic pathway and THC, hippocampectomy and 
anti-cholinergic drugs all impair the retention of new information such as digit span 
memory (Tinklenberg et al 1970, Dornbush et al 1971, Safer et al 1971 ) . Satz et al 
1976, mentioned that digit span is traditionally used to assess immediate recall in 
clinical practice. Similarly, Soueif (1975) used forwards and backwards in his research 
work on the effects of cannabis on cognition. 
Corsi ' s block tapping test was described by Milner ( 1971 ), Dr Renzi ( 1977) and Lezak 
( 1981) and Fig. 18 illustrates the Corsi board used in the present study. It is a non 
verbal spatially cued task. 
Table 35: 
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128 161 
160 146 3 
118 150 2 
.. 132,2 148,6 3 
118-150 145 -151 2-4 
144 
158 
152 
142 
129 136 3 
175 177 4 
166 176 4 
161 171 2 
172 136 3 
164,3 159,2 3,2 
129 -175 136 -176 2-4 
126 
142 175 4 
144 156 4 
105 122 6 
131 144 2 
185 140 2 
129 131 4 
137,4 144,7 3,7 
106 -186 122 -176 2-6 
The Pencil tapping test. The numbers recorded represents the 
number if dots made by the subject in a 30 second interval. 
Table 35: 
156 
175 162 2 
170 
175 · · 166 2 
162 -170 
160 144 3 
148 
123 
160 138,3 3 
123 -148 
Ihe_p~nciltapping test. The numbers recorded represent the 
number of dots made by the subject in a 30 second interval. 
\ U57 
/ 
\-. 
,. 
] 
\ 
.:_ i 
Ei.glS_: The Corsi black as described by Milner (1971) and De Renzi (1977) 
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This is of importance in the present study because in 32, 1 % of the sample, the level of 
formal education was unknown, 42, 7% of the sample only achieved a junior school 
education (up to Standard 5) and 25% achieved up to a Standard 9 education. (Table 
29). 
The digit sequence used was from the WAIS test and appears in Table 34. Soueif 
(1975) used the WAIS and found that when the digits forwards sequence was used , 
there was no statistical difference between users and controls but the digits backwards 
sequence differentiated at a high level of significance between cannabis users and the 
control group. Soueif also reported that cannabis users were inferior to the controls on 
the digits backwards sequence irrespective of literacy. 
Mendhiratta et al (1988) also used the W AJS sequence of digits and reported that in 
their sample of cannabis users, there was impairment in recall of both digits forwards 
and backwards compared to the control group. 
De Renzi (1977) described how the Corsi block tapping test was performed . The cubes 
were numbered so that the patient could not see the digits and strings of digits in length 
2 to 9 cubes were tapped out by the examiner at 1 digit\ sec and the subject was then 
asked to tap out the same sequence immediately afterwards. Two series of digit 
sequences were always given at each length and the test discontinued when the subject 
failed on both trials of a given length. 
The results on the Corsi board appear in Table 3 6 and 3 7. 
b) IMMEDIATE AND DELAYED RECALL OF A GROUP OF COMMON, 
FAMil,IAR OB,JECTS. 
In this test, a tray containing 8 familiar objects was displayed to the subjects on 
admission (Figs 19, 20) . After it was established that each subject could correctly 
identify all 8 objects, the tray was removed and the subject asked to recall all 8 objects. 
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_;. -- -..{_~-:-· ~;.:~ ., ·;;::\ .. • ·~; :.~~ ~- )1.\ 1 
• '\'. ~~i-!,: .. :~ ~::~/{ 2-4 
6-8 
6-2-9 
4-1-5 
3-2-7-9 
4-9-6-8 
1-5-2-8-6 
6-1-8-4-3 
6-3-9-4-1-8 
7-2-4-8-5-6 
8-1-2-9-3-6-5 
4-7-3-9-1-2-8 
9-4-3-7-6-2-5-8 
7-2-8-1-9-6-5-3 
Table 34: The digit span forward and backwards used with the Corsi board 
(from the WAIS test). 
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·. - ______________ , _____ ·_:_ __ : __ ,yt~JW_Q~!TE]'tte.t~JI~.:: 
-GROUP~---~ -----:--- --_1:iRSTAt:rEMPT - SECOND.AT.TEMPT;, "·~-~·· uAYS) .... ,..,.;.._· ... ,.:-.,:,, ~.,. 
RANGE 
-, -
~ 
THC-\ LFT+ 
~: 
9 9 5 
4 4 4 
8 7 4 
5 7 3 
4 7 2 
6 6,8 3,6 
4-9 4-9 2-5 
7 5 5 
2 6 4 
3 4 5 
7 7 IS 
5 3 3 
7 5 4 
4 6 4 
6 6 2 
3 5 3 
4,9 5,2 3,9 
3-7 3-7 2-5 
7 7 4 
3 5 4 
6 5 4 
4 8 6 
6 4 2 
6 6 2 
8 6 2 
5,7 5,8 3,4 
3-8 4-8 2-6 
The Corsi block tapping test using the WAIS sequence of numbers. 
Digits forward to 3 consecutive errors. The first attempt was done 
on admission to hospital. 
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Table 36: 
5 5 2 
6 6 5 
5,5 5,5 3,5 
5-6 5-6 2-5 
6 6 3 
2 6 5 
0 0 4 
2,7 4 4 
0-6 0-6 3-5 
The Corsi block tapping trest using the WAIS sequence of 
numbers. Digits forwards to 3 consecutive errors. The first 
attempt was done on admission to hospital. 
Table 37: 
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7 2 5 
4 6 4 
7 9 4 
5 6 3 
8 7 2 
6,2 6,0 3,6 
4-8 2-9 2-5 
7 7 5 
0 2 4 
2 2 5 
2 2 5 
2 5 3 
4 5 4 
2 2 4 
6 6 2 
5 5 3 
3,3 4 3,9 
0-7 2-7 2 - 5 
2 3 4 
6 6 4 
6 6 4 
5 6 6 
4 5 2 
5 5 2 
2 6 2 
4,3 5,1 3,4 
2-6 3-6 2 - 6 
The Corsi block tapping test using the WAIS sequence of numbers. 
Digits backwards to 3 consecutive errors. The first attempt was 
done on admission to hospital. 
Table 37: 
J() j 
3 2 2 
6 5 6 
4,5 3,6 3,6 
3-6 2-5 2-6 
2 2 3 
5 2 3 
0 0 4 
2,3 1,3 4 
0-5 0-2 3-5 
The Corsi block tapping test using the WAIS sequence of numbers. 
Digits backwards to 3 consecutive errors. The first attempt was 
done on admission to hospital. 
I 
Fig. 19: 
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The tray of 8 familiar objects shown to the subject on admission. It 
was first established that the subject could identify all 8 objects and 
then he was required _t~ immediately recall the objects when tJ1e 
tray was removed from sight After a 5 mi1iute delay, the subject 
- . 
was again requested to recall the 8 objects for a s·econd time. · 
I 
'/ 
Fig. 20: 
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'\ I. 
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/ 
/ 
.. .J .. 
The tray of 8 familiar objects shown to the subject after a few days " 
post admission. After it was established the subject could correctly . 
. . 
identify each object, the tray was removed from sight and the 
subject was asked to recall the·s objects. After a-delay of 5 
minutes, the subject was again asked to recall the 8 objects. 
\ 
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If an object was not recalled spontaneously, the subject was given a clue. Failure to 
recall the object after a clue was given was recorded as an error in storage of 
information. 
This test was then repeated after a 5 minute interval in which the subject was distracted 
by doing a simple jig-saw. 
This test is based on the one used by Satz et al (1976) and Dornbush (1973). 
Satz et al (1976) presented line drawings of familiar objects to the subjects, whereas 
Dornbush (1973) read ·out a list of familiar objects at the rate of one item\ second. 
The results are recorded in Table 38. 
c) TESTS OF REPRODUCTIVE MEMORY. 
Several tests have been used to measure reproductive memory deficits in cannabis 
users . A deficit in these tests could be due to: 
a) Decreased attention. 
b) Decreased filtering of information. 
c) Decreased encoding of information. 
d) Decreased retrieval of information (Schwartz et al 1989). 
Three commonly used tests are: 
1) The Benton visual retention test . (BVR T - Benton l 959) 
In this test, most cards had 3 geometrical designs of varying complexity which were 
shown to the subjects for varying periods of time (5 - 10 seconds) and then the subject 
was required to reproduce the design either immediately or after a delay of 15 seconds. 
Schwartz et al (1989) found that cannabis dependent individuals committed more errors 
on the BVRT and that there was no improvement after a 6 week period which suggests 
lb/ 
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Table 38: 
6 
4 
8 
5 
6 
5,8 
4-8 
7 
3 
5 
5 
6 
3 
6 
6 
7 
5,2 
3-7 
5 
5 
7 
7 
. 4 
4 
5 
5,3 
4-7 
5 
1 
8 
5 
3 
4,4 
1-8 
7 
0 
5 
5 
2 
4 
6 
3 
6 
4,1 
0-7 
3 
5 
6 
7 
2 
3 
6 
4,6 
2-7 
5 
4 
4 
3 
2 
3,6 
2-5 
5 
4 
5 
5 
3 
4 
4 
2 
3 
3,9 
2-5 
4 
4 
4 
6 
2 
2 
2 
3,4 
2-6 
8 
7 
8 
6 
8 
7,4 
6-8 
6 
7 
6 
7 
6 
7 
6 
5 
6 
6,1 
5-7 
8 
7 
5 
5 
3 
5 
4 
6,3 
3-8 
8 
6 
6 
6 
6 
·s,4 
6-8 
7 
5 
5 
6 
4 
3 
6 
4 
6 
5 
3-7 
6 
6 
5 
5 
4 
5 
3 
4,1 
3-6 
8 common object recall test. The subject was shown 8 common 
objects on admission and was then asked to recall the objects 
immediately and then 5 minutes later after being distracted by a 
jig-saw puzzle. A few days later the subject was re-tested using 8 
different common objects. 
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-- · . - -._ - ---· IMMEDIATE :_,. - ." -- · . • , RETEST . i - .··_:; . ~ ... >,.. ---~::: .. (<.~-~'.~--'\:) 
_ RECALL ON RECALLS MINS INTERVAL I IN ·. · 1MMEDlATE _ - :iU:CALL 6:MINs· '; 
GROUP - __ :. ADMISSION - . LATER · - , .. -DAYSL , ., , - .,.REl:ALL. .... ,". ; __ l.AIEIL .,:; (_,~; . 
6 6 2 5 3 
6 3 5 6 0 
6 4,6 3,6 6,6 1,6 
6 3-6 2-5 5-6 0-3 
6 4 3 7 6 
6 5 6 7 7 
0 0 4 0 0 
AVERAGE • -- 3,7 3 4 4,7 4,3 
.. . . . ._ ._ .... 
~;RANGE ',.,:;:; ..... :.;~ 0-6 0-6 3-6 0-7 0-7 
- ~ :~---:- : 
Table 38: The 8 common object recall test. 
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a lingering impact on short term auditory and visual memory processes as well as 
spatial organization problems. 
ln contrast, Satz et al (1976) found no differences between the cannabis dependent 
group and a set of controls when each were administered the B VR T. 
2. The Benton visual motor gestalt test (BVMG). 
In this test, subjects are required to copy 6 designs, one at a time. The BVMG has 
been more frequently used that the BVRT in the study of STM deficits in cannabis 
users. 
Many researchers have demonstrated an abnormal performance in the BVMG test when 
completed by cannabis dependent individuals and compared to matched controls 
(Soueif 1967, Soueif 1971, Agarwal et al 1975, Soueif 1975, Soueif 1976, Fletcher et 
al 1977, Wig et al 1977, Mendhratta et al 1978, Ray et al 1978). However the work of 
Varma et al (1988) failed to find a difference in performance on the BVMG when 
cannabis dependence subjects were compared with controls. 
3. The Graham Kendall memory for Designs (MFD). 
This test consists of 15 geometrical designs of varying complexity and are shown one at 
a time to the subject for 5 seconds. Irnn1ediately after exposure, the subject is asked to 
draw what he has seen. 
The MFD has been compared to the BVMG test and the two tests have the same 
sensitivity (Lezak 1981). Lezak has pointed out that impaired immediate memory is a 
common early symptom in what ultimately results in general intellectual deterioration. 
The MFD has the advantage of an easy scoring system. 
1/U 
It was decided to adapt the MFD test in the present study as it had an easy scoring 
system, was simple to administer and did not require great effort on the part of the 
subject. 
Figs. 21 and 22 illustrate the cards used in the present study. Two sets of cards were 
used to eliminate any residual memory from the first test. 
Each subject was shown the first set of 5 cards on admission (Fig. 21 ) . Each card was 
shown to the subject for 5 seconds. The subject was instructed to : 
a) Remember the design. 
b) Remember the colour of the design . 
Immediately afterwards the subject was given a blank piece of paper and a box of 
crayons and asked to reproduce all 5 designs in their correct colours . 
The subject was then distracted for 5 minutes by being asked to complete a simple 
jig-saw puzzle. 
The subject was then asked to re-draw the 5 designs using the correct colours . 
A different set of 5 cards was used a few days later (Fig. 22), and the test repeated . 
One point was awarded for each correct design. 
One point was awarded for each correct colour used . 
A maximum score of 5 in each category indicated that the subject was able to correctly 
reproduce the design using the correct colour. 
The results are recorded in Table 39 . 
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Fig. 21: 
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The above cards were shown on admission to the subject. Each 
card was sh.own for 5 seconds. The subject was instructed to 
remember both the design on the card and the colour of the design. 
The subject was asked to reproduce the designs immediately and 
then 5 minutes later during which time the subject was distracted 
by being asked to complete a sim'ple jig-saw puzzie. 
. ·/"" 
·,.-·· 
f. 
Fig 22: 
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The above ca.rds were shown to the subject :i few days after 
. ,. 
}, . 
~dmission . . Each card was shown to the subject for5 ~co11ds. The 
subject was instructed to remember both the design on the card 
a.nd the colour of the design. J;he ~ubject was asked to reproduce 
the designs immediately an~ then 5 minutes later during which 
. 
time the subject was distracted by, being asked to complete a ·simple 
. > \ 
jig-saw puzzle~ 
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GROUP ON ADMISSION TIME INTERVAL (IN DAYS REPEAT TEST 
IMMEDIATE 5 MINUTES IMMEDIATE 5 MINUTES __ 
RECALL LATER RECALL LATER 
DESIGN COLOUR DESIGN COLOUR DESIGN COLOUR DESIGN COLOUR 
5 5 5 3 5 3 2 3 2 
THC+\LFT- 2 2 0 0 4 5 5 4 4 
3 3 2 2 4 5 5 5 5 
3 1 3 2 3 3 1 3 1 
--·-
4 5 4 5 2 4 2 4 2 
AVERAGE 3,4 3,2 2,8 2,4 3, 6 4 3 3,8 2,8 
RANGE 2-5 1-5 0-5 0-5 2-5 ~5 1-5 ~5 1-5 
>--------- ·-
5 2 5 2 5 5 5 5 5 
THC-\LFT+ 0 0 0 0 4 3 2 3 2 
3 1 2 0 5 2 0 2 0 
4 1 3 1 5 5 4 4 4 
3 1 3 1 3 0 0 0 0 
4 4 4 4 4 4 2 4 2 
2 1 2 1 4 2 0 1 0 
5 3 5 2 2 4 0 5 0 
2 1 2 0 3 1 0 0 0 
AVERAGE 31 16 2,9 1 2 3 9 2,9 1,4 27 1,4 
RANGE 0-5 0-4 0-5 0-4 2-5 0-5 0-5 0-5 0-5 
1 1 0 0 4 2 2 1 1 
4 4 4 4 4 4 2 4 1 
THC-\ LFT- 4 3 4 1 4 5 2 4 0 
----
3 3 4 3 6 3 0 3 0 
3 2 3 1 2 1 0 1 0 
3 1 3 0 2 5 1 5 0 
3 3 2 0 2 3 1 1 0 
AVERAGE 3 24 26 1,3 3 4 3 ~ 1 27 0,3 
RANGE 1-4 1-4 0-4 0-4 2-6 1-5 0-2 1-5 0-1 
THC+\LFT-+ 5 1 4 2 2 1 1 2 0 
1 1 1 1 5 2 0 2 0 
AVERAGE 3 1 25 1 5 3 5 15 02..._ 2 0 
RANGE 1-5 1 1-4 1-2 2-5 1-2 0-1 2 0 
4 4 4 4 3 2 2 2 2 
------VDRL+ 4 4 4 2 5 0 0 0 0 
0 0 0 0 4 0 0 0 0 
TABLE 39: The adapted MFD test used inthe present sample. One point was 
awarded for each correct design reproduced and one point 
awarded if the correct colour was used. 
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ASSIGNMENT OF THE MEN TO THE VARIOUS GROUPS. 
Five groups were considered in this study: 
GROUP NUMBER IN EACH GROUP 
THC+\LFf- 5 
THC-\LFf+ 9 
THC-\LFf- 7 
THC+\LFf+ 2 
VDRL+ 4 
TOTAL j 27 
THC+ This indicates that a urine sample taken on admission had a reading greater than 
25 ng\ ml using the EMIT system. 
THC - This indicates that a urine sample taken on admission had a reading less than 25 
ng\ ml using the EMIT system. 
LET± This indicates that blood was taken on admission and analysis indicated raised 
liver enzymes. Raised GGT is not specific for recent alcohol consumption but a AST/ 
ALT ratio of greater than 2 is a good indicator of recent alcohol use. 
LFT - This indicates that blood was taken on admission and analysis indicated normal 
levels of liver enzymes. 
YDRL+ This indicates blood taken on admission was positive for RPR. This was 
automatically followed by a more specific TPHA test . A positive TPHA was in turn 
followed by a lumbar puncture to obtain cerebra-spinal fluid (C.S.F.) for serology. 
CSF positive for TPHA indicated neurosyphilis . Such a result was followed by 
standard treatment with lM penicillin. 
The 27 subjects were not assigned to two groups "aggressive" and "non aggressive" because of the 
heterogeneity implied in this classification. 
Muller (1997) noted that the presentation of violence in subjects may well be a reflection of the 
manner in which they were handled by staff rather than a reflection of any underlying pathology in 
the subject. 
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Powel et al (1994) also noted that the restrictive hospital environment may be a precipitator of 
violence in patients. This situational model to explain violence in psychiatric patients has been 
emplored by Bowers (1973), Endler et al (1976) and Seridan et al (1990). 
All the patients in this study had come from outlying centres so that the situational variable could 
not be controlled. 
Likewise, the other variables involved in the ultimate expression of aggression could not be 
controlled. It was more practical to consider history examination, blood and urine results in the 
assignment of a subject to a particular group. 
On admission, the following sources of information were available: 
1. Admission notes which accompanied the patient. These notes sometimes mentioned 
the recent use of alcohol or cannabis by the patient. 
2 . Admission history from the patient . Each patient was asked about his current use of 
alcohol and cannabis as part of the routine history taking . 
3. Physical examination of each subject to note any signs of long term alcohol or 
cannabis use . 
These include: 
a) Cannabis use: (i) burn marks on the palms of both hands (see Fig. 1 I) as a result of 
using a bottle pipe such as illustrated in Fig . l 2(c) . (ii) an area of depigmentation 
which is often seen on the lower lip of cannabis abu sers It is thought this is due to the 
high temperature which results from the ignition of cannabis. 
b) Alcohol use On examination the following were noted : 
Palmar erythema 
hepatomegaly 
Spider naevi 
Dupetran 's contractures 
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4. Blood and urine samples from the patient on admission. 
Based on the information from 1,2,3 and 4, a patient was assigned to one specific 
group. One doctor (J.S.) was responsible for 1,2,3 and 4 above whereas another 
doctor (NF) was responsible for doing the various perceptuo-motor and cognitive tests . 
This means at the time of testing, it was unknown to which group a patient had been 
consigned. 
RESULTS 
1. THC and LFT results 
Table 40 records the THC and LFT results of the relevant groups in the present 
project . The present laboratory recorded normal values as follows : 
a) THC less than 25 ng\ ml was recorded as a negative result. 
b) AST range O - 40 . 
c) ALT range O - 53 . 
The men in the present study were assigned to one of the 5 subgroups based on: 
a) Admission history accompanying patient. 
b) History from patient 
c) Physical examinati on . 
d) Blood and urine results . 
[n the THC+\ LFT - Subgroup, the average THC concentration in the urine on 
admission was 321 ,4 ng\ ml with a range of 80 to 664,5 ng\ ml. With reference to 
Table 4, a range of 20 - 50 ng\ ml suggests the person is using cannabis, 50 - I 00 ng\ 
ml is diagnostic that the person is using cannabis and levels greater than I 50 ng\ 1111 are 
associated with a Cannabis induced psychosis. 
Only two men in the THC+\ LFT - Subgroup had a THC level less than 90 ng\ ml. The 
other three men presented with a range of 344,9 to 664 ,5. 
In the subgroup THC+\ LFT +, the range in the THC concentrations was 28, I to 80 I 
ng\ ml. 
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In the Subgroup THC-\ LFT+, the average AST concentration was 61 ,4 with a range 
of 47 - 84 l.U. The average ALT concentration was 44,2 with a range of27 - 67 l.U . 
It was very difficult to establish an accurate alcohol history from the subjects . Also, 
there was often a few days delay between the acute presentation and admission to Fort 
England hospital. This was because of the delay in transport of the patients and the 
distances between the subject's home town and the hospital. Nearly one half of the 
men in the THC -\ LFT + Subgroup were admitted on a Friday. This may reflect the 
delay in admission since most drinking was confined to the weekend with presentation 
during the weekend or to a local hospital on Monday and referral to Fort England 
hospital by Friday 
The THC+\ LFT - Subgroup was too small to draw any similar conclusions except to 
point out that 4 of the 5 subjects presented between a Monday and Wednesday, 
perhaps after a weekend of smoking cannabis. 
In terms of the present random sample of27 consecutive men who presented with 
acute symptoms to Fort England Mental Hospital , 7 had urine positive for cannabis 
(25 ,9% of sample). In previous research projects in South Africa , Rottanberg et al 
( 1982) reported 59 ,8% of their sample had urine positive for cannabis, Ben Arie ( 1984) 
reported 66% of his sample of male coloured men had positi ve urine samples and 
Solomons et al ( 1970) reported 3 I% of his sample being positive for cannabis in the 
unne. 
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-----.------,--------, 
GROUP THC 
ng/ ml 
THC+\ LFT 428 
80 
344, 9 
89, 5 
----·- 664, 5 
AVERAGE 321 , 4 
LFT 
AST ALT 
RANGE 80 - 664,5 ~ 
THC-\ LFT + 54 56 
84 52 1--------1------------1 
72 46 
---!-----+--------
AVERAGE 
RANGE 
RANGE 
THC+ 
LFT+ 
VERAGE 
RANGE 
66 39 
67 28 
49 45 
60 61 
----+--------
47 27 
54 44 
~ -
.§1A_ ____ ~ !2_ 
47 - 27 -
84 61 
--- -- ·- ·- -- - - -·--- -- --- · 
801 72 25 
28, 1 58 48 
65 36,5 
28, 1 - 801 58 - 72 25 - 48 
TABLE 40: THC and LFT results from the 5 groups in the Fort England 
hospital sample. 
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Wilkins et al (1991) reported 35,3% of their sample was THC postive and Mathers et al 
(1991) reported 34,5% of their sample had urine positive for THC. 
2. PRESENTING SYMPTOMS IN THE VARIOUS SUBGROUPS. 
a) THC+\ LEI - Subgroup 
The results appear in Table 41 as well as in Tables 31 and 32. 
In all cases, the only presenting symptom mentioned in the admission papers was 
aggression. In three cases, the subject had assaulted someone and in one case property 
had been destroyed. 
In two cases, the admission papers mentioned the subjects had smoked cannabis and 
two other subjects denied the use of cannabis but subsequent urine testing revealed 
levels of 82 and 428,5 ng/ ml respectively. 
The average length of stay in hospital for this sub-group was 12,4 days with a range of 
7 td 23 days. 
By comparison, Rashid et al ( 1991) recorded that 80% of their cannabis using sample 
presented with hostility and Poisson et al (1982) found 63,6% of their sample presented 
with aggression following cannabis use. 
The present subgroup does not fulfill the criteria of a cannabis induced psychosis as 
described in Table 15 and by Solomons et al ( 1990). 
Table 15 does mention aggression associated with cannabis use and Table 24 lists the 
research groups who have found a relationship between cannabis use and resultant 
aggressive behaviour. 
Table 41: 
llSU 
Presenting symptoms, cannabis history, length of stay in hospital 
and previous hospitalisations in the THC+\ LFT- sub-group. 
UH 
Abel (1977) has suggested that cannabis has a specific aggression inducing effect by 
acting on the limbic system. Both Mclssac et al (1971) and Drew et al (1974) have 
demonstrated the preferential concentration of THC in the hippocampal region and 
Maykut (1985) noted THC causes damage to the septum. 
Abood et al (1992) erected a 3 phase model of cannabis intoxication and the last phase 
was characterized by overt aggression. The implication of this model is that aggression 
will only be observed as a presenting symptom if the cannabis using subject has passed 
through the two preceding phases of: 
a) initial euphoria 
b) drowsiness with sedation, distortions in time, hearing and vision 
Abood et al (1992) also proposed an alternative way of examining the link between 
cannabis use and aggression. They proposed that the individual ' s culture shapes the 
observed response to cannabis. 
David (1991) felt it was rather the subject's socio-economic status rather that his 
culture which determined the observed response to cannabis. He observed that those 
individuals who came from a low socio-economic status presented with aggression 
following cannabis use . 
Abel ( 1977) proposed that it was neither the culture or the socio-economic status of 
the subject but rather environmental cues which determined the observed response to 
cannabis. If the environmental setting was non-threatening, then the subject was 
unlikely to react in a threatening manner. 
Harris ( 1971) observed that the most important determinant in deciding the response to 
cannabis use was the past experience with the drug, experienced users did not present 
with aggression. 
l~L 
Abel ( 1977) did not support this proposal. He found that chronic users of cannabis 
were more hostile and rebellious compared to naive users . 
The dose of cannabis used has also to be considered when examining the observed 
response. Field ( 1980) has noted the South African cannabis ranks among the more 
potent variants of the plant in terms of THC content and he further mentioned the 
Transkei cannabis had the highest THC content in the whole of South Africa. 
Fig. 13 summarizes the diverse variables which are thought to shape the observed 
response to cannabis use. 
There is litt le information available to comment on the socio-economic status of the 
THC+\ LFT - Subgroup except to observe that 80% of the sample were single, all were 
unemployed and only two had achieved a Secondary level of education. Three of the 
sample had a known past psychiatric history. 
No information was available on the setting in which cannabis was smoked. 
In conclusion, all of the men in the THC+\ LFT - Subgroup presented with aggression 
and settled rapidly in hospital. 
b) THC -\ LET+ Subgroup. 
The results appear in Table 42 as well as in Tables 31 and 32. In contrast to the THC+\ 
LFT - Subgroup, there were psychotic features mentioned in the THC-\ LFT+ 
Subgroup which included: 
visual, tactile, auditory hallucinations, Delusions. 
There was also evidence of restlessness, aggressiveness and excessive talking. 
Insomnia and poor personal hygiene was also mentioned . 
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Presenting symptoms, past psychiatric history and length of stay in 
hospital for the THC-\ LFT+ sub-group. 
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In eight cases it was known that there had been at least one previous admission to a 
mental hospital and the diagnosis was invariably Schizophrenia. It is interesting to note 
that in all previous admissions, the use of alcohol was not inquired into and blood had 
never been taken for liver enzyme evaluation. 
In the present study, the previous diagnosis of Schizophrenia could not be confirmed in 
any of the cases. Also, the rapid recovery period ( range 10 to 16 days) argues against a 
Schizophrenic illness. 
c) THC-\ LFT - Subgroup: 
The results appear in Table 43 as well as in Tables 31 and 32. 
The present Subgroup, similar to the THC-\ LFT+ Subgroup, presented with many 
psychotic features . 
These included: 
Withdrawn, isolated behaviour, speaking to self 
Mannerisms. 
Wandering aimlessly around, sometimes naked . 
Self neglect. 
Persecutory delusions. 
No hallucinations were mentioned . 
Four of the seven subjects had previously been diagnosed as Schizophrenic and one 
subject was known to be on IM Modecate. 
This Subgroup took the longest to settle, with a range of 7 to 32 days in hospital. 
In three subjects, a presenting complaint was violent, aggressive behaviour. Mention 
has been made of a concurrent diagnosis of substance abuse and a functional illness and 
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_,_.$_Ubjei:t_ . __ .'"' (admiS:.Si~l'.1-papei:s), _:__ -: _:; _.. _ ., _{Jrt-day1):_1UtP.A}teb.fAtl'i~JlJ$t~UY.i ~~ 
Talking nonsense, 
aggressive 
Aggressive, ~ssaulting 
children, roaming. 
Undergoing treatmentwith 
a traditional healer. 
Traditional healer identified 
_ . . . . -~ Subject needed to be seen 
· <-' .. --;;\;:~;;~~~ by Western doctors. Thin, 
- :!.:-~; 3:;:ft4; ·neglected, confused, .· 
~ ·~ 'c{:¥ . ..t ...... ~-';:'~~ ~-~ • . • • 
. : -->Jf:c: -';';::':f;: susp1c1ous. Believes that 
· '}:.'<{·tD--:::.2I:i there is _a problem with his 
·M :1~.!}~""':j: heart, keeps on stopping 
- --~--~ . :.• ·< .~··1~ because someone has 
: poisoned him. _ ' . 
•1 .,;, ·,!,'' ,)o·Ai[, ... \·t:.:, . 
Violent, assaultive, 
withdrawn, ? Mental 
retardation. 
Wandering around naked in 
· Wandering around, speaking 
to self, withdrawn, unable to 
answer questions, self 
neglect. 
Hitting cars, excitable, 
flight of ideas, mannerisms, 
gesti_culating. 
7 
12 
32 
Known schizophrenic. 
11 previous admissions 
to a hospital. 
One previous 
admission. 
Previous admission to a 
mental hospital. 
Diagnosed as 
schizophrenia. 
Previous admissions to a 
mental hospital. 
Diagnosed as 
schizophrenic. 
Previous admission to a 
mental hospital. 
Diagnosed as 
schizophrenic. 
Table 43: Presenting symptoms, past psychiatric history and length of stay in 
hospital for the THC-\ LFT- sub-group. 
US6 
in such people with a co-morbid diagnosis, there is increased hostility and 
assaultativeness (Alterman et al 1982, Bartels et al 1991, Convit et al 1988) 
Mathers et al (1991) reported that 34,5% of their sample had a co-morbid diagnosis of 
functional illness with substance abuse. 
Similarly Wilkins et al (1991) demonstrated that 36% of their sample of Schizophrenic 
patients had concurrent substance abuse problems. 
A substance abuse history was taken but all the subjects in this Subgroup denied recent 
use of alcohol and cannabis. Mathers et al (1991) pointed out that only 9% of their 
group of subjects admitted to substance abuse prior to admission and Zuckerman et al 
( 1989) reported urine analysis had revealed a higher incidence of cannabis use than was 
disclosed by self report . 
In the present Subgroup urine and blood analysis was negative for THC and alcohol. 
It could be argued that the resultant negative findings were due to the delay between 
last drug abuse and obtaining a urine an blood sample. However physical examination 
of the subjects failed to reveal any signs associated with cannabis or alcohol abuse. 
Also this Subgroup presented with the longest time in hospital, 7 to 32 days. 
The accuracy of the diagnosis of Schizophrenia was not explored. A brief reactive 
psychosis or a major depressive illness with psychotic features are two commonly 
missed diagnoses . 
d) THC+\ LFT+ Subgroup. 
The results for this Subgroup appear in Tables 44, 3 1, and 3 3. 
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Subject admission· papers). · (in days). . : ·Past psychiatric history. . 
Table 44: 
-~ Violent in the 'commu'nity . . 
~::.~d,n.i~ .. to'cannapis··.USE!C>rl 
'r:7a dailY,.basis. Restless~ t-
. shouting, smelt of alcohol 
,'on admission: " ... \'..:,,:'";, > 
: TH9 801,8 · AST 7,2 ALT 25 
,,., ... 
1
- •• ,.. ..'ij~'·;'.: '· I ' 
Wandering, assaulting "., 
people: Admits to cannabis . 
,, Had cannabis in his· : ", ~ ·· •. 
-_ possession. Admits to . 
. alcohol three days prior to 
admission, often drunk. -
THC,28,1 ~ST 58 ALT 48 
14 Considered to be epileptic. 
Known to mental hospital 
since 1984. · Previous 
admissions. Diagnosed as 
schizop~renic • 
Presenting symptoms, past psychiatric history and length of stay in 
hospital for he THC+\ LFT+ sub-group. 
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Only 2 subjects in the sample qualified for this Subgroup. Both admitted to extensive 
alcohol and cannabis use prior to admission and one subject smelt of alcohol when he 
was admitted to hospital. 
One subject had a long past psychiatric history and had previously been diagnosed as 
being Schizophrenic. 
Both subjects had been violent prior to admission. Johnsson et al (1990) noted that 
when subjects use both alcohol and cannabis concurrently, there is an increased chance 
of aggressive behaviour. The present sample is too small to confirm this or to draw 
comparisons with the THC+\ LFT - Subgroup. 
Du Toit (1980) reported that concurrent use of cannabis and alcohol was not common 
in South African black males. He also pointed out that most alcohol consumed was of 
the traditional home-brew variety. The current work suggests that there is a changing 
social pattern in South Africa in that the phenomenon of concurrent use of cannabis and 
alcohol is becoming more prevalent in black South African males and also the use of 
traditional home-brew beers is being replaced by the consumption of commercial 
alcoholic spirits (commonly brandy). 
VDRL+ Subgroup. 
The results for this Subgroup appears in Tables 45, 31 and 32. 
All 4 men in this Subgroup presented with violent, aggressive behaviour, both 
assaulting people and destroying property. All men gave a vague history of alcohol or 
cannabis use but physical examination and lab results did not support current use of 
toxins. 
All 4 men had a lumbar puncture following the positive blood TPHA result. In all 4 
cases, the CSF was reactive ie: the men had a diagnosis of neurosyphilis. In one case, 
the subject was presenting with seizures. 
U5':i 
' . . : .. . . . ' " . - ~ ' - . ' 
· · . · · .. · .· · .. · .' Le_ngth of 
Presenting history . . ·. . . . · stay In 
(from admission , Past~sychiatrlc hospital_ __ 
_ .Subjec.t ___ ·_ papers). __ ... _ . . . . _ .. Lab res_ults .. ____ hlstor.y. , ________ (in ~days).~ 
Table 45: 
admitted to cannabis 
• ·, over oh~ month. prior " 
. . . 
RPff1:.64 . 
CSF reactive 
AST5L ~ 
ALT .J s"'": , 
.THC neg~tive 
RPR 1:8 
TPHA positive 
· CSF reactive 
AST 22 • 
ALT10 
THC 20,6 
Aggressive, admits to · , RPR 1 :2 
alcohol in the past, 'no TPHA positive 
can·nabis. · · · ·· _ . CSF reactive 
. ·:. - \ THC 19,J 
AST29 
. ALT 9--.-
tl:.!i Aggressive,destroying · RPR 1 :64 · j property, undressing · TPHA positive 
Diagnosed as 
having epilepsy . 
and was on · 
anticonvulsants . 
Nil 
Previous admis-
ion to a mental 
hospital. 
Previously in 
jail as a member 
of "Bender 28'.'~ 
. in public. Vague past ·· CSF reactive Nil 
. alcohol history. . THC negative 
Denies cannabis. AST 22 
ALT 19 
16 
Presenting symptoms, past psychotic history, lab results and length 
of stay in hospital for the VDRL+ sub-group. 
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One subject (number 3) was a member of a prison gang (bender) known as the "28" 
gang. Such gang members participate in sexual activity with other prisoners and take 
the penetrative role in anal intercourse. The recipients are known as the "26" gang. 
AJI 4 subjects were treated with IM Penicillin whilst in hospital. 
1 ~ 1 
RESULTS 
The results were first analysed using the statistical package SPLUS which generated a 
graphical box plot. 
Following this, two further statistical tests were used . Both tests were non-parametrical 
because of the small sample size and the non normality of the data. 
The tests analysed the differences between categories and also the differences between 
the initial and repeat test scores. The 2 tests used were: 
1. Kruskal-Wallis test 
This test is used to test the equality of means, 
1.e. Ho : E(X) = E(Y) 
Hi : E(X) 1:- E(Y) 
This test was used to test whether the mean of the control group (THC-\LFT- and 
referred to as group 3 ) is equal to the mean of the toxin abusing groups (a 
combination ofTHC+\LFT-, THC-\LFT+ and THC+\LFT+ and referred to as 
group 7) . 
1':IL 
2. Wilcoxon Test 
The Wilco~on test is used to test the equality of means, 
1.e. Ho: E(X) = E(Y) 
H1 : E(X) ":f;; E(Y) 
This test will be used to test whether the mean of the initial scores is equal to 
the mean of the repeat test scores. Thus, the set of initial scores is paired with 
the set of repeat scores. This test is therefore used for related samples. 
Both tests return a p value. A p value between O and 0,05 is considered significant. 
Values ofless than 0,02 suggest significance but do not provide strong evidence to 
reject the null hypothesis. 
l~j 
The Pencil Tapping Test 
The results as recorded in table 35 were analyzed using the statistical package SPLUS 
and the generated graphical analysis appears in fig. 34. 
No clear trend emerges. The control group (3, I and 3,2) showed no superiority over 
the other groups. 
The group of individuals who had neurosyphilis was next excluded and the toxin 
using group (group 7) was compared to the control group (group 3). Fig. 35 displays 
the resultant box plot. 
The results were next analyzed using the Kruskal-Wallis rank sum test: 
x 2 = 1,5286 (df= 1) 
p value = 0,2163 
This result suggests that the toxin abusing group performs the pencil tapping test as 
well as the control group. 
Further analysis demonstrated no change in score between the first and second 
attempt at the pencil tapping test. The differences obtained in the initial and repeat 
test scores were analyzed using the Wilcoxon signed rank sum test. 
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ii I I 
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i 
' Ll.J 
1.2 2.1 2.2 3 .1 3.2 '4.1 4.2 5.1 5.2 
The results from the pencil tapping test. The data from table 35 was 
analysed using the statistical package SPLUS which generated the 
above box graph. 
First attempt Second attempt 
1, 1 1,2 
2, 1 2,2 
3, I 3,2 
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3 All Other 
Comparison of results in the pencil tapping test between the control 
group (3) and all other groups which have been collapsed into one 
group (all other) . 
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Fig. 36 represents the delay plot in the pencil tapping test. It was necessary to 
discover if the length of the lag is a factor in the change of performance. For 
instance, it may be assumed that performance increases as a linear function of time. 
Fig. 36 demonstrated no clear trend emerging, i.e. the length of delay does not appear 
to be a significant influence in the change in performance. A subject who waited 2 
days to repeat the test performs as well as a subject who waited 5 days to repeat the 
test. 
Previous workers using the pencil tapping test as a function of perceptuo-motor 
functioning demonstrated that cannabis users performed less well in this task 
compared to a control group, (Williams et al 1946, Kielholz et al 1973, Soueif 1975, 
Kvalseth 1977, Mendhiratta et al 1988, Varma et al 1988, Schwartz et al 1989, Deahl 
1991, Abood et al 1992). 
A comparison of the results obtained by Varma et al ( 1988) and the present study 
appear in table 47. The FEH control group demonstrate a wider range of scores than 
those recorded by Varma et al ( 1988) in that the present study recorded scores well 
below the minimum score recorded by Varma et al ( 1988). By contrast, the scores of 
the cannabis users in both studies is the same. 
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Delay plot of the pencil tapping test. The lag for each subject is plotted 
on the x axis and the change in score is plotted on the y axis. The plot 
is used to determine trends in performance as a function of lag. 
Group 
Cannabis users 
Controls 
Table 47: 
Pencil tapping score (30 sec. interval) 
Varma et al (1988) Fort England hospital study 
First attempt Second attempt 
151,5±25,40 133,2 (R== 118-150) 148,6 (R==145-151) 
16 7, 76± 18,35 134,4 (R== l 05-185) 144,7 (R== I22-175) 
Comparison of the pencil tapping scores for a 30 second interval from 
the work of Varma et al ( 1988) and the present work. 
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The Canadian commission of enquiry (1972, quoted in Soueif 1975) likewise reported 
cannabis use does not influence the pencil tapping score. 
Weil et al ( 1968) and Abood et al ( 1992) offered an explanation for this result. Both 
groups noted that on some tests, cannabis users demonstrated a superior performance 
co·mpared to a control group and explained this in terms of over compensation by the 
cannabis users. 
Conclusion 
The pencil tapping test is a measure of perceptuo-motor skill and the present study 
has failed to demonstrate that users of cannabis and\or alcohol perform less well 
compared to a control group. 
2UU 
Results for the Corsi board digit span memory test. 
The results are recorded in tables 36 and 37 as well as in figs . 37, 38, 39 and 40. 
Results from tables 36 and 37 were analyzed using the statistical package SPLUS and 
the generated graphical analyses are represented in figs . 37, 38, 39 and 40 . 
Fig. 37 indicated that no differences emerged between the control group (3 , l and 3,2) 
performance and the performance of the other 4 groups . The results were then 
analyzed using the Wilcoxon test to see if there was a difference between the initial 
and repeat test results. 
Z value 
p value 
0,8834 
0,3770 
This result suggests that the subjects ' performance on admission was the same as 
when retested a few days later. 
Fig. 38 compares the control group (3) to the other 4 groups collapsed into one 
group (all other) . Again there appears to be no difference between the performance 
of the control group and the experimental groups . 
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KEY: 
Groups First Attempt Second Attempt 
THC+\LFf- 1, 1 1,2 
THC-\ LFf + 2, 1 2,2 
THC-\LFf- 3, 1 3,2 
THC+\LFf+ 4, 1 4,2 
VDRL+ 5, 1 5,2 
Figure 37 
Box plot of the results for the digits forwards sequence using the Corsi board. The data was 
analyzed using the statistical package SPLUS. 
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Fig. 38: 
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I 
I j 
I 
~ 
All Other 
Box plot of the results for digit forwards sequence using the Corsi 
board . The control group (3) has been compared to the other 4 groups 
collapsed into one group (all other). 
Fig. 39: 
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3 7 
Box plot comparing the scores for digits forwards on the Corsi board 
in the control group (3) and the toxin abusing group (7) . 
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Box plot comparing the digits backwards performance of a control 
group (3) with the toxin abusing group (7). 
The results suggest the toxin abusing group performs as well as the 
control group in this task. 
LU) 
Groups 3 ( control) and 7 (toxin abuse) were then compared and the box plot appears 
in fig . 39. Again no differences emerged . When the Kruskal-Wallis test was applied 
to the data, the results were: 
xz 
p value 
0,2573 (df = I) 
0,61 l 9 
which again supports the conclusion that the toxin abuse group performs as well as 
the control group in the digits forwards test using the Corsi board. 
Fig. 40 is the box plot for the digits backwards test using the Corsi board . When the 
data was analyzed using the Kruskal-Wallis test the results were: 
xz 
p value 
= 0, 04 15 ( d f = I ) 
0,8386 
These results confirm that the toxin abusing groups perform as well as the control 
group in this test. 
Tinklenberg et al (1970), Safer et al ( 1971), Dornbusch ( 1971) and Mendhiratta et al 
( 1988) all found that in cannabis users there was impairment in digit span memory, 
both for digits forwards and backwards. 
Soueif ( 1975) found that cannabis users performed as well as the controls on the 
digits forwards sequence but performed significantly less well on the digits backwards 
sequence. 
l.Ub 
Hollister (1971) and Weil et al (1968) felt that cognitive deficits, if any, in cannabis 
users would be of a temporary nature and so predicted that non-intoxicated cannabis 
users would perform as well as a control group in any cognitive test. 
Bowman (1973) worked with Jamaican cannabis users who came from a low socio-
economic status and he felt that in this group, any cognitive deficit would be hard to 
detect. 
ln the present sample, the patients all came from a low socio-economic status with 
little formal education and were predominantly unemployed. 
Conclusion: 
The digits forwards and backwards sequence using the Corsi board has failed to 
demonstrate any differences in performance between cannabis users and the other 
groups. 
The world literature gives conflicting results. It has been postulated that in those 
individuals from a low socio-economic status and who smoke cannabis it would be 
difficult to detect any cognitive deficit when compared to a matched control. 
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Results for the immediate and delayed recall of a group of 8 familiar objects 
The data from table 38 was analyzed using the statistical package SPLUS and the 
generated graphical analyses appear in figs. 41, 42, 43 and 44 . 
It appears that the 4 experimental groups perform as well as the control group. 
Furthermore, recall after a 5 minute interval with a distraction task showed no 
impairment in recall. When the test was repeated a few days later using a different set 
of 8 objects all groups performed as well as when first tested . 
Fig. 43 is a delay plot which examines if there are changes in performance due to the 
size of the lag. Fig. 43 demonstrates that no pattern of change as a function of the 
lag. This means that there is no difference in performance when tested initially and a 
few days later. Statistical analysis of the data using the Wilcoxon test to test for a 
difference in the repeat and initial recall of 8 objects gave the values : 
Z value 
p value 
= - 1,7407 
0,0817 
i.e. subjects performed equally well initially compared to their performance a few days 
later. 
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Figure 41 
Immediate and delayed recoil of a group of 8 fami liar objects. The data was a nalyzed 
using the statistical package SPLUS. 
KEY : First Attempt Second Attempt (a few Mean number of days (and range) 
Groups (on admission) days after admission) between first and second attempt 
THC+\LFf- 1, 1 l ,2 x = 3,6 
R = 2-5 
THC-\LFf+ 2, l 2,2 x = 3,9 
R = 2-5 
THC-\LFf- 3, l 3,2 x = 3,4 
R = 2-6 
THC+\LFf+ 4,1 4,2 x = 3,5 
R= 2-5 
VDRL+ 5,1 5,2 x = 4,0 
R = 3-5 
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• I 
3 All Other 
Recall of 8 familiar objects by the control group (3) and all the other 
groups collapsed into one group (all other). 
The box graph indicates that all experimental groups performed as well 
as the control group in recalling 8 familiar objects. 
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The delay plot which examines if there are changes in performance in 
recalling 8 familiar objects due to the size of the lag. 
The lag for each of the subjects is plotted on the x axis and the change 
in score is plotted on the y axis . 
The plot looks at trends in performance as a function of lag. The 
present data demonstrates that the subjects perform as well initially as 
they do a few days later. 
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Comparison plot between the control group (3) and the toxin abusing 
group (7) . 
The results indicate that the toxin abusing group performs as well as 
the control group in recalling 8 common objects both initially and after 
a lag period . 
LlL 
Fig. 44 is a comparison plot between the control group (3) and the toxin abusing 
group (7) . When the Kruskal-Wallis test was performed on the data, the results were: 
x2 
p value 
0,3015 (df= I) 
0,5829 
i.e. the toxin abusing group could recall 8 common objects as well as a control group. 
Dornbush (1974) presented his group of subjects with 8 lists consisting of J 0 
common objects. The objects were presented by a pre-recorded auditory tape at the 
rate of 1 object/sec. At the end of each list, the subject was given l minute to recall 
the items on the preceding list. Following the 8 lists, all subjects were given a 
distraction task of 50 minutes and then asked to recall as many objects as possible 
from the 8 lists. He found that in the cannabis using group, recall of information was 
impaired . 
In contrast, Satz et al (1976) used 41 chronic cannabis users and 41 matched controls. 
A total of 17 neuropsychological tests were used, one of which was the subject was 
shown a card with 9 line drawings of common objects. After a l O minute delay, the 
subject was asked to recall the objects. 
Satz et al found no significant difference between the experimental and control groups 
in object recall. 
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Therefore, the present set of results support the work of Satz et al ( 1976), that is 
object recall is not affected by cannabis use. 
Results of the test for reproductive memory 
The present test was an adaptation of the Graham Kendall memory for design test 
(MFD). 
Other tests of reproductive memory ( e.g. B YR T) have indicated that cannabis 
dependant individuals commit more errors in these tests compared to a control group. 
Schwartz et al (1989) have suggested that the observed memory deficit may be long 
lasting in cannabis users. 
The results from table 39 were analyzed using the statistical package SPLUS and the 
generated graphical analyses appear in figs. 45, 46, 47 and 48 . 
Fig. 45 indicates that there is no overall difference in performance between the control 
group (3) and the 4 experimental groups . 
When the data was analyzed to see if there was a statistical difference between the 
initial and repeat tests using the Wilcoxon test, the following values were obtained : 
Z value 
p value 
= 0,4305 
0,6668 
i.e. subjects performed as well a few days later compared to their initial performance 
on admission. 
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Fig. 48 is a comparison plot comparing the performance of the control group (3) with 
the toxin abusing group (7) . It does not appear that the toxin abusing group performs 
less well than the control group. This is confirmed by the Kruskal-Wallis test which 
gave values: 
xi 
p value = 
0,1435 (df = 1) 
0, 7408 
In terms of comparing the various groups in their ability to reproduce geometric 
shape vs. correct colour, fig . 46 indicates that groups 2 (THC-\LFT+) and 3 (THC-\ 
LFT-) reproduce shape better than colour but this result is not seen as statistically 
significant. 
In fig . 47 all experimental groups have been collapsed into one group (all other) and 
compared to the control group (3) . Again the box graph indicated that the 
experimental group did not differ in performance compared to the control group. 
Conclusion: 
The present adaptation of the MFD test has failed to demonstrate any significant 
differences in reproductive memory between the control group and the 4 
experimental groups. 
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Figure 45 
Box graph of results from the adapted MFD test showing the results from the first attempt 
(X.1 ) a nd the second attempt (X. 2) a few days later. The data was analyzed using the 
statistica l package SPLUS. 
The graph d oes not show any signific ant changes in performance over time or between 
the d ifferent categories. 
KEY: First Attempt Second Attempt (a few Mean number of days (and range) 
Groups (on admission) days after admission) between first and second attempt 
THC+\LFT- 1, 1 1,2 x = 3,6 
R = 2-5 
THC-\LFT+ 2,1 2,2 x = 3,9 
R= 2-5 
THC-\LFT- 3, I 3,2 x = 3,4 
R = 2-5 
THC+\LFT+ 4,1 4 ,2 x = 3,5 
R = 2-5 
VDRL+ 5, 1 5,2 x = 4,5 
R = 4-5 
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Figure 46 
Results form the adaptation of the MFD test to discover if some groups are better at 
rep roducing shape or colour of the geometric designs. 
KEY: 
Groups 
TIIC+\LFr-
TIIC-\LFr+ 
TIIC-\LFr-
TIIC+\LFr+ 
VDRL+ 
The data was analysed using the statistical package SPLUS which 
generated the above box graph. The results indicate that group 2 
(THC-\LFT +) and group 3 (THC-\LFT-) reproduce shape better than 
colour but this result is no t statistically significant. 
First Attemp.t Second Attempt (a few Mean number of days (and range) 
(on admission) days after admission) between first and second attempt 
1,1 1,2 x = 3,6 
R = 2-5 
2,1 2,2 x = 3,9 
R = 2-5 
3,1 3,2 x = 3,4 
R = 2-6 
4,1 4,2 x = 3,5 
R = 2-5 
5, 1 5,2 x = -l,5 
R = 4-5 
Fig. 47: 
• 
3 All Other 
The results from the adaptation of the MFD test. The 4 experimental 
groups have been collapsed into one group (all other) and compared to 
the control group (J) . 
The box graph indicates that the experimental groups 
(all other) did not differ in performance compared to 
the control group (3). 
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Comparison plot of the adapted MFD test comparing the control 
group (3) with the toxin abusing group (7) . 
Statistical analysis demonstrated that the toxin abusing group do as 
well in this test as the control group . 
220 
DISCUSSION 
There has been considerable debate in the literature as to whether cannabis does or does 
not produce cognitive deficits in the user. Satz et al ( 1976) noted that, "despite more 
than 4 decades of marijuana research, considerable controversy still exists concerning the 
acute and/or chronic effects of this drug on human adaptive functions, particularly on 
cognition, attention and personality." 
The topic is complex because of the many variables which need to be considered which 
includes the concurrent use of other drugs such as alcohol. 
One test of perceptuo-motor skills and three memory tests were used in the present 
study conducted on 27 consecutive male admissions to the acute ward at Fort England 
Hospital, Grahamstown, E. Cape. 
The results were analyzed using the statistical package SPLUS which generated box 
graphs and in addition 2 non para-metric tests were used : 
a) The Kruskal-Wallis test 
b) The Wilcoxon test 
These 2 tests were chosen because of the small sample size and the non normality of the 
data 
LL! 
The statistical analysis failed to demonstrate any differences in performance between 
the drug using groups and the control group. There are a number of explanations for 
this besides the assumption that cannabis has no lasting effect on cognition . 
These include: 
1) Dose of cannabis and/or alcohol was too small to interfere with the cognitive 
process. 
2) Dose of cannabis and/or alcohol was sufficient to interfere with cognition but 
the time lapse between the initial intake of toxin and admission to hospital was 
so great that no short term effects were evident. Many patients in this sample 
came considerable distances from the Transkei . 
. 3) All men in this sample had limited formal education and all were 
unemployed except one. All men came from a low socio-economic status so 
detection of any cognitive deficit would be difficult. 
4) The small sample size may not have enabled any differences in performance to 
be detected . 
5) The tests used were not sensitive enough to detect cognitive changes. 
6) Subjects who abuse toxins could have learnt compensatory techniques in order 
to perform as well as those subjects who did not abuse toxins. 
7) The control group could have been non-representative and so differences in 
cognitive capacity could not be detected. 
222 
Likewise, the role of cannabis in producing an aggressive response is not clear. It 
appears that many variables need to be considered such as dose of cannabis, prior 
experience of the user with cannabis, concurrent use of other drugs and the setting in 
which the cannabis is consurned. 
In all likelihood, cannabis may cause some dis-inhibition in vulnerable individuals and 
in the correct setting thi s could manifest as aggression . 
A common presenting feature of patients to Fort England l-lospital was extreme 
aggression following use of cannabis. This appeared to be a shor1 lived emotive state 
and the aggression usually disappeared together with any psychotic features . Mention 
has been made of the distances travelled by patients to reach Fo11 England Hospital 
and often the transient states of aggression and psychosis had disappeared prior to 
admission . 
Due to the variables discussed and the fact that no satisfactory standardized measure of 
aggression is available, constructing a study designed to examine a direct relationship 
between cannabis use and resultant aggression in a South African psychiatric hospital 
setting is and will be a formidable task. 
l.2J . 
APPENDIX 1 
LL'+ 
Record dagga haul near Q'town 
i:;)UEENSTOWN;Narcotics f!ureau police have seized what 
ii; '. believed to be the biggest dagga haul in the country. 
: · ,1'he dagga, with an estimated street value of Rll ,2m, was 
found In a routine check on the Queenstown-Cathcart road 
last night. ' . · ·. · . . 
: Investigating officer Frikkie Smith and Sergeant Tank 
Hattingh made the find when they stopped a 30-ton truck at 
10pm and found the interior packed to the roof with 453 
black refuse bags of dagga, a police spokesman said. 
:-:The dagga was later established to weigh 11,2 tons with an 
estimated street value of Rll ,27m.' The spokesman said it 
was believed to be :_the biggest dagga haul ever in South 
Africa. . 
The driver has been detained for questioning and the 
{ruck impounded. · 
· • The find is the third biggest in the Cape in the last 18 
months. In a massive haul in April, 1992, a provincial traffic 
officer who stopped a furniture removal van on the Nl 
between Hanover and Colesberg discovered it contained 511 
mealie bags of dagga with a street value of between R8m 
and RlOm. 
This find was thought by police to be the biggest seizure of 
· dagga in South Africa. 
In June this year two men were arrested in Cape Town 
with a R7m shipment of the drug from Transkei. 
Weekend Post 2.10.1993 
LL) 
I PE the distribution point 
for drugs in East Cape 
By KATHY PATON 
DRUG DEALERS are using Port Elizabeth as a central 
distribution point for their products in the Eastern Cape, 
says PE Narcotics Bureau head Major Willie O'Connell. 
He said a total of 54 832 Mandrax tablets - worth · R20 
each - had been confiscated in the city since the beginning 
of this year. ' . · · 
This was a marked increase from the 43 176 tablets 
recovered last year. ·· · 
In Cape Town lasf week a man carrying 5 000 Mandrax 
tablets was arrested at D F Malan Airport shortly before he 
was to fly to PE. . . . · . 
The drugs were discovered in a package m his hand 
luggage as it was X-rayed. . · 
Major O'Connell said although less dagga had been confis-
cated in PE than last year,· more was seized by police in 
other· Eastern Cape areas. · 
In 1992, 16,2 tons of dagga - selling at Rl a gram_ - was 
found in PE, but only 8,4 tons had been recovered this year. 
However when the dagga seized in PE, East London, 
Queenstow~. Middleburg and other towns in the region was 
combined, the figure shot up to 56,8 tons. 
Sanab detectives had also seized 43 units of LSD in PE in 
the past year. LSD sold for between R.7) and R30 a microdot, 
which made this a significant haul. 
· "PE is the only' big city from the Western Cape down 
· through the Eastern Cape and inland," Major O'Connell said. 
"The drugs come through to PE and are then distributed 
to George, Oudtshoorn, Graaff-Reinet, East London and 
other centres. PE is the central point of distribution. 
"It's difficult to say if the problem has become worse 
because there is no way to tell how much went through 
previously." 
He said cocaine - which sells for between R250 and R350 
. a gram - was used mainly at private parties. 
"A gram or two makes eight blades, which is usually gone 
within minutes. 
"It is mainly used by wealthier people as the price puts it 
beyond the reach of the middle or lower class drug users." 
• Police are investigating a number of cases involving 
escort agencies which are allegedly operating illegally 
within the city. 
Major O'Connell said there wece a number of cases 
pending involving unlicensed agencies. Several people had 
been arrested. . 
"A number ·of these agencies work from private homes 
and flats and most of them are unlicensed," he said. 
"A couple are legitimate, but most are fly-by-night opera-
tions that close down after a short time: ' 
Weekend Post 20.11.1993 
'J..26 
:Mandra?<, 
daggais 
confiscated 
MEMBERS of the South Afri-
can Narcotics Bureau team have 
been busy this week. Dagg a and , i 
mandrax . turned up in Fort 
. Beaufort and two other hauls 
were made on the N2. · 
On Tuesday, Sergeant Manie 
van . Dalen led a team who 
stopped a white ldv with regis-
tration CAJ 5278 on the N2. It . 
was found to contain 133kg of'. 
dagga· (value: R 133 000) which ' 
was confiscated. 
Two men, aged 25 and 30 
were arrested. The vehicle was 
found to have been stolen in 
Addo last month. 
Three hours later, also on N2, • 
a bus travelling from Transkei to 
Cape Town was · stopped. The 
luggage was searched and 
SANAB personnel turned up 
three suitcases containing 32kg 
of dagga (street value: R32 000). 
It was confiscated but no ar-
rests were made.· 
Next day Sergeant Ronald 
Vogel and Sergeant Clirisjan 
Elbrug with Sergeant Neil 
Kilian, working on information 
received, discovered a white 
'Toyota Hilux, with XR registra: 
·tion, in a garage in Fort 
Beaufort. . 
, The vehicle, which contained 
-4 l kg of dagga (value: R4 l 000), 
·belongs to a Port Elizabeth man 
:who had taken it into a garage in 
Port Elizabeth for repairs. 
vehicle 'plus the possession of 
dagga is being investigated. An 
arrest is expected shortly. 
Also in Fort Beaufort a man, 
25, was arrested for possession 
of four mandrax tablets (value: 
R80). He was due to appear in 
court yesterday. · 
Grocott's mail 22.11.1993 
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